WO2005047523A2 - Short cycle methods for sequencing polynucleotides - Google Patents

Short cycle methods for sequencing polynucleotides Download PDF

Info

Publication number
WO2005047523A2
WO2005047523A2 PCT/US2004/037613 US2004037613W WO2005047523A2 WO 2005047523 A2 WO2005047523 A2 WO 2005047523A2 US 2004037613 W US2004037613 W US 2004037613W WO 2005047523 A2 WO2005047523 A2 WO 2005047523A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleotide
primer
template
incoφorated
nucleotides
Prior art date
Application number
PCT/US2004/037613
Other languages
French (fr)
Other versions
WO2005047523A3 (en
Inventor
Stanley N. Lapidus
Philip Richard Buzby
Timothy A. Harris
Original Assignee
Helicos Biosciences Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34595948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2005047523(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Helicos Biosciences Corporation filed Critical Helicos Biosciences Corporation
Priority to CA002545619A priority Critical patent/CA2545619A1/en
Priority to EP04810723A priority patent/EP1692312A4/en
Publication of WO2005047523A2 publication Critical patent/WO2005047523A2/en
Publication of WO2005047523A3 publication Critical patent/WO2005047523A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Definitions

  • the invention relates to methods for sequencing a polynucleotide, and more particularly, to methods for high throughput single molecule sequencing of target polynucleotides.
  • Cancer is a disease that is rooted in heterogeneous genomic instability. Most cancers develop from a series of genomic changes, some subtle and some significant, that occur in a small subpopulation of cells. Knowledge of the sequence variations that lead to cancer will lead to an understanding of the etiology of the disease, as well as ways to treat and prevent it.
  • An essential first step in understanding genomic complexity is the ability to perform high-resolution sequencing.
  • nucleic acid sequencing Various approaches to nucleic acid sequencing exist.
  • One conventional way to do bulk sequencing is by chain termination and gel separation, essentially as described by Sanger et al., Proc Natl Acad Sci U S A, 74(12): 5463-67 (1977). That method relies on the generation of a mixed population of nucleic acid fragments representing terminations at each base in a sequence. The fragments are then run on an electrophoretic gel and the sequence is revealed by the order of fragments in the gel.
  • Another conventional bulk sequencing method relies on chemical degradation of nucleic acid fragments. See, Maxam et al., Proc. Natl. Acad. Sci., 74: 560-564 (1977).
  • methods have been developed based upon sequencing by hybridization.
  • nucleotide analogues that have a modification at the 3' carbon of the sugar that reversibly blocks the hydroxyl group at that position.
  • the added nucleotide is detected by virtue of a label that has been incorporated into the 3' blocking group.
  • the blocking group is cleaved, typically, by photochemical means to expose a free hydroxyl group that is available for base addition during the next cycle.
  • those methods require excessive reagents, including numerous primers complementary to at least a portion of the target nucleic acids and differentially- labeled nucleotide analogues. They also require additional steps, such as cleaving the blocking group and differentiating between the various nucleotide analogues incorporated into the primer. As such, those methods have only limited usefulness. [0009] Need therefore exists for more effective and efficient methods and devices for single molecule nucleic acid sequencing. Summary of the Invention
  • the invention provides methods for high throughput single molecule sequencing.
  • the invention provides methods for controlling at least one parameter of a nucleotide extension reaction in order to regulate the rate at which nucleotides are added to a primer.
  • the invention provides several ways of controlling nucleic acid sequence-by-synthesis reactions in order to increase the resolution and reliability of single molecule sequencing.
  • Methods of the invention solve the problems that imaging systems have in accurately resolving a sequence at the single-molecule level.
  • methods of the invention solve the problem of determining the number of nucleotides in a homopolymer stretch.
  • Methods of the invention generally contemplate terminating sequence-by- synthesis reactions prior to completion in order to obtain increased resolution of individual nucleotides in a sequence.
  • nucleotides to a mixture comprising a template, a primer, and a polymerase under conditions sufficient for only limited primer extension. Reactions are conducted under conditions such that it is statistically unlikely that more than 1 or 2 nucleotides are added to a growing primer strand in any given incorporation cycle.
  • An incorporation cycle comprises exposure of a template/primer to nucleotides directed at the base immediately downstream of the primer (this may be all four conventional nucleotides or analogs if the base is not known) and washing unhybridized nucleotide.
  • Nucleotide addition in a sequence-by-synthesis reaction is a stochastic process.
  • nucleotide addition obeys the laws of probability.
  • Methods of the invention are concerned with controlling the rate of nucleotide addition on a per-cycle basis. That is, the invention teaches ways to control the rate of nucleotide addition within an extension cycle given the stochastic nature of the extension reaction itself. Methods of the invention are intended to control reaction rates within the variance that is inherent in a reaction that is fundamentally stochastic.
  • base addition reactions such that, on average, no more than two bases are added in any cycle takes into account the inherent statistics of the reactions.
  • One embodiment of the invention provides methods for slowing or reversibly inhibiting the activity of polymerase during a sequencing-by-synthesis reaction.
  • Other methods teach altering the time of exposure of nucleotides to the template-primer complex.
  • Still other methods teach the use of physical blockers that temporarily halt or slow polymerase activity and/or nucleotide addition.
  • any component of the reaction that permits regulation of the number of labeled nucleotides added to the primer per cycle, or the rate at which the nucleotides are incorporated and detected per cycle is useful in methods of the invention.
  • Additional components include, but are not limited to, the presence or absence of a label on a nucleotide, the type of label and manner of attaching the label; the linker identity and length used to attach the label; the type of nucleotide (including, for example, whether such nucleotide is a dATP, dCTP, dTTP, dGTP or dUTP; a natural or non-natural nucleotide, a nucleotide analogue, or a modified nucleotide); the "half-life" of the extension cycle (where one half-life is the time taken for at least one incorporation to occur in 50% of the complementary strands); the local sequence immediately 3' to the addition position; whether such base is the first, second, third, etc.
  • the base added added; the type of polymerase used; the particular batch characteristics of the polymerase; the processivity of the polymerase; the incorporation rate of the polymerase; the number of wash cycles (i.e., the number of times a nucleotide is introduced to the reaction then washed out); the number of target nucleic acids in the reaction; the temperature of the reaction and the reagents used in the reaction.
  • a nucleic acid template is exposed to a primer capable of hybridizing to the template and a polymerase capable of catalyzing nucleotide addition to the primer.
  • a labeled nucleotide is introduced for a period of time that is statistically insufficient for incorporation of more than about 2 nucleotides per cycle.
  • Nucleotide exposure may also be coordinated with polymerization inhibition such that, on average, 0, 1, or 2 labeled nucleotides are added to the primer, but that 3 labeled nucleotides are almost never added to the primer in each cycle.
  • the exposure time, during which labeled nucleotides are exposed to the template-primer complex is statistically insufficient for incorporation of more nucleotides than are resolvable by a detection system used to detect incorporation.
  • the invention also contemplates performing a plurality of base incorporation cycles. Each cycle comprises exposing a template nucleic acid to a labeled nucleotide that is not a chain-terminating nucleotide.
  • the labeled nucleotide is incorporated into a primer hybridized to the template nucleic acid if the nucleotide is capable of hybridizing to the template nucleotide immediately upstream of the primer and there is about a 99% probability that two or fewer of said nucleotides are incorporated into the same primer strand per cycle. Incorporated nucleotides are then identified.
  • Methods of the invention also make use of differential base incorporation rates in order to control overall reaction rates.
  • the rate of incorporation is lower for a second nucleotide given incorporation of a prior nucleotide immediately upstream of the second.
  • the first nucleotide comprises a label or other group that hinders processivity of the polymerase.
  • the invention may also be conducted using a plurality of primer extension cycles, wherein each cycle comprises exposing a target nucleic acid to a primer capable of hybridizing to the target, thereby forming a primed target; exposing the primed target to a labeled nucleic acid in the presence of a nucleic acid polymerase, coordinating transient inhibition of the polymerase and time of exposure to the labeled nucleotide such that it is statistically likely that at least one of said labeled nucleic acid is incorporated in the primer, but statistically unlikely that more than two of the labeled nucleotide are incorporated in the primer.
  • methods of the invention comprise conducting a cycle of template-dependent nucleic acid primer extension in the presence of a polymerase and a labeled nucleotide; inhibiting polymerase activity such that it is statistically unlikely that more than about 2 nucleotides are incorporated into the same primer strand in the cycle; washing unincorporated labeled nucleotide away from the template; detecting any incorporation of the labeled nucleotide; neutralizing label in any inco ⁇ orated labeled nucleotide; removing the inhibition; repeating the foregoing steps; and compiling a sequence based upon the sequence of nucleotides incorporated into the primer.
  • the invention provides a method comprising exposing a nucleic acid template to a primer capable of hybridizing to a portion of the template in order to form a template/primer complex reaction mixture; adding a labeled nucleotide in the presence of a polymerase to the mixture under conditions that promote incorporation of the nucleotide into the primer if the nucleotide is complementary to a nucleotide in the template that is downstream of said primer; coordinating removal of the labeled nucleotide and inhibition of the polymerase so that no more than about 2 nucleotides are incorporated into the same primer; identifying labeled nucleotide that has been incorporated into said primer; repeating the foregoing steps at least once; and determining a sequence of the template based upon the order of the nucleotides inco ⁇ orated into the primer.
  • the method comprises exposing a template nucleic acid to a primer capable of hybridizing to a portion of the template upstream of a region of the template to be sequenced; introducing a labeled nucleic acid and a polymerase to the template under conditions wherein the labeled nucleic acid will be inco ⁇ orated in the primer if the labeled nucleic acid is capable of hybridizing with a base downstream of the primer; and controlling the rate of the inco ⁇ oration by limiting the time of exposure of the labeled nucleic acid to the template or by inhibiting the polymerase at a predefined time after exposure of the template to the labeled nucleotide; detecting inco ⁇ oration of the labeled nucleotide into the primer; and identifying the nucleotide in the template as the complement of labeled nucleotide inco ⁇ orated into the primer.
  • methods of the invention comprise exposing a target polynucleotide to a primer capable of hybridizing to the polynucleotide, extending the primer in the presence of a polymerizing agent and one or more extendible nucleotides, each comprising a detectable label.
  • the polymerizing agent is exposed to a cofactor (i.e., any agent that decreases or halts polymerase activity), and the inco ⁇ oration of label is detected.
  • the steps of extending the primer and exposing the polymerizing agent to a cofactor may be performed simultaneously, or may be performed in separate steps.
  • the method further comprises inactivating the cofactor, thereby reversing its effect on the polymerizing agent. Modes of inactivation depend on the cofactor. For example, where the cofactor is attached to the nucleotide, inactivation can typically be achieved by cleaving the cofactor from the nucleotide.
  • Methods of the invention also address the problem of reduced detection due to a failure of some strands in a given cycle to inco ⁇ orate labeled nucleotide. In each inco ⁇ oration cycle, a certain number of strands fail to inco ⁇ orate a nucleotide that should be inco ⁇ orated based upon its ability to hybridize to a nucleotide present in the template.
  • the strands that fail to inco ⁇ orate a nucleotide in a cycle will not be prepared to inco ⁇ orate a nucleotide in the next cycle (unless it happens to be the same as the uninco ⁇ orated nucleotide, in which case the strand will still lag behind unless both nucleotides are inco ⁇ orated in the same cycle). Essentially, this situation results in the strands that failed to inco ⁇ orate being unavailable for subsequent polymerase-catalyzed additions to the primer. That, in turn, leads to fewer strands available for base addition in each successive cycle (assuming the non-inco ⁇ oration occurs in all or most cycles).
  • the invention overcomes this problem by exposing a template/primer complex to a labeled nucleotide that is capable of hybridizing to the template nucleotide immediately downstream of the primer. After removing unbound labeled nucleotide, the sample is exposed to unlabeled nucleotide, preferably in excess, of the same species. The unlabeled nucleotide "fills in" the positions in which hybridization of the labeled nucleotide did not occur. That functions to increase the number of strands that are available for participation in the next round. The effect is to increase resolution in subsequent rounds over background.
  • the labeled nucleotide comprises a label that impedes the ability of polymerase to add a downstream nucleotide, thus temporarily halting the synthesis reaction until unlabeled nucleotide can be added, at which point polymerase inhibition is removed and t he next inco ⁇ oration cycle is conducted
  • One feature of this embodiment is that a sequence is compiled based upon the inco ⁇ oration data, while allowing maximum strand participation in each cycle.
  • methods of the invention are useful for identifying placeholders in some strands in a population of strands being sequenced. As long as there are no more than two consecutive placeholders in any one strand, the invention has a high tolerance for placeholders with little or no effect on the ultimate sequence determination.
  • Methods of the invention are also useful for identifying a single nucleotide in a nucleic acid sequence.
  • the method comprises the steps of sequentially exposing a template- bound primer to a labeled nucleotide and an unlabeled nucleotide of the same type in the presence of a polymerase under conditions that allow template-dependent primer extension; determining whether the first nucleotide is inco ⁇ orated in the primer at a first position; repeating the sequentially exposing step using subsequent labeled and unlabeled nucleotides until a nucleotide is identified at the first position.
  • Identification of nucleotides in a sequence can be accomplished according to the invention using fluorescence resonance energy transfer (FRET).
  • FRET fluorescence resonance energy transfer
  • Single pair FRET is a good mechanism for increasing signal-to-noise in single molecule sequencing.
  • a FRET donor e.g., cyanine-3
  • the primer/template complex then is exposed to a nucleotide comprising a FRET acceptor (e.g., cyanine-5). If the nucleotide is inco ⁇ orated, the acceptor is activated and emits detectable radiation, while the donor goes dark. That is the indication that a nucleotide has been inco ⁇ orated.
  • the nucleotide is identified based upon knowledge of which nucleotide species contained the acceptor.
  • the invention also provides methods for identifying a placeholder in a nucleic acid sequence using FRET.
  • a nucleic acid primer is hybridized to a target nucleic acid at a primer binding site in the target.
  • the primer comprises a donor fluorophore.
  • the hybridized primer is exposed to a first nucleotide comprising an acceptor fluorophore that, when inco ⁇ orated into the primer, prevents further polymerization of the primer. Whether there is fluorescent emission from the donor and the acceptor is determined, and a placeholder in the nucleic acid sequence is identified as the absence of emission in both the donor and the acceptor.
  • the method comprises hybridizing a nucleic acid primer comprising a donor fluorophore to a target nucleic acid at a primer binding site in the target; exposing the hybridized primer to a first nucleotide comprising an acceptor fluorophore that, when inco ⁇ orated into the primer, prevents further polymerization of the primer; detecting the presence or absence of fluorescent emission from each of the donor and the acceptor; identifying a nucleotide that has been inco ⁇ orated into the primer via complementary base pairing with the target as the presence of fluorescent emission from the acceptor; identifying a sequence placeholder as the absence of fluorescent emission from the donor and the acceptor; and repeating the exposing, detecting, and each of the identifying steps, thereby to compile a sequence of the target nucleic acid based upon the sequence of the inco ⁇ orated nucleotides and the placeholders.
  • the invention is useful in sequencing any form of polynucleotides, such as double-stranded DNA, single-stranded DNA, single-stranded DNA hai ⁇ ins, DNA/RNA hybrids, RNAs with a recognition site for binding of the polymerizing agent, and RNA hai ⁇ ins.
  • the invention is particularly useful in high throughput sequencing of single molecule polynucleotides in which a plurality of target polynucleotides are attached to a solid support in a spatial arrangement such that each polynucleotides is individually optically resolvable. According to the invention, each detected inco ⁇ orated label represents a single polynucleotide.
  • Figure 1 shows asynchronous single molecule sequencing.
  • Figure 2 are screenshots showing data from short cycle sequencing with long homopolymer regions.
  • Figure 2a shows full cycle sequencing used to analyze 10 target polynucleotides in a simulated synthesis of their complementary strands using cycle periods of 10 half-lives and repeating the wash cycles 12 times.
  • Figure 2b shows a short cycle sequencing to analyze 10 target polynucleotides by simulating the synthesis of their complementary strands using short cycle periods of 0.8 half-life periods and repeating the wash cycles 60 times.
  • Figure 3 shows a short cycle embodiment for analyzing 200 target polynucleotides in a simulated synthesis of their complementary strands using short cycle periods of 0.8 half-life periods and repeating the wash cycles 60 times.
  • Figure 4 shows a statistical analysis of inco ⁇ oration, showing that polymerizing agent may inco ⁇ orate repeat labeled nucleotides less readily than the first labeled nucleotide.
  • Figure 5 shows a simulation showing the effect of decreasing the activity rate of the polymerizing agent and lengthening half-lives on the cycle period.
  • Figure 6 shows the number of cycles needed with cycle periods of various half-lives taking into account stalling factors of two (squares), five (triangles) and 10
  • Figure 7 is a series of screenshots showing the effects of altering reaction conditions on the inco ⁇ oration of nucleotides in a single molecule sequencing by synthesis reaction.
  • the invention provides methods for high throughput single molecule sequencing.
  • one or more parameters of a sequencing-by-synthesis reaction are preselected such that the inco ⁇ oration of, preferably, a single nucleotide on a primed target template is optically detectable.
  • the preselected parameters regulate the rate at which the nucleotides are inco ⁇ orated, and the rate at which the inco ⁇ orated nucleotides are detected.
  • the nucleotides are individually detected either as they are inco ⁇ orated or shortly thereafter, essentially in "realtime.
  • the preselected parameters permit the regulation of the number of nucleotides inco ⁇ orated during a single extension cycle.
  • the extension cycle is stopped short at a predetermined point at which, on average, only 0, 1, 2, or 3 nucleotides have been inco ⁇ orated into the primer, rather than permitting the reaction to run to near or full completion in each cycle.
  • Short cycle methods increase the resolution of individual nucleotides inco ⁇ orated into the primer, but can decrease the yield of target templates successfully inco ⁇ orating a nucleotide in a single extension cycle.
  • nucleotides may be allowed to react in the presence of a polymerizing agent until at least one becomes inco ⁇ orated into at least 99% of the complementary strands. This would produce a yield of (0.99) n x 100% for a complementary strand extended by n nucleotides.
  • an inco ⁇ oration reactions fails to occur on a particular target polynucleotide, it can be completed in a later cycle without producing erroneous information, or interfering with data from other target molecules being analyzed in parallel.
  • a cytosine inco ⁇ orates into the extension product of one copy of a target polynucleotide, but fails to incorporate into the other copy.
  • a C can be inco ⁇ orated, without adversely affection sequencing information.
  • an inco ⁇ oration that failed to occur on a particular target in one-cycle can "catch up" in later cycles, permitting the use of shorter, even if more numerous, cycles.
  • short cycle methods according the invention permit the detection of, for example, one, two or three individual nucleotides inco ⁇ orated into a primed template
  • the invention overcomes the difficulty posed by homopolymer regions of a template sequence. While detection techniques may be able to quantify signal intensity from a smaller number of inco ⁇ orated nucleotides of the same base-type, for example two or three inco ⁇ orated nucleotides, longer runs of identical bases may not permit quantification due to increasing signal intensity. That is, it may become difficult to distinguish n bases from n+ 1 bases, where the fractional increase in signal intensity from the (n+ l)'h base is small relative to the signal intensity from the already-inco ⁇ orated n bases.
  • an extension cycle comprising a labeled nucleotide is followed by an extension cycle using an unlabeled nucleotide of the same type so that the position in each of the target template in which a labeled nucleotide failed to inco ⁇ orated becomes occupied by an unlabeled nucleotide.
  • target polynucleotides may be a specific portion of a genome of a cell, such as an intron, regulatory region, allele, variant or mutation; the whole genome; or any portion therebetween.
  • the target polynucleotides may be mRNA, tRNA, rRNA, ribozymes, antisense RNA or RNAi.
  • the target polynucleotide may be of any length, such as at least 10 bases, at least 25 bases, at least 50 bases, at least 100 bases, at least 500 bases, at least 1000 bases, or at least 2500 bases.
  • the invention is particularly useful in high throughput sequencing of single molecule polynucleotides in which a plurality of target polynucleotides are attached to a solid support in a spatial arrangement such that each polynucleotides is individually optically resolvable.
  • each detected inco ⁇ orated label represents a single polynucleotide
  • Nucleotides useful in the invention include both naturally-occurring and modified or non-naturally occurring nucleotides, and include nucleotide analogues.
  • a nucleotide according to the invention may be, for example, a ribonucleotide, a deoxyribonucleotide, a modified ribonucleotide, a modified deoxyribonucleotide, a peptide nucleotide, a modified peptide nucleotide or a modified phosphate-sugar backbone nucleotide.
  • Many aspects of nucleotides useful in the methods of the invention are subject to manipulation provide and suitable mechanisms for controlling the reaction.
  • nucleotide i.e., natural or synthetic dATP, dCTP, dTTP, dGTP or dUTP; a natural or non- natural nucleotide
  • dATP dCTP
  • dTTP dGTP
  • dUTP a natural or non- natural nucleotide
  • Labeled nucleotides of the invention include any nucleotide that has been modified to include a label which is directly or indirectly detectable.
  • Such labels include optically-detectable labels such fluorescent labels, including fluorescein, rhodamine, phosphor, polymethadine dye, fluorescent phosphoramidite, texas red, green fluorescent protein, acridine, cyanine, cyanine 5 dye, cyanine 3 dye, 5-(2'-aminoethyl)-aminonaphthalene- 1 -sulfonic acid (EDANS), BODIPY, ALEXA, or a derivative or modification of any of the foregoing.
  • fluorescence resonance energy transfer (FRET) technology is employed to produce a detectable, but quenchable, label.
  • FRET may be used in the invention by, for example, modifying the primer to include a FRET donor moiety and using nucleotides labeled with a FRET acceptor moiety.
  • the fluorescently labeled nucleotides can be obtained commercially (e.g., from NEN DuPont, Amersham, and BDL). Alternatively, fluorescently labeled nucleotides can also be produced by various techniques, such as those described in Kambara et al., Bio/Techol. (1988) 6:816-821; Smith et al., Nucl. Acid Res. (1985) 13: 2399-2412, and Smith et al.., Nature (1986) 321: 674-79.
  • the fluorescent dye is preferably linked to the deoxyribose by a linker arm which is easily cleaved by chemical or enzymatic means.
  • the length of the linker between the dye and the nucleotide can impact the inco ⁇ oration rate and efficiency (see Zhu et al., Cytometry (1997) 28, 206).
  • the invention is exemplified herein with fluorescent labels, the invention is not so limited and can be practiced using nucleotides labeled with any form of detectable label, including radioactive labels, chemoluminescent labels, luminescent labels, phosphorescent labels, fluorescence polarization labels, and charge labels.
  • detectable label including radioactive labels, chemoluminescent labels, luminescent labels, phosphorescent labels, fluorescence polarization labels, and charge labels.
  • any parameter that permits the regulation of the number of labeled nucleotides added to the primer, or the rate at which the nucleotides are inco ⁇ orated and detected can be controlled or exploited in the practice of the invention.
  • Such parameters include, for example, the presence or absence of a label on a nucleotide, the type of label and manner of label attachment; the linker identity and length used to attach the label; the type of nucleotide (including, for example, whether such nucleotide is a dATP, dCTP, dTTP, dGTP or dUTP; a natural or non-natural nucleotide, a nucleotide analogue, or a modified nucleotide); the local sequence immediately 3' to the addition position; whether the base is the first, second, third, etc.
  • Such conditions include the "half-life" of the extension cycle (where one half-life is the time taken for at least one inco ⁇ oration to occur in 50% of the complementary strands); the number of wash cycles (i.e., the number of times a nucleotide is introduced to the reaction then washed out); the number of target nucleic acids in the reaction; and the temperature of the reaction and the reagents used in the reaction.
  • Half-Lives and Wash Cycles [0053] Based on the methods disclosed herein, those of skill in the art will be able to determine the period of half-lives required to limit the number inco ⁇ orations per cycle for a given number of target polynucleotides. (See Examples 2 and 3, Figures 2 and 3).
  • Statistical simulations can also provide the number of repeated cycles needed to obtain a given number of inco ⁇ orations, for example, to sequence a 25 base pair sequence. (See Examples 2 and 3, Figures 2 and 3). Referring to the simulations above, for example, it can be dete ⁇ nined that 60 cycles, each 0.8 half-lives long, would be required for at least 25 inco ⁇ orations in each of ten complementary strands (Example 2b, Figure 2b). With 200 complementary strands, 60 cycles each 0.8 half-lives long produce at least 20 inco ⁇ orations in each strand (Example 3, Figure 3).
  • the cycle period may also be chosen to permit a certain chance of inco ⁇ oration of a given number of nucleotides in a complementary strand, and the cycle may be repeated a number of times to analyze the sequence of various numbers of target polynucleotides of varying length.
  • nucleotide half-lives for the inco ⁇ oration reaction are affected by the fact that polymerizing agent may inco ⁇ orate labeled nucleotides less readily than unlabeled nucleotides.
  • Figure 4 illustrates the statistics of inco ⁇ oration for a certain embodiment using a Klenow exo-minus polymerizing agent and Cy3- or Cy5- labeled nucleotides. The results show that polymerase may inco ⁇ orate subsequent labeled nucleotides less readily than a prior labeled nucleotide. The graph of Figure 4 indicates, for example, that it may take five to ten times longer, resulting in a "stalling" of the inco ⁇ oration reaction.
  • the stalling may vary with the use of other labeled nucleotides, other polymerizing agents and various reaction conditions.
  • Polymerase stalling is a useful mechanism for controlling inco ⁇ oration rates in single molecule reactions. As is shown in the Examples below, polymerase stalling is useful to limit inco ⁇ oration of nucleotides into any given strand in a fairly precise manner. According to the invention, polymerase stalling is useful to limit inco ⁇ oration to 1 nucleotide per strand per cycle, on average.
  • the rate at which polymerase inco ⁇ orates labeled nucleotides into a complementary strand may be slowed by a factor of about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, or about 15 times compared to that observed with unlabeled nucleotides or compared to that observed for a prior inco ⁇ orated labeled nucleotide.
  • the graph of Figure 4 shows the number of cycles needed with cycle periods of various half-lives, taking into account stalling factors of two (squares), five (triangles), and 10 (crosses), in order to obtain 25 inco ⁇ orations in over 80% of target strands, with at least a 97% chance of inco ⁇ orating two or fewer nucleotides per cycle (or a smaller than 3% chance of inco ⁇ orating three or more nucleotides per cycle).
  • stalling allows longer half-lives, which, in turn, permits the use of fewer cycles to obtain a "full" sequence with a defined e ⁇ or rate.
  • the cycle period may be selected to pe ⁇ nit about a 70%, about a 75%, about an 80%>, about an 85%, about a 90%, about a 95%>, about a 96%, about a 97%, about a 98%, and about a 99% chance of inco ⁇ oration of two or less nucleotides into the complementary strand.
  • cycle periods that may be used in embodiments of the invention include, for example, no more than about 5 half-lives, no more than about 4 half-lives, no more than about 3 half-lives, no more than about 2 half-lives, no more than about 1 half-lives, no more than about 0.9 half-lives, no more than about 0.8 half- lives, no more than about 0.7 half-lives, no more than about 0.6 half-lives, no more than about 0.5 half-lives, no more than about 0.4 half-lives, no more than about 0.3 half-lives, and no more than about 0.2 half-lives of the inco ⁇ oration reactions.
  • various cycle periods and number of times the cycles are repeated may be used with various numbers of targets in certain embodiments of the invention. These include, for example, using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 50 times; using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 60 times; using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 70 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 50 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 60 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 70 times;
  • signal from inco ⁇ orated nucleotides may be reduced after each or a number of cycles.
  • the number of times the cycles need to be repeated is also determined based on methods described herein. In general, the number of cycles increases with the length of the sequence to be analyzed and the duration of the half life of nucleotide exposure decreases as the length of sequence to be analyzed becomes longer. Also in general, half lives of nucleotide exposure increase and cycle numbers decrease with greater inhibitory or delaying effects on nucleotide inco ⁇ oration
  • examples of cycle periods and number repeat cycles that may be used in certain embodiments further include a cycle period of no more than about 0.5 half-lives with a stalling factor of about 2, repeated at least about 90 times; a cycle period of no more than about 0.75 half-lives, with a stalling factor of about 2, repeated at least about 75 times; a cycle period of no more than about 1 half-lives, with a stalling factor of about 2, repeated at least about 50 times; a cycle period of no more than about 1.5 half-lives with a stalling factor of about 2 or about 5, repeated at least about 45 times; a cycle period of no more than about 1.75 half-lives, with a stalling factor of about 5, repeated at least about 35 times; a cycle period of no more than about 2 half-lives, with a stalling factor of about 5 or about 10, repeated at least about 35 times; a cycle period of no more than about 2.25 half-lives, with a stalling factor of
  • Polymerizing agents useful in the invention include DNA polymerases (such as Taq polymerase, T7 mutant DNA polymerase, Klenow and Sequenase, 9°N or a variant thereof), RNA polymerases, thermostable polymerases, thermodegradable polymerases, and reverse transcriptases.
  • DNA polymerases such as Taq polymerase, T7 mutant DNA polymerase, Klenow and Sequenase, 9°N or a variant thereof
  • RNA polymerases such as Taq polymerase, T7 mutant DNA polymerase, Klenow and Sequenase, 9°N or a variant thereof
  • thermostable polymerases such as thermostable polymerases
  • thermodegradable polymerases such as reverse transcriptases.
  • Cofactors of the invention function to inhibit the polymerizing agent, thereby slowing or stopping synthesis activity, permitting the detection of an inco ⁇ orated labeled nucleotide.
  • Cofactors of the invention include any chemical agent or reaction condition that results in the inhibition of the polymerizing agent. Such inhibition may be in whole or in part and may be permanent, temporary or reversible.
  • a cofactor may be a label, an antibody, an aptamer, an organic or inorganic small molecule, or a polyanion, or it may comprise a chemical modification to a nucleotide (i.e., a nucleotide analogue may comprise a cofactor).
  • a cofactor can be in solution, or it may be attached, either directly or through a linker to a nucleotide, primer, template or polymerase.
  • Examples of useful cofactor agents include, among others, light sensitive groups such as 6-nitoveratryloxycarbonyl (NVOC), 2-nitobenzyloxycarbonyl (NBOC), ⁇ , ⁇ - dimethyl-dimethoxybenzyloxycarbonyl (DDZ), 5-bromo-7-nitroindolinyl, o-hyrdoxy-2- methyl cinnamoyl, 2-oxymethylene anthraquinone, and t-butyl oxycarbonyl (TBOC).
  • NVOC 6-nitoveratryloxycarbonyl
  • NBOC 2-nitobenzyloxycarbonyl
  • DDZ ⁇ , ⁇ - dimethyl-dimethoxybenzyloxycarbonyl
  • TBOC t-butyl oxycarbonyl
  • the detectable label may comprise a dye having a bulky chemical structure that, once the nucleotide is inco ⁇ orated into the extending primer, causes a steric hindrance of the polymerizing agent, blocking the polymerizing agent from any further synthesis.
  • Examples of labels that may be useful for this pu ⁇ ose are described in the Example, as well as in Zhu et al., Polynucleotides Res. (1994) 22: 3418-22.
  • fluorophore labels that may be used to stall the polymerase include Cy3, Cy5, Cy7, ALEXA647, ALEXA 488, BODIPY 576/589, BODIPY 650/665, BODIPY TR, Nile Blue, Sulfo-IRD700, NN382, R6G, Rho 123, tetramethylrhodamine and Rhodamine X.
  • the labels are as bulky as Cy5, with molecular weights at least about 1.5 kDa.
  • the labels are bulkier than Cy5, having molecular weights of at least about 1.6 kDa, at least about 1.7 kDa, at least about 1.8 kDa, at least about 1.9 kDa, at least about 2.0 kDa at least bout 2.5 kDa, or at least about 3.0 kDa.
  • Such larger dyes include the following, with corresponding formula weights (in g/mol) in parentheses: Cy5 (534.6); Pyrene (535.6); 6- Carboxyfluorescein (FAM) (537.5); 6-Carboxyfluorescein-DMT (FAM-X (537.5); 5(6) Carboxyfluorescein (FAM) (537.5); 5-Fluorescein (FITC) (537.6); Cy3B (543.0); WellRED D4-PA (544.8); BODIPY 630/650 (545.5); 3* 6-Carboxyfluorescein (FAM) (569.5); Cy3.5 (576.7); Cascade Blue (580.0); ALEXA Fluor 430 (586.8); Lucifer Yellow (605.5); ALEXA Fluor 532 (608.8); WellRED D2-PA (611.0); Cy5.5 (634.8); DY-630 (634.8); DY-555 (636.2); WellRED D3-PA (645.0); Rhodamine Red
  • linking moieties and methods for attaching fluorophore moieties to nucleotides there are also many linking moieties and methods for attaching fluorophore moieties to nucleotides, as described in Oligonucleotides and Analogues, supra; Guisti et al., supra; Agrawal et al, Tetrahedron Letters (1990) 31: 1543-46; and Sproat et al., Polynucleotide Research (1987) 15: 4837.
  • the method further comprises inactivating the cofactor, thereby reversing its effect on the polymerizing agent.
  • Modes of inactivation depend on the cofactor.
  • inactivation can typically be achieyed by chemical, enzymatic, photochemical or radiation cleavage of the cofactor from the nucleotide. Cleavage of the cofactor can be achieved if a detachable connection between the nucleotide and the cofactor is used.
  • the use of disulfide bonds enables one to disconnect the dye by applying a reducing agent like dithiothreitol (DTT).
  • DTT dithiothreitol
  • the cofactor is a fluorescent label
  • inactivation may comprise adjusting the reaction temperature.
  • an antibody that binds to thermostable polymerase at lower temperatures and blocks activity, but is denatured at higher temperatures, thus rendering the polymerase active; or single-stranded aptamers that bind to thermophilic polymerase at lower temperatures but are released at higher temperatures, may be inactivated by increasing the reaction temperature such the cofactor is released but polymerase activity is permitted.
  • transient inhibition of the polymerase and the time of exposure to the labeled nucleotide are coordinated such that it is statistically likely that at least one of the labeled nucleotide is inco ⁇ orated in the primer, but statistically unlikely that more than two of the labeled nucleotide are inco ⁇ orated.
  • the reaction is controlled by inhibiting the polymerase activity such that it is statistically unlikely that more than, for example, one or two nucleotides are inco ⁇ orated into the same primer strand in the cycle.
  • Temperature and Reagents include reaction temperature and reagents.
  • buffer reagents useful in the methods of the invention include a detergent or surfactant, such as Triton®-X 100, or salt and/or ion concentrations that facilitate or inhibit nucleotide inco ⁇ oration. Predetermined Points For Stopping a Cycle
  • the predetermined point at which a short cycle is stopped is defined, for example, by the occurrence of an event (such as the inco ⁇ oration of a nucleotide comprising a blocking moiety that prevents further extension of the primer), the lapse of a certain amount of time (such as a specific number of half-lives), or the achievement of a statistically- significant datapoint (such as a period at which a statistically significant probability of two or less nucleotides have been inco ⁇ orated).
  • the predetermined period of time is coordinated with an amount of polymerization inhibition such that, on average, a certain number of labeled nucleotides are added to the primer.
  • the number of inco ⁇ orated labeled nucleotides is, on average, 0, 1 or 2, but almost never more than 3.
  • the time period of exposure is defined in terms of statistical significance.
  • the time period may be that which is statistically insufficient for inco ⁇ oration of more nucleotides than are resolvable by a detection system used to detect inco ⁇ oration of the nucleotide into the primer.
  • the time period that is statistically insufficient for inco ⁇ oration of a greater number of nucleotides that are individually optically resolvable during a predetermined detection period i.e., a period of time during which the inco ⁇ orated nucleotides are detected).
  • the reaction may be stopped by washing or flushing out the nucleotides that remain uninco ⁇ orated and/or washing or flushing out polymerization agent. Further, many aspects of the repeated cycles may be automated, for example, using microfluidics for washing nucleotides to sites of anchored target polynucleotides, and washing out uninco ⁇ orated nucleotides to halt each cycle.
  • Primers are synthesized from nucleoside triphosphates by known automated oligonucleotide synthetic techniques, e.g., via standard phosphoramidite technology utilizing a nucleic acid synthesizer, such as the ABI3700 (Applied Biosystems, Foster City, CA).
  • the oligonucleotides are prepared as duplexes with a complementary strand, however, only the 5' terminus of the oligonucleotide proper (and not its complement) is biotinylated.
  • Double stranded target nucleic acids are blunt-end ligated to the oligonucleotides in solution using, for example, T4 ligase.
  • the single strand having a 5' biotinylated terminus of the oligonucleotide duplex permits the blunt-end ligation on only on end of the duplex.
  • the solution-phase reaction is performed in the presence of an excess amount of oligonucleotide to prohibit the formation of concantamers and circular ligation products of the target nucleic acids.
  • a plurality of chimeric polynucleotide duplexes result.
  • Chimeric polynucleotides are separated from unbound oligonucleotides based upon size and reduced to single strands by subjecting them to a temperature that destabilizes the hydrogen bonds.
  • Preparation of Solid Support A solid support comprising reaction chambers having a fused silica surface is sonicated in 2% MICRO-90 soap (Cole-Parmer, Vernon Hills, IL) for 20 minutes and then cleaned by immersion in boiling RCA solution (6:4:1 high-purity H 2 O/30% NH 4 OH/30% H 2 0 2 ) for 1 hour.
  • biotinylated single-stranded chimeric polynucleotides are deposited via ink-jet printing onto the streptavidin-coated chamber surface at 10 pMfor 10 minutes in Tris buffer that contain 100 mM MgCl 2 .
  • Equipment [0080] The experiments are performed on an upright microscope (BH-2, Olympus,
  • TIR total internal reflection
  • An objective collects the fluorescence signal through the top plastic cover of the chamber, which is deflected by the objective to R. 0 ⁇ m from the silica surface.
  • An image splitter Optical Insights, Santa Fe, NM
  • directs the light through two bandpass filters 630dcxr, HQ585/80, HQ690/60; Chroma Technology, Brattleboro, VT) to an intensified charge-coupled device (I- PentaMAX; Roper Scientific, Trenton, NJ), which records adjacent images of a 120- x 60- ⁇ m section of the surface in two colors.
  • chimeric polynucleotides i.e., the polynucleotide portion added to the bound oligonucleotides is different at least one location
  • all four labeled dNTPs initially are cycled.
  • the result is the addition of at least one donor fluorophore to each chimeric strand.
  • the number of initial inco ⁇ orations containing the donor fluorophore is limited by either limiting the reaction time (i.e., the time of exposure to donor-labeled nucleotides), by polymerase stalling, or both in combination.
  • the inventors have shown that base-addition reactions are regulated by controlling reaction conditions.
  • inco ⁇ orations can be limited to 1 or 2 at a time by causing polymerase to stall after the addition of a first base.
  • One way in which this is accomplished is by attaching a dye to the first added base that either chemically or sterically interferes with the efficiency of inco ⁇ oration of a second base.
  • a computer model was constructed using Visual Basic (v. 6.0, Microsoft Co ⁇ .) that replicates the stochastic addition of bases in template-dependent nucleic acid synthesis. The model utilizes several variables that are thought to be the most significant factors affecting the rate of base addition. The number of half-lives until dNTPs are flushed is a measure of the amount of time that a template-dependent system is exposed to dNTPs in solution.
  • the model demonstrates that, by controlling reaction conditions, one can precisely control the number of bases that are added to an extending primer in any given cycle of inco ⁇ oration. For example, as shown in Figure 7, at a constant rate of inhibition of second base inco ⁇ oration (i.e., the inhibitory effect of inco ⁇ oration of a second base given the presence of a first base), the amount of time that dNTPs are exposed to template in the presence of polymerase determines the number of bases that are statistically likely to be inco ⁇ orated in any given cycle (a cycle being defined as one round of exposure of template to dNTPs and washing of unbound dNTP from the reaction mixture).
  • a cycle being defined as one round of exposure of template to dNTPs and washing of unbound dNTP from the reaction mixture.
  • nucleotides comprising acceptor fluorophores (here, cyanine-5) are added in a template-dependent manner.
  • acceptor fluorophores here, cyanine-5
  • the Foster radius of Cy-3/Cy5 fluorophore pairs is about 5 nm (or about 15 nucleotides, on average).
  • donor must be refreshed about every 15 bases. This is accomplished under the parameters outlined above.
  • each ' cycle preferably is regulated to allow inco ⁇ oration of 1 or 2, but never 3 bases.
  • FIG. 1 shows schematically the process of FRET-based, template-dependent nucleotide addition as described in this example.
  • the methods described above are alternatively conducted with the FRET donor attached to the polymerase molecule.
  • donor follows the extending primer as new nucleotides bearing acceptor fluorophores are added.
  • a nucleotide binding protein e.g., DNA binding protein
  • the DNA binding protein is spaced at intervals (e.g., about 5 nm or less) to allow FRET.
  • Primers are hybridized to the primer attachment site of bound chimeric polynucleotides Reactions are conducted in a solution comprising Klenow fragment Exo-minus polymerase (New England Biolabs) at 10 nM (100 units/ml) and a labeled nucleotide triphosphate in EcoPol reaction buffer (New England Biolabs). Sequencing reactions takes place in a stepwise fashion. First, 0.2 ⁇ M dUTP-Cy3 and polymerase are introduced to support-bound chimeric polynucleotides, incubated for 6 to 15 minutes, and washed out. Images of the surface are then analyzed for primer-inco ⁇ oratedU- Cy5.
  • an oxygen scavenging system can be used during all green illumination periods, with the exception of the bleaching of the primer tag.
  • the above protocol is performed sequentially in the presence of a single species of labeled dATP, dGTP, dCTP or dUTP.
  • a first sequence can be compiled that is based upon the sequential inco ⁇ oration of the nucleotides into the extended primer.
  • the first compiled sequence is representative of the complement of the template.
  • the sequence of the template can be easily determined by compiling a second sequence that is complementary to the first sequence. Because the sequence of the oligonucleotide is known, those nucleotides can be excluded from the second sequence to produce a resultant sequence that is representative of the target template.
  • Figure 2 illustrates the advantage of short-cycle sequencing with respect to avoiding long homopolymer reads.
  • Figure 2a illustrates a simulated analysis of 10 target polynucleotides using non-short-cycle sequencing (Example 2a)
  • Figure 2b illustrates a simulated analysis of the same number of target polynucleotides using short-cycle sequencing (Example 2 b).
  • the first input value corresponded to the period of time allowed for inco ⁇ oration reactions of provided nucleotides into the growing complementary strands of the polynucleotides to be analyzed. This period was conveniently measured in half-lives of the inco ⁇ oration reaction itself. Each cycle of inco ⁇ oration was simulatedly stalled after a period of time, representing, for example, the time when uninco ⁇ orated nucleotides would be flushed out or the inco ⁇ oration reactions otherwise stalled.
  • the second input value corresponds to the number of times each cycle of inco ⁇ oration was repeated. That is, the number of times the steps of providing nucleotides, allowing inco ⁇ oration reactions into the complementary sfrands in the presence of polymerizing agent, and then stopping the inco ⁇ orations are repeated.
  • the nucleotides were simulatedly provided as a wash of each of dATPs, dGTPs, dTTPs, and dCTPs.
  • the program then recorded which nucleotides were inco ⁇ orated, corresponding to a detection step of detecting inco ⁇ oration.
  • the third input value corresponds to number of strands of target polynucleotides to by analyzed in the simulation.
  • the program allowed up to 1100 target polynucleotide molecules to be analyzed in a given simulation.
  • the program After the program was started, as described above, the program first generated the inputted number of strands composed of random sequences. The program then simulated hybridization and polymerization of the correct base of each inco ⁇ oration reaction, based on the generated sequence of the target polynucleotide templates. The program continued these simulated reactions for the allowed amount of simulated time, determined by the inputted number of half-lives.
  • Example 2 a the input values used were a cycle period of 10 half-lives, 12 repeats of the cycle, and 10 target polynucleotide strands.
  • Figure 2a illustrates the results obtained.
  • Figure 2a illustrates that the output values included the longest extended complementary strand obtained during the simulation (Longest extension in the ensemble of molecules); the shorted extended complementary strand obtained during the simulation (Shortest extension in the ensemble of molecules); and the average extension.
  • Figure 2a indicates that for the input values of Example 2a, the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 100.0%; and the percentage of growing strands extended by three or more nucleotides in a homopolymer stretch was 60.0%. That is, using a cycle period of 10 half-lives resulted in only 40% of the complementary strands being extended by two or less nucleotides in a homopolymer stretch per cycle of inco ⁇ oration.
  • output values also indicated the total number of inco ⁇ orations for each of the growing strands for the total number of repeated cycles. This represents the length of the sequence of target polynucleotide analyzed.
  • Figure 2a illustrates that in Example 2 a, 100.0% of the 10 target polynucleotides of the simulation were extended by at least 25 inco ⁇ orated nucleotides. This illustrates that using a cycle period of 10 half-lives, and repeating the cycles 12 times, allowed analysis of a 25 base sequence of 10 target polynucleotides.
  • Example 2b the input values used were a cycle period of 0.8 half-lives, 60 repeats of the cycle, and 10 target polynucleotide strands.
  • Figure 2b illustrates the results obtained. Homopolymers stretches which occurred in the same simulated complementary strand are highlighted in magenta wherever 2 nucleotides of the same base type were inco ⁇ orated in a row, and in cyan wherever more than two nucleotides of the same base type were inco ⁇ orated in a row.
  • Figure 2b illustrates that the output values included the longest extended complementary strand obtained during the simulation (longest extension in the ensemble of molecules); the shortest extended complementary sfrand obtained during the simulation (shortest extension in the ensemble of molecules); and the average extension. These numbers represent the greatest number of inco ⁇ orations into any of the 10 simulatedly growing complementary sfrands, the smallest number of inco ⁇ orations for any of the 10, and the average number of inco ⁇ orations for the 10.
  • Figure 2b indicates that the values obtained for Example 2b were 37 inco ⁇ orations in the longest extension, 26 in the shortest, and 32.00 as the average number of inco ⁇ orations.
  • the output values also provided information on the number of inco ⁇ orations that occurred in each of growing complementary strands during each cycle period of the simulation.
  • Figure 2b indicates that for the input values of Example 2b, the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 80.0%; and the percentage of growing sfrands extended by three or more nucleotides in a homopolymer stretch was 10.0%. That is, using a cycle period of 0.8 half-lives resulted in 90% of the complementary strands being extended by two or less nucleotides per cycle of inco ⁇ oration.
  • Output values also indicated the total number of inco ⁇ orations for each of the growing strands for the total number of repeated cycles. As in Example 2a, this represents the length of the sequence of target polynucleotide analyzed.
  • Figure 2b illustrates that in Example 2b, 100.0% of the 10 target polynucleotides of the simulation were again extended by at least 25 inco ⁇ orated nucleotides. This illustrates that using a cycle period of 0.8 half- lives, and repeating the cycles 60 times, allowed analysis of a 25 base sequence of 10 target polynucleotides.
  • Comparing Examples 2a and 2b also indicated that a greater number of repeated cycles were needed to analyze a given length of sequence when using shorter cycles. That is, the 10 half-lives cycle was repeated 12 times to result in 100.0% of the 10 complementary sfrands being extended by at least 25 nucleotides, whereas the 0.8 half-lives cycle was repeated 60 times to obtain this same result and thereby analyze the 25 nucleotides sequence. [0107] Nonetheless, many aspects of the repeated cycles may be automated, for example, using micro fluidics for washing nucleotides to sites of anchored target polynucleotides, and washing out uninco ⁇ orated nucleotides to halt each cycle.
  • Option Explicit all variables must be declared
  • Option Base 1 'array pointers start at '1' not '0'
  • the s imulation w as run using the program described in Examples 2a and 2b but using a larger number of target polynucleotides.
  • the input values used were a cycle period of 0.8 half-lives, 60 repeats of the cycle, and 200 target polynucleotide strands.
  • Figure 2 illustrates the results obtained. Homopolymers stretches which occurred in the same simulated complementary strand are highlighted in magenta wherever nucleotides of the same base type were inco ⁇ orated in a row, and in cyan wherever more than two nucleotides of the same base type were inco ⁇ orated in a row.
  • the output values obtained were 48 inco ⁇ orations in the longest extended complementary strand, 20 in the shortest, and 32.00 as the average number of inco ⁇ orations for the 200 simulatedly extended complementary sfrands.
  • the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 78.5%; and the percentage of growing sfrands extended by three or more nucleotides in a homopolymer stretch was 4.0%. That is, using a cycle period of 0.8 half-lives resulted in 96.0% of the complementary strands being extended by two or less nucleotides in a homopolymer stretch per cycle of inco ⁇ oration. Moreover, 95.5% of the 200 target polynucleotides of the simulation were extended by at least 25 inco ⁇ orated nucleotides, while 100% were extended by at least 20 nucleotides. This illustrated that using a cycle period of 0.8 half-lives, and repeating the cycles 60 times, allows analysis of a 20 base sequence of 200 target polynucleotides.
  • This example demonstrates a method according to the invention in which a single nucleotide in a position in a nucleic acid sequence is identified.
  • a template-bound primer is sequentially exposed first to a labeled nucleotide and then to an unlabeled nucleotide of the same type under conditions and in the presence of reagents that allow template-dependent primer extension.
  • the template is analyzed in order to determine whether the first nucleotide is inco ⁇ orated in the primer at the first position or not. If not, then the sequential exposure to labeled and unlabeled nucleotides is repeated using another type of nucleotide until one such nucleotide is dete ⁇ nined to have inco ⁇ orated at the first position.
  • Example 5 [0114] In this example, a series of reactions are performed as described above in
  • a nucleic acid primer is hybridized to a target nucleic acid at a primer binding site in the target.
  • the primer comprises a donor fluorophore.
  • the hybridized primer is exposed to a first nucleotide comprising an acceptor fluorophore comprising a blocking moiety that, when inco ⁇ orated into the primer, prevents further polymerization of the primer.
  • the presence or absence of fluorescent emission from each of the donor and the acceptor is determined.
  • a nucleotide that has been inco ⁇ orated into the primer via complementary base pairing with the target is identified by the presence of fluorescent emission from the acceptor, and a sequence placeholder is identified as the absence of fluorescent emission from the donor and the acceptor.
  • a sequence of the target nucleic acid is complied based upon the sequence of the inco ⁇ orated nucleotides and the placeholders.

Abstract

The invention provides methods for sequencing a polynucleotide comprising stopping an extension cycle in a sequence by synthesis reaction before the reaction has run to near of full completion.

Description

Short Cycle Methods For Sequencing Polynucleotides
Related Applications
[0001] This application claims the benefit of U.S. Provisional Application Nos.
60/546,277, filed on February 19, 2004, 60/547,611, filed on February 24, 2004, and 60/519,862, filed on November 12, 2003. Field of the Invention
[0002] The invention relates to methods for sequencing a polynucleotide, and more particularly, to methods for high throughput single molecule sequencing of target polynucleotides.
Background [0003] Completion of the human genome has paved the way for important insights into biologic structure and function. Knowledge of the human genome has given rise to inquiry into individual differences, as well as differences within an individual, as the basis for differences in biological function and dysfunction. For example, single nucleotide differences between individuals, called single nucleotide polymorphisms (SNPs), are responsible for dramatic phenotypic differences. Those differences can be outward expressions of phenotype or can involve the likelihood that an individual will get a specific disease or how that individual will respond to treatment. Moreover, subtle genomic changes have been shown to be responsible for the manifestation of genetic diseases, such as cancer. A true understanding of the complexities in either normal or abnormal function will require large amounts of specific sequence information.
[0004] An understanding of cancer also requires an understanding of genomic sequence complexity. Cancer is a disease that is rooted in heterogeneous genomic instability. Most cancers develop from a series of genomic changes, some subtle and some significant, that occur in a small subpopulation of cells. Knowledge of the sequence variations that lead to cancer will lead to an understanding of the etiology of the disease, as well as ways to treat and prevent it. An essential first step in understanding genomic complexity is the ability to perform high-resolution sequencing.
[0005] Various approaches to nucleic acid sequencing exist. One conventional way to do bulk sequencing is by chain termination and gel separation, essentially as described by Sanger et al., Proc Natl Acad Sci U S A, 74(12): 5463-67 (1977). That method relies on the generation of a mixed population of nucleic acid fragments representing terminations at each base in a sequence. The fragments are then run on an electrophoretic gel and the sequence is revealed by the order of fragments in the gel. Another conventional bulk sequencing method relies on chemical degradation of nucleic acid fragments. See, Maxam et al., Proc. Natl. Acad. Sci., 74: 560-564 (1977). Finally, methods have been developed based upon sequencing by hybridization. See, e.g., Drmanac, et al., Nature Biotech., 16: 54-58 (1998). Bulk techniques, such as those described above, cannot effectively detect single nucleotide differences between samples, and are not useful for comparative whole genome sequencing. Single molecule techniques are necessary for high-resolution detection of sequence differences. [0006] There have been several recent reports of sequencing using single molecule techniques. Most conventional techniques have proposed incorporation of fluorescently- labeled nucleotides in a template-dependent manner. A fundamental problem with conventional single molecule techniques is that the sequencing reactions are run to completion. For purposes of single molecule chemistry, this typically means that template is exposed to nucleotides for incorporation for about 10 half lives. This gives rise to problems in the ability to resolve single nucleotides as they incorporate in the growing primer strand. The resolution problem becomes extreme in the situation in which the template comprises a homopolymer region. Such a region is a continuous sequence consisting of the same nucleotide species. When optical signaling is used as the detection means, conventional optics are able to reliably distinguish one from two identical bases, and sometimes two from three, but rarely more than three. Thus, single molecule sequencing using fluorescent labels in a homopolymer region typically results in a signal that does not allow accurate determination of the number of bases in the region. [0007] One method that has been developed in order to address the homopolymer issue provides for the use of nucleotide analogues that have a modification at the 3' carbon of the sugar that reversibly blocks the hydroxyl group at that position. The added nucleotide is detected by virtue of a label that has been incorporated into the 3' blocking group. Following detection, the blocking group is cleaved, typically, by photochemical means to expose a free hydroxyl group that is available for base addition during the next cycle. [0008] However, techniques utilizing 3' blocking are prone to errors and inefficiencies. For example, those methods require excessive reagents, including numerous primers complementary to at least a portion of the target nucleic acids and differentially- labeled nucleotide analogues. They also require additional steps, such as cleaving the blocking group and differentiating between the various nucleotide analogues incorporated into the primer. As such, those methods have only limited usefulness. [0009] Need therefore exists for more effective and efficient methods and devices for single molecule nucleic acid sequencing. Summary of the Invention
[0010] The invention provides methods for high throughput single molecule sequencing. In particular, the invention provides methods for controlling at least one parameter of a nucleotide extension reaction in order to regulate the rate at which nucleotides are added to a primer. The invention provides several ways of controlling nucleic acid sequence-by-synthesis reactions in order to increase the resolution and reliability of single molecule sequencing. Methods of the invention solve the problems that imaging systems have in accurately resolving a sequence at the single-molecule level. In particular, methods of the invention solve the problem of determining the number of nucleotides in a homopolymer stretch. [0011] Methods of the invention generally contemplate terminating sequence-by- synthesis reactions prior to completion in order to obtain increased resolution of individual nucleotides in a sequence. Fundamentally, this requires exposing nucleotides to a mixture comprising a template, a primer, and a polymerase under conditions sufficient for only limited primer extension. Reactions are conducted under conditions such that it is statistically unlikely that more than 1 or 2 nucleotides are added to a growing primer strand in any given incorporation cycle. An incorporation cycle comprises exposure of a template/primer to nucleotides directed at the base immediately downstream of the primer (this may be all four conventional nucleotides or analogs if the base is not known) and washing unhybridized nucleotide. [0012] Nucleotide addition in a sequence-by-synthesis reaction is a stochastic process. As in any chemical reaction, nucleotide addition obeys the laws of probability. Methods of the invention are concerned with controlling the rate of nucleotide addition on a per-cycle basis. That is, the invention teaches ways to control the rate of nucleotide addition within an extension cycle given the stochastic nature of the extension reaction itself. Methods of the invention are intended to control reaction rates within the variance that is inherent in a reaction that is fundamentally stochastic. Thus, the ability to control, according to the invention, base addition reactions such that, on average, no more than two bases are added in any cycle takes into account the inherent statistics of the reactions. [0013] The invention thus teaches polynucleotide sequence analysis using short cycle chemistry. One embodiment of the invention provides methods for slowing or reversibly inhibiting the activity of polymerase during a sequencing-by-synthesis reaction. Other methods teach altering the time of exposure of nucleotides to the template-primer complex. Still other methods teach the use of physical blockers that temporarily halt or slow polymerase activity and/or nucleotide addition. In general, any component of the reaction that permits regulation of the number of labeled nucleotides added to the primer per cycle, or the rate at which the nucleotides are incorporated and detected per cycle is useful in methods of the invention. Additional components include, but are not limited to, the presence or absence of a label on a nucleotide, the type of label and manner of attaching the label; the linker identity and length used to attach the label; the type of nucleotide (including, for example, whether such nucleotide is a dATP, dCTP, dTTP, dGTP or dUTP; a natural or non-natural nucleotide, a nucleotide analogue, or a modified nucleotide); the "half-life" of the extension cycle (where one half-life is the time taken for at least one incorporation to occur in 50% of the complementary strands); the local sequence immediately 3' to the addition position; whether such base is the first, second, third, etc. base added; the type of polymerase used; the particular batch characteristics of the polymerase; the processivity of the polymerase; the incorporation rate of the polymerase; the number of wash cycles (i.e., the number of times a nucleotide is introduced to the reaction then washed out); the number of target nucleic acids in the reaction; the temperature of the reaction and the reagents used in the reaction.
[0014] In a preferred embodiment of the invention, a nucleic acid template is exposed to a primer capable of hybridizing to the template and a polymerase capable of catalyzing nucleotide addition to the primer. A labeled nucleotide is introduced for a period of time that is statistically insufficient for incorporation of more than about 2 nucleotides per cycle. Nucleotide exposure may also be coordinated with polymerization inhibition such that, on average, 0, 1, or 2 labeled nucleotides are added to the primer, but that 3 labeled nucleotides are almost never added to the primer in each cycle. Ideally, the exposure time, during which labeled nucleotides are exposed to the template-primer complex, is statistically insufficient for incorporation of more nucleotides than are resolvable by a detection system used to detect incorporation.
[0015] The invention also contemplates performing a plurality of base incorporation cycles. Each cycle comprises exposing a template nucleic acid to a labeled nucleotide that is not a chain-terminating nucleotide. The labeled nucleotide is incorporated into a primer hybridized to the template nucleic acid if the nucleotide is capable of hybridizing to the template nucleotide immediately upstream of the primer and there is about a 99% probability that two or fewer of said nucleotides are incorporated into the same primer strand per cycle. Incorporated nucleotides are then identified. [0016] Methods of the invention also make use of differential base incorporation rates in order to control overall reaction rates. For example, the rate of incorporation is lower for a second nucleotide given incorporation of a prior nucleotide immediately upstream of the second. This effect is magnified if the first nucleotide comprises a label or other group that hinders processivity of the polymerase. By determining an approximate reduction in the rate of incorporation of the second nucleotide, one can regulated the time of exposure of a sample to a second labeled nucleotide such that the time is statistically insufficient for incorporation of more nucleotides than are resolvable by a detection system used to detect incorporation of the nucleotide into the primer. [0017] The invention may also be conducted using a plurality of primer extension cycles, wherein each cycle comprises exposing a target nucleic acid to a primer capable of hybridizing to the target, thereby forming a primed target; exposing the primed target to a labeled nucleic acid in the presence of a nucleic acid polymerase, coordinating transient inhibition of the polymerase and time of exposure to the labeled nucleotide such that it is statistically likely that at least one of said labeled nucleic acid is incorporated in the primer, but statistically unlikely that more than two of the labeled nucleotide are incorporated in the primer.
[0018] According to another embodiment, methods of the invention comprise conducting a cycle of template-dependent nucleic acid primer extension in the presence of a polymerase and a labeled nucleotide; inhibiting polymerase activity such that it is statistically unlikely that more than about 2 nucleotides are incorporated into the same primer strand in the cycle; washing unincorporated labeled nucleotide away from the template; detecting any incorporation of the labeled nucleotide; neutralizing label in any incoφorated labeled nucleotide; removing the inhibition; repeating the foregoing steps; and compiling a sequence based upon the sequence of nucleotides incorporated into the primer. [0019] In another embodiment, the invention provides a method comprising exposing a nucleic acid template to a primer capable of hybridizing to a portion of the template in order to form a template/primer complex reaction mixture; adding a labeled nucleotide in the presence of a polymerase to the mixture under conditions that promote incorporation of the nucleotide into the primer if the nucleotide is complementary to a nucleotide in the template that is downstream of said primer; coordinating removal of the labeled nucleotide and inhibition of the polymerase so that no more than about 2 nucleotides are incorporated into the same primer; identifying labeled nucleotide that has been incorporated into said primer; repeating the foregoing steps at least once; and determining a sequence of the template based upon the order of the nucleotides incoφorated into the primer.
[0020] According to another embodiment, the method comprises exposing a template nucleic acid to a primer capable of hybridizing to a portion of the template upstream of a region of the template to be sequenced; introducing a labeled nucleic acid and a polymerase to the template under conditions wherein the labeled nucleic acid will be incoφorated in the primer if the labeled nucleic acid is capable of hybridizing with a base downstream of the primer; and controlling the rate of the incoφoration by limiting the time of exposure of the labeled nucleic acid to the template or by inhibiting the polymerase at a predefined time after exposure of the template to the labeled nucleotide; detecting incoφoration of the labeled nucleotide into the primer; and identifying the nucleotide in the template as the complement of labeled nucleotide incoφorated into the primer.
[0021] In yet another embodiment, methods of the invention comprise exposing a target polynucleotide to a primer capable of hybridizing to the polynucleotide, extending the primer in the presence of a polymerizing agent and one or more extendible nucleotides, each comprising a detectable label. The polymerizing agent is exposed to a cofactor (i.e., any agent that decreases or halts polymerase activity), and the incoφoration of label is detected. The steps of extending the primer and exposing the polymerizing agent to a cofactor may be performed simultaneously, or may be performed in separate steps. In one embodiment, the method further comprises inactivating the cofactor, thereby reversing its effect on the polymerizing agent. Modes of inactivation depend on the cofactor. For example, where the cofactor is attached to the nucleotide, inactivation can typically be achieved by cleaving the cofactor from the nucleotide.
[0022] Methods of the invention also address the problem of reduced detection due to a failure of some strands in a given cycle to incoφorate labeled nucleotide. In each incoφoration cycle, a certain number of strands fail to incoφorate a nucleotide that should be incoφorated based upon its ability to hybridize to a nucleotide present in the template. The strands that fail to incoφorate a nucleotide in a cycle will not be prepared to incoφorate a nucleotide in the next cycle (unless it happens to be the same as the unincoφorated nucleotide, in which case the strand will still lag behind unless both nucleotides are incoφorated in the same cycle). Essentially, this situation results in the strands that failed to incoφorate being unavailable for subsequent polymerase-catalyzed additions to the primer. That, in turn, leads to fewer strands available for base addition in each successive cycle (assuming the non-incoφoration occurs in all or most cycles). The invention overcomes this problem by exposing a template/primer complex to a labeled nucleotide that is capable of hybridizing to the template nucleotide immediately downstream of the primer. After removing unbound labeled nucleotide, the sample is exposed to unlabeled nucleotide, preferably in excess, of the same species. The unlabeled nucleotide "fills in" the positions in which hybridization of the labeled nucleotide did not occur. That functions to increase the number of strands that are available for participation in the next round. The effect is to increase resolution in subsequent rounds over background. In a preferred embodiment, the labeled nucleotide comprises a label that impedes the ability of polymerase to add a downstream nucleotide, thus temporarily halting the synthesis reaction until unlabeled nucleotide can be added, at which point polymerase inhibition is removed and t he next incoφoration cycle is conducted
[0023] One feature of this embodiment is that a sequence is compiled based upon the incoφoration data, while allowing maximum strand participation in each cycle. Thus, methods of the invention are useful for identifying placeholders in some strands in a population of strands being sequenced. As long as there are no more than two consecutive placeholders in any one strand, the invention has a high tolerance for placeholders with little or no effect on the ultimate sequence determination.
-[0024] Methods of the invention are also useful for identifying a single nucleotide in a nucleic acid sequence. The method comprises the steps of sequentially exposing a template- bound primer to a labeled nucleotide and an unlabeled nucleotide of the same type in the presence of a polymerase under conditions that allow template-dependent primer extension; determining whether the first nucleotide is incoφorated in the primer at a first position; repeating the sequentially exposing step using subsequent labeled and unlabeled nucleotides until a nucleotide is identified at the first position. [0025] Identification of nucleotides in a sequence can be accomplished according to the invention using fluorescence resonance energy transfer (FRET). Single pair FRET (spFRET) is a good mechanism for increasing signal-to-noise in single molecule sequencing. Generally, a FRET donor (e.g., cyanine-3) is placed on the primer, on the polymerase, or on a previously incoφorated nucleotide. The primer/template complex then is exposed to a nucleotide comprising a FRET acceptor (e.g., cyanine-5). If the nucleotide is incoφorated, the acceptor is activated and emits detectable radiation, while the donor goes dark. That is the indication that a nucleotide has been incoφorated. The nucleotide is identified based upon knowledge of which nucleotide species contained the acceptor. The invention also provides methods for identifying a placeholder in a nucleic acid sequence using FRET. A nucleic acid primer is hybridized to a target nucleic acid at a primer binding site in the target. The primer comprises a donor fluorophore. The hybridized primer is exposed to a first nucleotide comprising an acceptor fluorophore that, when incoφorated into the primer, prevents further polymerization of the primer. Whether there is fluorescent emission from the donor and the acceptor is determined, and a placeholder in the nucleic acid sequence is identified as the absence of emission in both the donor and the acceptor.
[0026] In another embodiment, the method comprises hybridizing a nucleic acid primer comprising a donor fluorophore to a target nucleic acid at a primer binding site in the target; exposing the hybridized primer to a first nucleotide comprising an acceptor fluorophore that, when incoφorated into the primer, prevents further polymerization of the primer; detecting the presence or absence of fluorescent emission from each of the donor and the acceptor; identifying a nucleotide that has been incoφorated into the primer via complementary base pairing with the target as the presence of fluorescent emission from the acceptor; identifying a sequence placeholder as the absence of fluorescent emission from the donor and the acceptor; and repeating the exposing, detecting, and each of the identifying steps, thereby to compile a sequence of the target nucleic acid based upon the sequence of the incoφorated nucleotides and the placeholders. [0027] The invention is useful in sequencing any form of polynucleotides, such as double-stranded DNA, single-stranded DNA, single-stranded DNA haiφins, DNA/RNA hybrids, RNAs with a recognition site for binding of the polymerizing agent, and RNA haiφins. The invention is particularly useful in high throughput sequencing of single molecule polynucleotides in which a plurality of target polynucleotides are attached to a solid support in a spatial arrangement such that each polynucleotides is individually optically resolvable. According to the invention, each detected incoφorated label represents a single polynucleotide. [0028] A detailed description of the certain embodiments of the invention is provided below. Other embodiments of the invention are apparent upon review of the detailed description that follows. Brief Description of the Drawings [0029] The patent or application file contains at least one drawing executed in color.
Copies of this patent or patent application publication with color drawings will be provided by the Office upon request and payment of the necessary fee. [0030] Figure 1 shows asynchronous single molecule sequencing.
[0031] Figure 2 are screenshots showing data from short cycle sequencing with long homopolymer regions. Figure 2a shows full cycle sequencing used to analyze 10 target polynucleotides in a simulated synthesis of their complementary strands using cycle periods of 10 half-lives and repeating the wash cycles 12 times. Figure 2b shows a short cycle sequencing to analyze 10 target polynucleotides by simulating the synthesis of their complementary strands using short cycle periods of 0.8 half-life periods and repeating the wash cycles 60 times.
[0032] Figure 3 shows a short cycle embodiment for analyzing 200 target polynucleotides in a simulated synthesis of their complementary strands using short cycle periods of 0.8 half-life periods and repeating the wash cycles 60 times. [0033] Figure 4 shows a statistical analysis of incoφoration, showing that polymerizing agent may incoφorate repeat labeled nucleotides less readily than the first labeled nucleotide.
[0034] Figure 5 shows a simulation showing the effect of decreasing the activity rate of the polymerizing agent and lengthening half-lives on the cycle period. [0035] Figure 6 shows the number of cycles needed with cycle periods of various half-lives taking into account stalling factors of two (squares), five (triangles) and 10
(crosses), in order to obtain over 25 incoφorations in over 80% of target homopolymers, with at least a 97% chance of incoφorating two or less nucleotides per cycle (or a smaller than 3% chance of incoφorating more than 2 nucleotides per cycle). [0036] Figure 7 is a series of screenshots showing the effects of altering reaction conditions on the incoφoration of nucleotides in a single molecule sequencing by synthesis reaction. Detailed Description [0037] The invention provides methods for high throughput single molecule sequencing. According to the invention, one or more parameters of a sequencing-by-synthesis reaction are preselected such that the incoφoration of, preferably, a single nucleotide on a primed target template is optically detectable. In one embodiment, the preselected parameters regulate the rate at which the nucleotides are incoφorated, and the rate at which the incoφorated nucleotides are detected. According to this embodiment, the nucleotides are individually detected either as they are incoφorated or shortly thereafter, essentially in "realtime. In another embodiment, the preselected parameters permit the regulation of the number of nucleotides incoφorated during a single extension cycle. In one aspect, the extension cycle is stopped short at a predetermined point at which, on average, only 0, 1, 2, or 3 nucleotides have been incoφorated into the primer, rather than permitting the reaction to run to near or full completion in each cycle.
[0038] Short cycle methods according to the invention increase the resolution of individual nucleotides incoφorated into the primer, but can decrease the yield of target templates successfully incoφorating a nucleotide in a single extension cycle. In traditional full cycle sequencing, nucleotides may be allowed to react in the presence of a polymerizing agent until at least one becomes incoφorated into at least 99% of the complementary strands. This would produce a yield of (0.99)n x 100% for a complementary strand extended by n nucleotides. Obtaining incoφoration in 99% of the complementary strands, however, requires a period of several half-lives of the incoφoration reaction, where one half-life is the time taken for at least one incoφoration to occur in 50% of the complementary strands. Typically, the more strands that complete an incoφoration during each cycle, the more n-mers obtained after n cycles. [0039] According to the invention, short cycle methods rely on a period of only a limited number of half-lives of exposure to nucleotides, thus resulting in fewer target templates having incoφorated a nucleotide in the short extension cycle. However, the short sequencing cycles provided by methods of the invention allow asynchronous analysis of polynucleotides. Thus, if an incoφoration reactions fails to occur on a particular target polynucleotide, it can be completed in a later cycle without producing erroneous information, or interfering with data from other target molecules being analyzed in parallel. As demonstrated in Figure 1, a cytosine ("C") incoφorates into the extension product of one copy of a target polynucleotide, but fails to incorporate into the other copy. During subsequent cycles of incoφoration, however, a C can be incoφorated, without adversely affection sequencing information. Thus, in asynchronous incoφoration, an incoφoration that failed to occur on a particular target in one-cycle can "catch up" in later cycles, permitting the use of shorter, even if more numerous, cycles.
[0040] Because short cycle methods according the invention permit the detection of, for example, one, two or three individual nucleotides incoφorated into a primed template, the invention overcomes the difficulty posed by homopolymer regions of a template sequence. While detection techniques may be able to quantify signal intensity from a smaller number of incoφorated nucleotides of the same base-type, for example two or three incoφorated nucleotides, longer runs of identical bases may not permit quantification due to increasing signal intensity. That is, it may become difficult to distinguish n bases from n+ 1 bases, where the fractional increase in signal intensity from the (n+ l)'h base is small relative to the signal intensity from the already-incoφorated n bases.
[0041] In embodiments using short-cycles, it is possible to limit the number of nucleotides that become incoφorated in a given cycle. For example, it can be determined by simulation that using a cycle period of about 0.8 half-lives can result in two or less incoiporations in nine out often homopolymer complementary strands. (See Example 2b). In another simulation, a 0.8 half-life period was shown to allow no more than two incoφorations in about 96.0% of 200 homopolymer complementary strands. As detection means can more readily quantify signal intensity from the smaller number of incoφorated nucleotides rather than from larger numbers, the use of short-cycles addresses this issue. For example, imaging systems known in the art can reliably distinguish the difference in signal intensity between one versus two fluorescent labeling moieties on consecutively-incoφorated nucleotides. Other imaging systems can reliably distinguish the difference in signal intensity between two versus three fluorescent labeling moieties on consecutively-incoφorated nucleotides. [0042] In a further embodiment of the invention, an extension cycle comprising a labeled nucleotide is followed by an extension cycle using an unlabeled nucleotide of the same type so that the position in each of the target template in which a labeled nucleotide failed to incoφorated becomes occupied by an unlabeled nucleotide. Methods in accordance with this embodiment provide for continued participation of specific template nucleic acids in which no incoφoration of the labeled nucleotide occurred and reduced probability of missing nucleotides in the resulting compiled sequence.
[0043] Further methods of the invention provide for identifying a placeholder in a nucleic acid sequence in the event that an accurate determination of a nucleotide at a particular position is not possible. A placeholder is simply a position of unknown identity. Such a placeholder may be represented in a nucleic acid sequence with, for example, an "X," a traditional symbol for an unspecified nucleotide. Slotting a placeholder in a nucleic acid sequence avoids frameshift-type errors in sequence determination. [0044] Additional aspects of the invention are described in the following sections and illustrated by the Examples. Target Nucleic Acids and Nucleotides
[0045] The invention is useful in sequencing any form of polynucleotides, including double-stranded DNA, single-stranded DNA single-stranded DNA haiφins, DNA RNA hybrids, RNAs with a recognition site for binding of the polymerizing agent, and RNA haiφins. Further, target polynucleotides may be a specific portion of a genome of a cell, such as an intron, regulatory region, allele, variant or mutation; the whole genome; or any portion therebetween. In other embodiments, the target polynucleotides may be mRNA, tRNA, rRNA, ribozymes, antisense RNA or RNAi. The target polynucleotide may be of any length, such as at least 10 bases, at least 25 bases, at least 50 bases, at least 100 bases, at least 500 bases, at least 1000 bases, or at least 2500 bases. The invention is particularly useful in high throughput sequencing of single molecule polynucleotides in which a plurality of target polynucleotides are attached to a solid support in a spatial arrangement such that each polynucleotides is individually optically resolvable. According to the invention, each detected incoφorated label represents a single polynucleotide
[0046] Nucleotides useful in the invention include both naturally-occurring and modified or non-naturally occurring nucleotides, and include nucleotide analogues. A nucleotide according to the invention may be, for example, a ribonucleotide, a deoxyribonucleotide, a modified ribonucleotide, a modified deoxyribonucleotide, a peptide nucleotide, a modified peptide nucleotide or a modified phosphate-sugar backbone nucleotide. Many aspects of nucleotides useful in the methods of the invention are subject to manipulation provide and suitable mechanisms for controlling the reaction. In particular, the species or type of nucleotide (i.e., natural or synthetic dATP, dCTP, dTTP, dGTP or dUTP; a natural or non- natural nucleotide) will affect the rate or efficiency of the reaction and therefore require consideration in preselecting parameters to produce the desire results.
[0047] In addition, certain modifications to the nucleotides, including attaching a label, will affect the reaction. The size, polarity, hydrophobicity, hydrophilicity, charge, and other chemical attributes should be considered in determining parameters that will produce the desired results in the reaction. Labeled nucleotides of the invention include any nucleotide that has been modified to include a label which is directly or indirectly detectable. Such labels include optically-detectable labels such fluorescent labels, including fluorescein, rhodamine, phosphor, polymethadine dye, fluorescent phosphoramidite, texas red, green fluorescent protein, acridine, cyanine, cyanine 5 dye, cyanine 3 dye, 5-(2'-aminoethyl)-aminonaphthalene- 1 -sulfonic acid (EDANS), BODIPY, ALEXA, or a derivative or modification of any of the foregoing. In one embodiment of the invention, fluorescence resonance energy transfer (FRET) technology is employed to produce a detectable, but quenchable, label. FRET may be used in the invention by, for example, modifying the primer to include a FRET donor moiety and using nucleotides labeled with a FRET acceptor moiety.
[0048] The fluorescently labeled nucleotides can be obtained commercially (e.g., from NEN DuPont, Amersham, and BDL). Alternatively, fluorescently labeled nucleotides can also be produced by various techniques, such as those described in Kambara et al., Bio/Techol. (1988) 6:816-821; Smith et al., Nucl. Acid Res. (1985) 13: 2399-2412, and Smith et al.., Nature (1986) 321: 674-79.
[0049] The fluorescent dye is preferably linked to the deoxyribose by a linker arm which is easily cleaved by chemical or enzymatic means. The length of the linker between the dye and the nucleotide can impact the incoφoration rate and efficiency (see Zhu et al., Cytometry (1997) 28, 206). There are numerous linkers and methods for attaching labels to nucleotides, as shown in Oligonucleotides and Analogues: A Practical Approach (1991) (IRL Press, Oxford); Zuckerman et al., Polynucleotides Research (1987) 15: 5305-21; Sharma et al., Polynucleotides Research, (1991) 19: 3019; Giusti et al., PCR Methods and Applications (1993) 2: 223-227; Fung et al., U.S. Patent No. 4,757,141; Stabinsky, U.S. Patent No. 4, 739,044; Agrawal et al., Tetrahedron Letters, (1990) 31: 1543-46; Sproat et al., Polynucleotides Research (1987) 15: 4837; and Nelson et al., Polynucleotides Research, (1989) 17: 7187-94.
[0050] While the invention is exemplified herein with fluorescent labels, the invention is not so limited and can be practiced using nucleotides labeled with any form of detectable label, including radioactive labels, chemoluminescent labels, luminescent labels, phosphorescent labels, fluorescence polarization labels, and charge labels. Reaction Parameters
[0051] Any parameter that permits the regulation of the number of labeled nucleotides added to the primer, or the rate at which the nucleotides are incoφorated and detected can be controlled or exploited in the practice of the invention. Such parameters include, for example, the presence or absence of a label on a nucleotide, the type of label and manner of label attachment; the linker identity and length used to attach the label; the type of nucleotide (including, for example, whether such nucleotide is a dATP, dCTP, dTTP, dGTP or dUTP; a natural or non-natural nucleotide, a nucleotide analogue, or a modified nucleotide); the local sequence immediately 3' to the addition position; whether the base is the first, second, third, etc. base added; the type of polymerase used; the particular batch characteristics of the polymerase; the processivity of the polymerase; the incoφoration rate of the polymerase, and use of polymerase cofactors. [0052] In addition, a variety of the conditions of the reaction provide useful mechanisms for controlling either the number of nucleotides incoφorated in a single extension reaction or the rates of nucleotide incoφoration and detection. Such conditions include the "half-life" of the extension cycle (where one half-life is the time taken for at least one incoφoration to occur in 50% of the complementary strands); the number of wash cycles (i.e., the number of times a nucleotide is introduced to the reaction then washed out); the number of target nucleic acids in the reaction; and the temperature of the reaction and the reagents used in the reaction. Half-Lives and Wash Cycles [0053] Based on the methods disclosed herein, those of skill in the art will be able to determine the period of half-lives required to limit the number incoφorations per cycle for a given number of target polynucleotides. (See Examples 2 and 3, Figures 2 and 3). Statistical simulations can also provide the number of repeated cycles needed to obtain a given number of incoφorations, for example, to sequence a 25 base pair sequence. (See Examples 2 and 3, Figures 2 and 3). Referring to the simulations above, for example, it can be deteπnined that 60 cycles, each 0.8 half-lives long, would be required for at least 25 incoφorations in each of ten complementary strands (Example 2b, Figure 2b). With 200 complementary strands, 60 cycles each 0.8 half-lives long produce at least 20 incoφorations in each strand (Example 3, Figure 3). Following the methodologies outlined herein, such as the simulated working examples detailed below, those of skill in the art will be able to make similar determinations for other numbers of targets of varying lengths, and use appropriate cycle periods and numbers of cycles to analyze homopolymer without using blocking moieties or reversible chain termination. [0054] The cycle period may also be chosen to permit a certain chance of incoφoration of a given number of nucleotides in a complementary strand, and the cycle may be repeated a number of times to analyze the sequence of various numbers of target polynucleotides of varying length.
[0055] In some embodiments, nucleotide half-lives for the incoφoration reaction are affected by the fact that polymerizing agent may incoφorate labeled nucleotides less readily than unlabeled nucleotides. Figure 4 illustrates the statistics of incoφoration for a certain embodiment using a Klenow exo-minus polymerizing agent and Cy3- or Cy5- labeled nucleotides. The results show that polymerase may incoφorate subsequent labeled nucleotides less readily than a prior labeled nucleotide. The graph of Figure 4 indicates, for example, that it may take five to ten times longer, resulting in a "stalling" of the incoφoration reaction. In other embodiments, the stalling may vary with the use of other labeled nucleotides, other polymerizing agents and various reaction conditions. [0056] Polymerase stalling is a useful mechanism for controlling incoφoration rates in single molecule reactions. As is shown in the Examples below, polymerase stalling is useful to limit incoφoration of nucleotides into any given strand in a fairly precise manner. According to the invention, polymerase stalling is useful to limit incoφoration to 1 nucleotide per strand per cycle, on average. Given a priori knowledge of the statistics of incoφoration, single molecule reactions are controlled to provide a statistical likelihood that 1, sometimes 2, but rarely 3 nucleotides are incoφorated in a strand in any given cycle. [0057] For example, the rate at which polymerase incoφorates labeled nucleotides into a complementary strand may be slowed by a factor of about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, or about 15 times compared to that observed with unlabeled nucleotides or compared to that observed for a prior incoφorated labeled nucleotide. [0058] Moreover, this inhibition or delaying and longer half-lives can be taken into account when determining appropriate cycle periods and numbers of cycles to analyze homopolymer targets of a given length. Figures 3 and 4, for example, illustrate the results of simulations in which various factors affecting incoφoration rates are taken into account. The graph of Figure 4, for example, shows the number of cycles needed with cycle periods of various half-lives, taking into account stalling factors of two (squares), five (triangles), and 10 (crosses), in order to obtain 25 incoφorations in over 80% of target strands, with at least a 97% chance of incoφorating two or fewer nucleotides per cycle (or a smaller than 3% chance of incoφorating three or more nucleotides per cycle). As the graph shows, stalling allows longer half-lives, which, in turn, permits the use of fewer cycles to obtain a "full" sequence with a defined eπor rate. As Figure 5 illustrates, if the use of labeled nucleotides slows down the polymerizing agent by a factor of 5, a cycle period of 2.4 half-lives produces over 80% 25-mers in 30 cycles. Based on the teachings of the invention, one of ordinary skill in the art can determine the cycle period required to limit the number incoφorations per cycle for a given number of target polynucleotides of a given length.
[0059] Applying methods disclosed herein, the cycle period may be selected to peπnit about a 70%, about a 75%, about an 80%>, about an 85%, about a 90%, about a 95%>, about a 96%, about a 97%, about a 98%, and about a 99% chance of incoφoration of two or less nucleotides into the complementary strand. Other cycle periods that may be used in embodiments of the invention include, for example, no more than about 5 half-lives, no more than about 4 half-lives, no more than about 3 half-lives, no more than about 2 half-lives, no more than about 1 half-lives, no more than about 0.9 half-lives, no more than about 0.8 half- lives, no more than about 0.7 half-lives, no more than about 0.6 half-lives, no more than about 0.5 half-lives, no more than about 0.4 half-lives, no more than about 0.3 half-lives, and no more than about 0.2 half-lives of the incoφoration reactions.
[0060] In addition to the Examples provided below, various cycle periods and number of times the cycles are repeated may be used with various numbers of targets in certain embodiments of the invention. These include, for example, using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 50 times; using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 60 times; using about 200 target polynucleotides, a period of no more than about 0.6 half-lives and repeating at least about 70 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 50 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 60 times; using about 200 target polynucleotides, a period of no more than about 0.8 half-lives and repeating at least about 70 times; using about 200 target polynucleotides, a period of no more than about 1 half-life and repeating at least about 50 times; using about 200 target polynucleotides, a period of no more than about 1 half-life and repeating at least about 60 times; and using about 200 target polynucleotides, a period of no more than about 1 half-life and repeating at least about 70 times. In any of these embodiments, signal from incoφorated nucleotides may be reduced after each or a number of cycles. [0061] The number of times the cycles need to be repeated is also determined based on methods described herein. In general, the number of cycles increases with the length of the sequence to be analyzed and the duration of the half life of nucleotide exposure decreases as the length of sequence to be analyzed becomes longer. Also in general, half lives of nucleotide exposure increase and cycle numbers decrease with greater inhibitory or delaying effects on nucleotide incoφoration
[0062] Taking into account various stalling factors, examples of cycle periods and number repeat cycles that may be used in certain embodiments further include a cycle period of no more than about 0.5 half-lives with a stalling factor of about 2, repeated at least about 90 times; a cycle period of no more than about 0.75 half-lives, with a stalling factor of about 2, repeated at least about 75 times; a cycle period of no more than about 1 half-lives, with a stalling factor of about 2, repeated at least about 50 times; a cycle period of no more than about 1.5 half-lives with a stalling factor of about 2 or about 5, repeated at least about 45 times; a cycle period of no more than about 1.75 half-lives, with a stalling factor of about 5, repeated at least about 35 times; a cycle period of no more than about 2 half-lives, with a stalling factor of about 5 or about 10, repeated at least about 35 times; a cycle period of no more than about 2.25 half-lives, with a stalling factor of about 5 or about 10, repeated at least about 30 or at least about 35 times, and a cycle period of about 2.4 half-lives, with a stalling factor of about 5, repeated at least about 30 times. Polymerases and Polymerase Cofactors
[0063] Polymerizing agents useful in the invention include DNA polymerases (such as Taq polymerase, T7 mutant DNA polymerase, Klenow and Sequenase, 9°N or a variant thereof), RNA polymerases, thermostable polymerases, thermodegradable polymerases, and reverse transcriptases. See e.g., Doublie et al., Nature (1998) 391:251-58; Ollis et al. Nature (1985) 313: 762-66; Beese et al., Science (1993) 260: 352-55; Korolev et al., Proc. Natl.
Acad. Sci. USA (1995) 92: 9264-68; Keifer et al., Structure (1997) 5:95-108; and Kim et al., Nature (1995) 376:612-16.
[0064] Cofactors of the invention function to inhibit the polymerizing agent, thereby slowing or stopping synthesis activity, permitting the detection of an incoφorated labeled nucleotide. Cofactors of the invention include any chemical agent or reaction condition that results in the inhibition of the polymerizing agent. Such inhibition may be in whole or in part and may be permanent, temporary or reversible. For example, a cofactor may be a label, an antibody, an aptamer, an organic or inorganic small molecule, or a polyanion, or it may comprise a chemical modification to a nucleotide (i.e., a nucleotide analogue may comprise a cofactor). A cofactor can be in solution, or it may be attached, either directly or through a linker to a nucleotide, primer, template or polymerase.
[0065] Examples of useful cofactor agents include, among others, light sensitive groups such as 6-nitoveratryloxycarbonyl (NVOC), 2-nitobenzyloxycarbonyl (NBOC), α, α- dimethyl-dimethoxybenzyloxycarbonyl (DDZ), 5-bromo-7-nitroindolinyl, o-hyrdoxy-2- methyl cinnamoyl, 2-oxymethylene anthraquinone, and t-butyl oxycarbonyl (TBOC). Oligonucleotide Synthesis: A Practical Approach (IRL Press, Oxford). Useful polyanions are described in U.S. Patent No. 6,667,165 (the disclosure of which is incoφorated by reference herein); and useful aptamers are described in U.S. Patent Nos. 6,020,130 and 6,183,967 (the disclosures of which are incoφorated by reference herein). See U.S. Patent No. 5,338,671 for useful antibodies. Nucleotides possessing various labels and cofactors can be readily synthesized. Labeling moieties are attached at appropriate sites on the nucleotide using chemistry and conditions as described in Gait (1984). [0066] Further, the cofactor may also be the detectable label. Labels useful as combined labels/cofactors include larger or bulky dyes. For example, the detectable label may comprise a dye having a bulky chemical structure that, once the nucleotide is incoφorated into the extending primer, causes a steric hindrance of the polymerizing agent, blocking the polymerizing agent from any further synthesis. Examples of labels that may be useful for this puφose are described in the Example, as well as in Zhu et al., Polynucleotides Res. (1994) 22: 3418-22. For example, fluorophore labels that may be used to stall the polymerase include Cy3, Cy5, Cy7, ALEXA647, ALEXA 488, BODIPY 576/589, BODIPY 650/665, BODIPY TR, Nile Blue, Sulfo-IRD700, NN382, R6G, Rho 123, tetramethylrhodamine and Rhodamine X. In one embodiment, the labels are as bulky as Cy5, with molecular weights at least about 1.5 kDa. In another embodiment, the labels are bulkier than Cy5, having molecular weights of at least about 1.6 kDa, at least about 1.7 kDa, at least about 1.8 kDa, at least about 1.9 kDa, at least about 2.0 kDa at least bout 2.5 kDa, or at least about 3.0 kDa. [0067] Further examples of such larger dyes include the following, with corresponding formula weights (in g/mol) in parentheses: Cy5 (534.6); Pyrene (535.6); 6- Carboxyfluorescein (FAM) (537.5); 6-Carboxyfluorescein-DMT (FAM-X (537.5); 5(6) Carboxyfluorescein (FAM) (537.5); 5-Fluorescein (FITC) (537.6); Cy3B (543.0); WellRED D4-PA (544.8); BODIPY 630/650 (545.5); 3* 6-Carboxyfluorescein (FAM) (569.5); Cy3.5 (576.7); Cascade Blue (580.0); ALEXA Fluor 430 (586.8); Lucifer Yellow (605.5); ALEXA Fluor 532 (608.8); WellRED D2-PA (611.0); Cy5.5 (634.8); DY-630 (634.8); DY-555 (636.2); WellRED D3-PA (645.0); Rhodamine Red-X (654.0); DY-730 (660.9); DY-782 (660.9); DY-550 (667.8); DY-610 (667.8); DY-700 (668.9); 6-Tetrachlorofluorescein (TET) (675.2) ALEXA Fluor 568 (676.8); DY-650 (686.9); 5(6)- Carboxyeosin (689.0); Texas Red- X (702.0); ALEXA Fluor 594 (704.9); DY-675 (706.9); DY-750 (713.0); DY-681 (736.9); Hexachlorofluorescein (HEX) (744.1); DY-633 (751.9); LightCycler Red 705 (753.0); LightCycler Red 640 (758.0); DY-636 (760.9); DY-701 (770.9); FAR-Fuchsia (5'-Amidite) (776.0); FAR-Fuchsia (SE) (776.0); DY-676 (808.0); Erythrosin (814); FAR-Blue (5'- Amidite) (824.0); FAR-Blue (SE) (824.0); Oyster 556 (850.0); Oyster 656 (900.0); FAR- Green Two (SE) (960.0); ALEXA Fluor 546 (964.4); FAR-Green One (SE), (976.0); ALEXA Fluor 660 (985.0); Oyster 645 (1000.0); ALEXA Fluor 680 (1035.0); ALEXA Fluor 633 (1085.0); ALEXA Fluor 555 (1135.0); ALEXA Fluor 647 (1185.0); ALEXA Fluor 750 (1185.0); ALEXA Fluor 700 (1285.0). These reagents are commercially available from SYNTHEGEN, LLC (Houston, Tex.). [0068] There is extensive guidance in the literature for derivatizing fluorophore and quencher molecules for covalent attachment via common reactive groups that can be added to a nucleotide (see Haugland, Handbook of Fluorescent Probes and Research Chemicals (1992). There are also many linking moieties and methods for attaching fluorophore moieties to nucleotides, as described in Oligonucleotides and Analogues, supra; Guisti et al., supra; Agrawal et al, Tetrahedron Letters (1990) 31: 1543-46; and Sproat et al., Polynucleotide Research (1987) 15: 4837.
[0069] In one embodiment, the method further comprises inactivating the cofactor, thereby reversing its effect on the polymerizing agent. Modes of inactivation depend on the cofactor. For example, where the cofactor is attached to the nucleotide, inactivation can typically be achieyed by chemical, enzymatic, photochemical or radiation cleavage of the cofactor from the nucleotide. Cleavage of the cofactor can be achieved if a detachable connection between the nucleotide and the cofactor is used. For example, the use of disulfide bonds enables one to disconnect the dye by applying a reducing agent like dithiothreitol (DTT). In a further alternative, where the cofactor is a fluorescent label, it is possible to neutralize the label by bleaching it with radiation.
[0070] In the event that temperature-sensitive cofactors are utilized, inactivation may comprise adjusting the reaction temperature. For example, an antibody that binds to thermostable polymerase at lower temperatures and blocks activity, but is denatured at higher temperatures, thus rendering the polymerase active; or single-stranded aptamers that bind to thermophilic polymerase at lower temperatures but are released at higher temperatures, may be inactivated by increasing the reaction temperature such the cofactor is released but polymerase activity is permitted. [0071] In one embodiment, transient inhibition of the polymerase and the time of exposure to the labeled nucleotide are coordinated such that it is statistically likely that at least one of the labeled nucleotide is incoφorated in the primer, but statistically unlikely that more than two of the labeled nucleotide are incoφorated. In another embodiment, the reaction is controlled by inhibiting the polymerase activity such that it is statistically unlikely that more than, for example, one or two nucleotides are incoφorated into the same primer strand in the cycle. Temperature and Reagents [0072] Other reaction conditions that are useful in the methods of the invention include reaction temperature and reagents. For example, a temperature above or below the temperature required for optimal activity of the polymerizing agent, such as a temperature of about 20-70°, would be expected to result in a modulation of the polymerization rate, C. This form of inhibition is typically reversible with correction of the reaction temperature, provided that the delta in temperature was insufficient to cause a permanent damage to the polymerase. [0073] In another embodiment, buffer reagents useful in the methods of the invention include a detergent or surfactant, such as Triton®-X 100, or salt and/or ion concentrations that facilitate or inhibit nucleotide incoφoration. Predetermined Points For Stopping a Cycle
[0074] The predetermined point at which a short cycle is stopped is defined, for example, by the occurrence of an event (such as the incoφoration of a nucleotide comprising a blocking moiety that prevents further extension of the primer), the lapse of a certain amount of time (such as a specific number of half-lives), or the achievement of a statistically- significant datapoint (such as a period at which a statistically significant probability of two or less nucleotides have been incoφorated). In one embodiment, the predetermined period of time is coordinated with an amount of polymerization inhibition such that, on average, a certain number of labeled nucleotides are added to the primer. In another embodiment, the number of incoφorated labeled nucleotides is, on average, 0, 1 or 2, but almost never more than 3. The time period of exposure is defined in terms of statistical significance. For example, the time period may be that which is statistically insufficient for incoφoration of more nucleotides than are resolvable by a detection system used to detect incoφoration of the nucleotide into the primer. In another example, the time period that is statistically insufficient for incoφoration of a greater number of nucleotides that are individually optically resolvable during a predetermined detection period (i.e., a period of time during which the incoφorated nucleotides are detected).
[0075] The reaction may be stopped by washing or flushing out the nucleotides that remain unincoφorated and/or washing or flushing out polymerization agent. Further, many aspects of the repeated cycles may be automated, for example, using microfluidics for washing nucleotides to sites of anchored target polynucleotides, and washing out unincoφorated nucleotides to halt each cycle.
[0076] The following exemplifications of the invention are useful in understanding certain aspects of the invention but are not intended to limit the scope of the invention in any way. Example 1
[0077] Primers are synthesized from nucleoside triphosphates by known automated oligonucleotide synthetic techniques, e.g., via standard phosphoramidite technology utilizing a nucleic acid synthesizer, such as the ABI3700 (Applied Biosystems, Foster City, CA). The oligonucleotides are prepared as duplexes with a complementary strand, however, only the 5' terminus of the oligonucleotide proper (and not its complement) is biotinylated. Ligation of Oligonucleotides and Target polynucleotides [0078] Double stranded target nucleic acids are blunt-end ligated to the oligonucleotides in solution using, for example, T4 ligase. The single strand having a 5' biotinylated terminus of the oligonucleotide duplex permits the blunt-end ligation on only on end of the duplex. In a preferred embodiment, the solution-phase reaction is performed in the presence of an excess amount of oligonucleotide to prohibit the formation of concantamers and circular ligation products of the target nucleic acids. Upon ligation, a plurality of chimeric polynucleotide duplexes result. Chimeric polynucleotides are separated from unbound oligonucleotides based upon size and reduced to single strands by subjecting them to a temperature that destabilizes the hydrogen bonds. Preparation of Solid Support [0079] A solid support comprising reaction chambers having a fused silica surface is sonicated in 2% MICRO-90 soap (Cole-Parmer, Vernon Hills, IL) for 20 minutes and then cleaned by immersion in boiling RCA solution (6:4:1 high-purity H2O/30% NH4OH/30% H202) for 1 hour. It is then immersed alternately in polyallylamine (positively charged) and polyacrylic acid (negatively charged; both from Aldrich) at 2 mg/ml and pH 8 for 10 minutes each and washed intensively with distilled water in between. The slides are incubated with 5 mM biotin-amine reagent (Biotin-EZ-Link, Pierce) for 10 minutes in the presence of l-[3- (dimethylamino)propyl]-3-ethylcarbodiimidehydrochloride (EDC, Sigma) in MES buffer, followed by incubation with Streptavidin Plus (Prozyme, San Leandro, CA) at 0.1 mg/ml for 15 minutes in Tris buffer. The biotinylated single-stranded chimeric polynucleotides are deposited via ink-jet printing onto the streptavidin-coated chamber surface at 10 pMfor 10 minutes in Tris buffer that contain 100 mM MgCl2. Equipment [0080] The experiments are performed on an upright microscope (BH-2, Olympus,
Melville, NY) equipped with total internal reflection (TIR) illumination, such as the BH-2 microscope from Olympus (Melville, NY). Two laser beams, 635 (Coherent, Santa Clara, CA) and 532 nm (Brimrose, Baltimore), with nominal powers of 8 and 10 mW, respectively, are circularly polarized by quarter- wave plates and undergo TIR in a dove prism (Edmund Scientific, Baπϊngton, NJ). The prism is optically coupled to the fused silica bottom (Esco, Oak Ridge, NJ) of the reaction chambers so that evanescent waves illuminated up to 150 nm above the surface of the fused silica. An objective (DPlanApo, 100 UV 1.3 oil, Olympus) collects the fluorescence signal through the top plastic cover of the chamber, which is deflected by the objective to R. 0 μm from the silica surface. An image splitter (Optical Insights, Santa Fe, NM) directs the light through two bandpass filters (630dcxr, HQ585/80, HQ690/60; Chroma Technology, Brattleboro, VT) to an intensified charge-coupled device (I- PentaMAX; Roper Scientific, Trenton, NJ), which records adjacent images of a 120- x 60-μm section of the surface in two colors. Experimental Protocols FRET-Based Method Using Nucleotide-Based Donor Fluorophore [0081] In a first experiment, universal primer is hybridized to a primer attachment site present in support-bound chimeric polynucleotides. Next, a series of incoφoration reactions are conducted in which a first nucleotide comprising a cyanine-3 donor fluorophore is incoφorated into the primer as the first extended nucleotide. If all the chimeric sequences are the same, then a minimum of one labeled nucleotide must be added as the initial FRET donor because the template nucleotide immediately 3' of the primer is the same on all chimeric polynucleotides. If different chimeric polynucleotides are used (i.e., the polynucleotide portion added to the bound oligonucleotides is different at least one location), then all four labeled dNTPs initially are cycled. The result is the addition of at least one donor fluorophore to each chimeric strand. [0082] The number of initial incoφorations containing the donor fluorophore is limited by either limiting the reaction time (i.e., the time of exposure to donor-labeled nucleotides), by polymerase stalling, or both in combination. The inventors have shown that base-addition reactions are regulated by controlling reaction conditions. For example, incoφorations can be limited to 1 or 2 at a time by causing polymerase to stall after the addition of a first base. One way in which this is accomplished is by attaching a dye to the first added base that either chemically or sterically interferes with the efficiency of incoφoration of a second base. A computer model was constructed using Visual Basic (v. 6.0, Microsoft Coφ.) that replicates the stochastic addition of bases in template-dependent nucleic acid synthesis. The model utilizes several variables that are thought to be the most significant factors affecting the rate of base addition. The number of half-lives until dNTPs are flushed is a measure of the amount of time that a template-dependent system is exposed to dNTPs in solution. The more rapidly dNTPs are removed from the template, the lower will be the incoφoration rate. The number of wash cycles does not affect incoφoration in any given cycle, but affects the number bases ultimately added to the extending primer. The number of sfrands to be analyzed is a variable of significance when there is not an excess of dNTPs in the reaction. Finally, the inhibition rate is an approximation of the extent of base addition inhibition, usually due to polymerase stalling. The homopolymer count within any strand can be ignored for puφoses of this application. Figure 2 is a screenshot showing the inputs used in the model. [0083] The model demonstrates that, by controlling reaction conditions, one can precisely control the number of bases that are added to an extending primer in any given cycle of incoφoration. For example, as shown in Figure 7, at a constant rate of inhibition of second base incoφoration (i.e., the inhibitory effect of incoφoration of a second base given the presence of a first base), the amount of time that dNTPs are exposed to template in the presence of polymerase determines the number of bases that are statistically likely to be incoφorated in any given cycle (a cycle being defined as one round of exposure of template to dNTPs and washing of unbound dNTP from the reaction mixture). As shown in Figure 7a, when time of exposure to dNTPs is limited, the statistical likelihood of incoφoration of more than two bases is essentially zero, and the likelihood of incoφoration of two bases in a row in the same cycle is very low. If the time of exposure is increased, the likelihood of incoφoration of multiple bases in any given cycle is much higher. Thus, the model reflects biological reality. At a constant rate of polymerase inhibition (assuming that complete stalling is avoided), the time of exposure of a template to dNTPs for incoφoration is a significant factor in determining the number of bases that will be incoφorated in succession in any cycle. Similarly, if time of exposure is held constant, the amount of polymerase stalling will have a predominant effect on the number of successive bases that are incoφorated in any given cycle (See, Figure 7b). Thus, it is possible at any point in the sequencing process to add or renew donor fluorophore by simply limiting the statistical likelihood of incoφoration of more than one base in a cycle in which the donor fluorophore is added.
[0084] Upon introduction of a donor fluorophore into the extending primer sequence, further nucleotides comprising acceptor fluorophores (here, cyanine-5) are added in a template-dependent manner. It is known that the Foster radius of Cy-3/Cy5 fluorophore pairs is about 5 nm (or about 15 nucleotides, on average). Thus, donor must be refreshed about every 15 bases. This is accomplished under the parameters outlined above. In general, each ' cycle preferably is regulated to allow incoφoration of 1 or 2, but never 3 bases. So, refreshing the donor means simply the addition of all four possible nucleotides in a mixed- sequence population using the donor fluorophore instead of the acceptor fluorophore every approximately 15 bases (or cycles). Figure 2 shows schematically the process of FRET-based, template-dependent nucleotide addition as described in this example. [0085] The methods described above are alternatively conducted with the FRET donor attached to the polymerase molecule. In that embodiment, donor follows the extending primer as new nucleotides bearing acceptor fluorophores are added. Thus, there typically is no requirement to refresh the donor. In another embodiment, the same methods are carried out using a nucleotide binding protein (e.g., DNA binding protein) as the carrier of a donor fluorophore. In that embodiment, the DNA binding protein is spaced at intervals (e.g., about 5 nm or less) to allow FRET. Thus, there are many alternatives for using FRET to conduct single molecule sequencing using the devices and methods taught in the application. However, it is not required that FRET be used as the detection method. Rather, because of the intensities of the FRET signal with respect to background, FRET is an alternative for use when background radiation is relatively high. Non-FRET Based Methods [0086] Methods for detecting single molecule incoφoration without FRET are also conducted. In this embodiment, incoφorated nucleotides are detected by virtue of their optical emissions after sample washing. Primers are hybridized to the primer attachment site of bound chimeric polynucleotides Reactions are conducted in a solution comprising Klenow fragment Exo-minus polymerase (New England Biolabs) at 10 nM (100 units/ml) and a labeled nucleotide triphosphate in EcoPol reaction buffer (New England Biolabs). Sequencing reactions takes place in a stepwise fashion. First, 0.2 μM dUTP-Cy3 and polymerase are introduced to support-bound chimeric polynucleotides, incubated for 6 to 15 minutes, and washed out. Images of the surface are then analyzed for primer-incoφoratedU- Cy5. Typically, eight exposures of 0.5 seconds each are taken in each field of view in order to compensate for possible intermittency (e.g., blinking) in fluorophore emission. Software is employed to analyze the locations and intensities of fluorescence objects in the intensified charge-coupled device pictures. Fluorescent images acquired in the WinView32 interface (Roper Scientific, Princeton, NJ) are analyzed using ImagePro Plus software (Media Cybernetics, Silver Springs, Md). Essentially, the software is programmed to perform spot- finding in a predefined image field using user-defined size and intensity filters. The program then assigns grid coordinates to each identified spot, and normalizes the intensity of spot fluorescence with respect to background across multiple image frames. From those data, specific incoφorated nucleotides are identified. Generally, the type of image analysis software employed to analyze fluorescent images is immaterial as long as it is capable of being programmed to discriminate a desired signal over background. The programming of commercial software packages for specific image analysis tasks is known to those of ordinary skill in the art. If U-Cy5 is not incoφorated, the substrate is washed, and the process is repeated with dGTP-Cy5, dATP-Cy5, and dCTP-Cy5 until incoφoration is observed. The label attached to any incoφorated nucleotide is neutralized, and the process is repeated. To reduce bleaching of the fluorescence dyes, an oxygen scavenging system can be used during all green illumination periods, with the exception of the bleaching of the primer tag. [0087] In order to determine a template sequence, the above protocol is performed sequentially in the presence of a single species of labeled dATP, dGTP, dCTP or dUTP. By so doing, a first sequence can be compiled that is based upon the sequential incoφoration of the nucleotides into the extended primer. The first compiled sequence is representative of the complement of the template. As such, the sequence of the template can be easily determined by compiling a second sequence that is complementary to the first sequence. Because the sequence of the oligonucleotide is known, those nucleotides can be excluded from the second sequence to produce a resultant sequence that is representative of the target template.
Example 2
[0088] Figure 2 illustrates the advantage of short-cycle sequencing with respect to avoiding long homopolymer reads. Figure 2a illustrates a simulated analysis of 10 target polynucleotides using non-short-cycle sequencing (Example 2a), whereas Figure 2b illustrates a simulated analysis of the same number of target polynucleotides using short-cycle sequencing (Example 2 b).
[0089] The simulations were performed as follows: an Excel spreadsheet was opened and "Customize..." selected from the "Tools" menu of the Excel toolbar. The "Commands" tab was selected and, after scrolling down, "Macros" was clicked. The "smiley face" that appeared in the right panel was dragged to the toolbars on top of the spreadsheet. The
"Customize" box was closed and the "smiley face" clicked once. From the list of subroutines that appeared, "ThisWorkbook.MainJLine." was selected. The program was run by clicking again on the "smiley face." A copy of the source code for the Excel simulation is provided below. [0090] Input values were then entered into the tabbed sheet called "In Out." There were three input values: '
[0091] The first input value corresponded to the period of time allowed for incoφoration reactions of provided nucleotides into the growing complementary strands of the polynucleotides to be analyzed. This period was conveniently measured in half-lives of the incoφoration reaction itself. Each cycle of incoφoration was simulatedly stalled after a period of time, representing, for example, the time when unincoφorated nucleotides would be flushed out or the incoφoration reactions otherwise stalled.
[0092] The second input value corresponds to the number of times each cycle of incoφoration was repeated. That is, the number of times the steps of providing nucleotides, allowing incoφoration reactions into the complementary sfrands in the presence of polymerizing agent, and then stopping the incoφorations are repeated. The nucleotides were simulatedly provided as a wash of each of dATPs, dGTPs, dTTPs, and dCTPs. The program then recorded which nucleotides were incoφorated, corresponding to a detection step of detecting incoφoration. [0093] The third input value corresponds to number of strands of target polynucleotides to by analyzed in the simulation. The program allowed up to 1100 target polynucleotide molecules to be analyzed in a given simulation. [0094] After the program was started, as described above, the program first generated the inputted number of strands composed of random sequences. The program then simulated hybridization and polymerization of the correct base of each incoφoration reaction, based on the generated sequence of the target polynucleotide templates. The program continued these simulated reactions for the allowed amount of simulated time, determined by the inputted number of half-lives. Statistics of the simulation were then computed and reported, including the longest strand, the shortest strand, and the average length of all strands, as well as the fraction of strands extended by at least 25 nucleotide incoφorations, as discussed in more detail below. [0095] In the first part of this simulation, Example 2 a, the input values used were a cycle period of 10 half-lives, 12 repeats of the cycle, and 10 target polynucleotide strands. [0096] Figure 2a illustrates the results obtained. Homopolymers stretches which occurred in the same simulated complementary strand are highlighted in magenta wherever 2 nucleotides of the same base type were incoφorated in a row, and in cyan wherever more than two nucleotides of the same base type were incoφorated in a row. [0097] Figure 2a illustrates that the output values included the longest extended complementary strand obtained during the simulation (Longest extension in the ensemble of molecules); the shorted extended complementary strand obtained during the simulation (Shortest extension in the ensemble of molecules); and the average extension. These numbers represent the greatest number of incoφorations into any of the 10 simulatedly growing complementary strands, the smallest number of incoφorations for any of the 10, and the average number of incoφorations for the 10. Figure 2a indicates that the values obtained for Example 2a were 37 incoφorations in the longest extension, 25 in the shortest, and 30.00 as the average number of incoφorations. [0098] The output values also provided infonnation on the number of incoφorations that occurred in each of growing complementary sfrands during each cycle period of the simulation. For example, Figure 2a indicates that for the input values of Example 2a, the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 100.0%; and the percentage of growing strands extended by three or more nucleotides in a homopolymer stretch was 60.0%. That is, using a cycle period of 10 half-lives resulted in only 40% of the complementary strands being extended by two or less nucleotides in a homopolymer stretch per cycle of incoφoration.
[0099] Further, output values also indicated the total number of incoφorations for each of the growing strands for the total number of repeated cycles. This represents the length of the sequence of target polynucleotide analyzed. Figure 2a illustrates that in Example 2 a, 100.0% of the 10 target polynucleotides of the simulation were extended by at least 25 incoφorated nucleotides. This illustrates that using a cycle period of 10 half-lives, and repeating the cycles 12 times, allowed analysis of a 25 base sequence of 10 target polynucleotides.
[0100] In the second part of this simulation, Example 2b, the input values used were a cycle period of 0.8 half-lives, 60 repeats of the cycle, and 10 target polynucleotide strands. [0101] Figure 2b illustrates the results obtained. Homopolymers stretches which occurred in the same simulated complementary strand are highlighted in magenta wherever 2 nucleotides of the same base type were incoφorated in a row, and in cyan wherever more than two nucleotides of the same base type were incoφorated in a row. [0102] Figure 2b illustrates that the output values included the longest extended complementary strand obtained during the simulation (longest extension in the ensemble of molecules); the shortest extended complementary sfrand obtained during the simulation (shortest extension in the ensemble of molecules); and the average extension. These numbers represent the greatest number of incoφorations into any of the 10 simulatedly growing complementary sfrands, the smallest number of incoφorations for any of the 10, and the average number of incoφorations for the 10. Figure 2b indicates that the values obtained for Example 2b were 37 incoφorations in the longest extension, 26 in the shortest, and 32.00 as the average number of incoφorations.
[0103] The output values also provided information on the number of incoφorations that occurred in each of growing complementary strands during each cycle period of the simulation. For example, Figure 2b indicates that for the input values of Example 2b, the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 80.0%; and the percentage of growing sfrands extended by three or more nucleotides in a homopolymer stretch was 10.0%. That is, using a cycle period of 0.8 half-lives resulted in 90% of the complementary strands being extended by two or less nucleotides per cycle of incoφoration. [0104] Output values also indicated the total number of incoφorations for each of the growing strands for the total number of repeated cycles. As in Example 2a, this represents the length of the sequence of target polynucleotide analyzed. Figure 2b illustrates that in Example 2b, 100.0% of the 10 target polynucleotides of the simulation were again extended by at least 25 incoφorated nucleotides. This illustrates that using a cycle period of 0.8 half- lives, and repeating the cycles 60 times, allowed analysis of a 25 base sequence of 10 target polynucleotides.
[0105] Comparing the two simulations, it will be appreciated by those in the art that the use of short-cycles of sequencing overcame issues of reading long repeats of homopolymer stretches in sequencing by synthesis, without using blocking moieties, as only a few nucleotides were incoφorated per cycle. Comparing Examples 2a and 2b, the long cycles in 2a resulted in 40% of the extended complementary sfrands having two or less homopolymer nucleotide incoφorations per cycle. Conversely, the short cycles in 1 lb resulted in 90% of the extended complementary strands having two or less homopolymer nucleotide incoφorations per cycle, facilitating quantification. That is, as explained more thoroughly above, shorter reads can be quantitated to determine the number of nucleotides incoφorated, for example, where the nucleotides are of the same
[0106] Comparing Examples 2a and 2b also indicated that a greater number of repeated cycles were needed to analyze a given length of sequence when using shorter cycles. That is, the 10 half-lives cycle was repeated 12 times to result in 100.0% of the 10 complementary sfrands being extended by at least 25 nucleotides, whereas the 0.8 half-lives cycle was repeated 60 times to obtain this same result and thereby analyze the 25 nucleotides sequence. [0107] Nonetheless, many aspects of the repeated cycles may be automated, for example, using micro fluidics for washing nucleotides to sites of anchored target polynucleotides, and washing out unincoφorated nucleotides to halt each cycle.
[0108] As discussed herein, below is a copy of the source code for the simulation of short-cycle sequencing. Source Code for Simulation of Short Cycle Sequencing
Option Explicit 'all variables must be declared Option Base 1 'array pointers start at '1' not '0'
' Constant Declarations- Const NoColor = 0 Const Black = 1 Const White = 2 Const Red = 3 Const Green = 4 Const Blue = 5 Const Yellow = 6 Const Magenta = 7 Const Cyan = 8 Const A = Red Const G = Green Const T = Blue Const C = Yellow
Const TENTH HL = 0.93305
' Variable Declarations
'Note: HL is short for half-life
Dim MaxHalfLives As Integer 'The maximum number of half-lives the experiment will be run XI 0 for each wash cycle
Dim HalfLives 'the Half Life variable is stepped in increments 0.1 half lives during every wash cycle until the max is reached
Dim N, I, J, K, L, X, Y, Temp As Integer
Dim WashCyclesMax, WashCycles 'A wash cycle is completed after flowing each of
AGT&C Dim Molecule, Base, BaseType, Position As Integer
Dim TempReal As Single
Dim RandomMoleculesMax
Dim HomoPolymersMax
Dim MoleculesMax As Integer
' the following three variables used to slow things down for second base
Dim LongerJHL As Single Dim SecondMoleculeFactor As Integer
' The array variables Dim TargetStrand( 1100, 51) As Integer '--up 1100 molecules, with max length of 50
Dim SynthesizedSfrand(l 100, 51) As Integer
Dim HL_Tracker(l 100, 51) As Integer
Dim PolymerasePointer(l 100) As Integer '--contains the next available position on a given sfrand Dim StartPointer(l 100) As Integer 'pointers for determining run-lengths
Dim StopPointer(l 100) As Integer
Dim Extension(l 100) 'records how far each molecule has been extended
Dim TargetStrandFrequencyDist(15) As Integer '--for storing frequency distribution of n- mers of target strand Dim SyntheticSfrandFrequencyDist( 15) As Integer '--for storing frequency distribution of n- mers of target strand
Dim SecondMolecule(l 100) As Boolean
' Code
Sub Initialize() Dim XX As Integer
' clear the array which notes if a molecule is a second molecule For Molecule = 1 To 1100 SecondMolecule(Molecule) = False Next Molecule
'Clear the arrays For Base = l To 51 For Molecule = 1 To 1100 TargetSteand(Molecule, Base) = 0 SynthesizedStrand(Molecule, Base) = 0 HL_Tracker(Molecule, Base) = 0 PolymerasePointer(Molecule) = 1 Next Molecule Next Base
For XX = 1 To 15 '—clear the frequency distribution list TargetStrandFrequencyDistfXX) = 0 SyntheticSfrandFrequencyDist(XX) = 0 Next XX
For XX = l To 9 Worksheets("In Out").Cells(5 + XX, 10).Value = "" Next XX
With Worksheets("In Out") 'Get the "front panel" input values TempReal = .Range("D4").Value MaxHalfLives = IntfTempReal * 10) WashCyclesMax = .Range("D7").Value RandomMoleculesMax = .Range("D9").Value If RandomMoleculesMax > 1000 Then RandomMoleculesMax = 1000 HomoPolymersMax = .Range("D 11") .Value If HomoPolymersMax > 100 Then HomoPolymersMax = 100 MoleculesMax = RandomMoleculesMax + HomoPolymersMax SecondMoleculeFactor = .Range("D14").Value LongerJHL = Exp(-0.0693 / SecondMoleculeFactor)
' — Clear the output values .Range("D20").Value = "" .Range("D21").Value = "" .Range("D22")Nalue = "" .Range("E24")Nalue = "" .Range("E25").Value = "" .Range("E26")Nalue = "" End With 'WorksheetsC'In Out").Range("E2").Value = LongerJHL 'Display the Longer_HL value 'Clear the output area & Fill Row headings With Worksheets("Molecules") .Range("B2:AY4006").ClearContents .Range("B2:AY4006").Interior.ColorIndex = NoColor For XX = l To l l00 .Cells(3 + XX * 4, 1) .Value = XX dd the row headings as running numbers Next XX .Range("B3").Value = "Current Wash Cycle is:" .Range("L3").Value = "Current 'Half-Life' is:" .Range("U3").Value = "Current Base in the reaction is:"
End With
Randomize ' — Seed the Random Number Generator
End Sub
Sub DrawSynthesizedSfrands() Dim TempMolecule, TempBase As Integer
With Worksheets("molecules") For TempBase = 1 To 50 For TempMolecule = 1 To MoleculesMax If SynthesizedSfrand(TempMolecule, TempBase) = Blue Then .Cells(TempMolecule * 4 + 2, TempBase + l).Font.ColorIndex = 2 Else .CellsCTempMolecule * 4 + 2, TempBase + l).Font.ColorIndex = 0 End lf .Cells(TempMolecule * 4 + 2, TempBase + l).Interior.ColorIndex = SynthesizedSfrand(TempMolecule, TempBase) If HL_Tracker(TempMolecule, TempBase) > 0 Then .CellsfTempMolecule * 4 + 2, TempBase + 1) .Value = HL_Tracker(TempMolecule,
TempBase) End If Next TempMolecule Next TempBase End With
End Sub
Sub CreateTargetStrands() Dim TempRand As Integer
For Base = 1 To 50 For Molecule = 1 To RandomMoleculesMax TempRand = Int(4 * Rnd + 3) 'random number of value 3,4,5 or 6 'If TempRand = Blue Then TempRand = Cyan 'turn blue into cyan TargetStrand(Molecule, Base) = TempRand Worksheets("Molecules").Cells(Molecule * 4 + 3, Base + l).Interior.ColorIndex : TargetStrand(Molecule, Base) Next Molecule
Next Base
'--now draw molecules with long stretches of homopolymers For Base = 1 To 50 For Molecule = RandomMoleculesMax + 1 To MoleculesMax TargetStrand(Molecule, Base) = A Worksheets("Molecules").Cells(Molecule * 4 + 3, Base + l).Interior.ColorIndex = TargetStrand(Molecule, Base) Next Molecule Next Base
End Sub
Sub Synthesize() Dim MoleculeSynthesized As Integer Dim TempPointer As Integer Dim Parameter As Single
For Molecule = 1 To 1100 'clear array which shows if molecule is a second molecule SecondMolecule(Molecule) = False Next Molecule
For BaseType = A To C 'Cover each of AGT&C If BaseType = A Then Worksheets("Molecules").Range("AD3").Value = "A" If BaseType = G Then Worksheets("Molecules").Range("AD3").Value = " iiGn1ti If BaseType = T Then Worksheets("Molecules").Range("AD3").Value = "T" If BaseType = C Then Worksheets("Molecules").Range("AD3").Value = "C
For HalfLives = 1 To MaxHalfLives Worksheets("Molecules").Range("R3").Value = HalfLives / 10 For Molecule = 1 To MoleculesMax If SecondMolecule(Molecule) = False Then Parameter = TENTHJHL Else Parameter
= LongerJHL
-If we're flowing in A's, we attempt to polymerize only to T's If BaseType = A And TargetStrand(Molecule, PolymerasePointer(Molecule)) = T Then If Rnd > Parameter Then MoleculeSynthesized = 1 Else MoleculeSynthesized = 0 'did molecule go? If MoleculeSynthesized = 1 Then SecondMolecule(Molecule) = True SynthesizedSfrand(Molecule, PolymerasePointer(Molecule)) = A HL_Tracker(Molecule, PolymerasePointer(Molecule)) = WashCycles PolymerasePointer(Molecule) = PolymerasePointer(Molecule) + 1 If PolymerasePointer(Molecule) > 50 Then PolymerasePointer(Molecule) = 50 End If End If
' If we're flowing in T's, we attempt to polymerize only to A's If BaseType = T And TargetSfrand(Molecule, PolymerasePointer(Molecule)) = A
Then If Rnd > Parameter Then MoleculeSynthesized = 1 Else MoleculeSynthesized = 0 'did molecule go? If MoleculeSynthesized = 1 Then SecondMolecule(Molecule) = True SynthesizedSfrand(Molecule, PolymerasePointer(Molecule)) = T HL_Tracker(Molecule, PolymerasePointer(Molecule)) = WashCycles PolymerasePointer(Molecule) = PolymerasePointer(Molecule) + 1 If PolymerasePointer(Molecule) > 50 Then PolymerasePointer(Molecule) = 50 End If End If
' If we're flowing in G's, we attempt to polymerize only to C's If BaseType = G And TargetStrand(Molecule, PolymerasePointer(Molecule)) = C Then If Rnd > Parameter Then MoleculeSynthesized = 1 Else MoleculeSynthesized = 0 'did molecule go? If MoleculeSynthesized = 1 Then SecondMolecule(Molecule) = True SynthesizedSfrand(Molecule, PolymerasePointer(Molecule)) = G HL_Tracker(Molecule, PolymerasePointer(Molecule)) = WashCycles PolymerasePointer(Molecule) = PolymerasePointer(Molecule) + 1 If PolymerasePointer(Molecule) > 50 Then PolymerasePointer(Molecule) = 50 End If End If
' If we're flowing in C's, we attempt to polymerize only to G's If BaseType = C And TargetSfrand(Molecule, PolymerasePointer(Molecule)) = G
Then If Rnd > Parameter Then MoleculeSynthesized = 1 Else MoleculeSynthesized = 0 'did molecule go? If MoleculeSynthesized = 1 Then SecondMolecule(Molecule) = True SynthesizedSfrand(Molecule, PolymerasePointer(Molecule)) = C HL_Tracker(Molecule, PolymerasePointer(Molecule)) = WashCycles PolymerasePointer(Molecule) = PolymerasePointer(Molecule) + 1 If PolymerasePointer(Molecule) > 50 Then PolymerasePointer(Molecule) = 50 End If End If
Next Molecule 'DrawSynthesizedStrands '--for now, display is refreshed after each increment of half life for a given base Next HalfLives
Next BaseType
End Sub ' — Develop an analysis of the distribution of homopolymers in the full-length targets, report as a frequency
' — distribution of n-mers
Sub AnalyzeTargetStrands() Dim CurrentBase As Integer Dim BasesAhead As Integer Dim N As Integer
Dim NumberedBases(50) As Integer Dim RunLengths(50) As Integer
For N = 1 To 15 '--clear the frequency distribution list TargetSfrandFrequencyDistfN) = 0 ' SyntheticSfrandFrequencyDistfN) = 0
NextN
For Molecule = 1 To MoleculesMax 'Identify Changes among bases NumberedBases(l) = 1 'Worksheets("Molecules").Cells(4 + Molecule * 4, 2).Value = NumberedBases(l) 'take this out. For display only For Base = 2 To 50 If TargetSfrand(Molecule, Base - 1) <> TargetStrand(Molecule, Base) Then NumberedBases(Base) = 1 Else NumberedBases(Base) = 0 End If 'Worksheets("Molecules").Cells(4 + Molecule * 4, Base + 1). Value = NumberedBases(Base) 'take this out. For display only Next Base compute run lengths "But first we've got a boundary condition problem for the first base~we solve it here! ! RunLengths(l) = 1 'Worksheets("Molecules").Cells(5 + Molecule * 4, 2). Value = RunLengths(l)
For Base = 2 To 50 If NumberedBases(Base) = 1 Then RunLengths(Base) = 1 Else RunLengths(Base) = RunLengths(Base - 1) + 1 End If 'Worksheets("Molecules").Cells(5 + Molecule * 4, Base + 1). Value = RunLengths(Base) Next Base
' — save only the terminal value of a run length For Base = 1 To 49 If RunLengths(Base + 1) > RunLengths(Base) Then RunLengths(Base) = 0 'Worksheets("Molecules").Cells(6 + Molecule * 4, Base + 1) .Value = RunLengths(Base) Next Base 'Worksheets("Molecules").Cells(6 + Molecule * 4, 50 + 1). Value = RunLengths(50) 'boundary condition
' Now deteπnine the frequency distribution of each N-mer For Base = 1 To 50 If RunLengths(Base) = 1 Then TargetStrandFrequencyDist(l) = TargetSfrandFrequencyDist(l) + 1 If RunLengths(Base) = 2 Then TargetStrandFrequencyDist(2) = TargetStrandFrequencyDist(2) + 1 If RunLengths(Base) = 3 Then TargetStrandFrequencyDist(3) = TargetSfrandFrequencyDist(3) + 1 If RunLengths(Base) = 4 Then TargetStrandFrequencyDist(4) =
TargetSfrandFrequencyDist(4) + 1 If RunLengths(Base) = 5 Then TargetStrandFrequencyDist(5) = TargetSfrandFrequencyDist(5) + 1 If RunLengths(Base) = 6 Then TargetStrandFrequencyDist(6) = TargetStrandFrequencyDist(6) + 1 If RunLengths(Base) = 7 Then TargetStrandFrequencyDist(7) = TargetStrandFrequencyDist(7) + 1 If RunLengths(Base) = 8 Then TargetStrandFrequencyDist(8) =
TargetSfrandFrequencyDist(8) + 1 If RunLengths(Base) >= 9 Then TargetSfrandFrequencyDist(9) = TargetStrandFrequencyDist(9) + 1 Next Base Next Molecule For I = 1 To 9 WorksheetsC'In Out").Cells(5 + 1, 10).Value = TargetStrandFrequencyDist(I) 'copy to the spreadsheet Next I
End Sub
Sub AnalyzeResults() Dim N As Integer
Dim TwentyFiveMer, TwentyFiveMerAccumulator As Integer Dim LongestLength, ShortestLength As Integer Dim TempSum, Min, Max As Integer Dim AverageLength As Single
' — First we analyze the data about the degree of extension For N = 1 To 1100 "clear the extension array. Extension(N) = 0
NextN
For Molecule = 1 To MoleculesMax N = 0 For Base = 1 To 50 If SynthesizedStrand(Molecule, Base) o 0 Then N = Base 'N = 1 'debug statement Next Base
Extension(Molecule) = N 'WorksheetsC'In Out").Range("C13").Value = Extension(N) 'debug statement Next Molecule " — we now have an array of maximum lengths of each sfrand in Extension. We can now compute...
'First we do the average: TempSum = 0
ForN = l To ll00 ) TempSum = ExtensionfN) + TempSum '--grand total
Next N
AverageLength = TempSum / MoleculesMax
WorksheetsC'In Out").Range("D22").Value = AverageLength
'Now we find the Min and Max
Max = 0
Min = 50
For N = 1 To MoleculesMax If Max > ExtensionfN) Then Max = Max Else Max = ExtensionfN) If Min < Extension(N) Then Min = Min Else Min = ExtensionfN)
NextN
WorksheetsC'In Out").Range("D20").Value = Max
WorksheetsC'In Out").Range("D21").Value = Min
'Determine what fraction of molecules are more than 25 bases long TwentyFiveMerAccumulator = 0 For N = 1 To MoleculesMax If ExtensionfN) > 24 Then TwentyFiveMerAccumulator = TwentyFiveMerAccumulator + i 1
NextN
WorksheetsC'In Out").Range("E26").Value = TwentyFiveMerAccumulator / MoleculesMax
End Sub
Sub AnalyzeSynthesizedSfrandsO
Dim CurrentBase As Integer
Dim BasesAhead As Integer
Dim N As Integer
Dim NumberedBases(51) As Integer Dim RunLengths(51 ) As Integer
Dim TwoHitAccumulator, ThreePlusHitAccumulator, TwoHit, ThreeHit As Integer
TwoHitAccumulator = 0 ThreePlusHitAccumulator = 0
For I = 1 To 50 NumberedBases(I) = 3 Next I
For Molecule = 1 To MoleculesMax 'Identify Changes among bases NumberedBases(l) = 1 'Worksheets("Molecules").Cells(l + Molecule * 4, 2).Value = NumberedBases(l) 'take this out. For display only For Base = 2 To Extension(Molecule) If SynthesizedSfrand(Molecule, Base - 1) <> SynthesizedStrandfMolecule, Base) Or HL_Tracker(Molecule, Base - 1) <> HL_Tracker(Molecule, Base) Then NumberedBases(Base) = 1 Else NumberedBases(Base) = 0 End If 'Worksheets("Molecules").Cells(l + Molecule * 4, Base + 1). Value =
NumberedBases(Base) 'take this out. For display only Next Base
' compute run lengths '""But first we've got a boundary condition problem for the first base~we solve it here! ! RunLengths(l) = 1 'Worksheets("Molecules").Cells(l + Molecule * 4, 2).Value = RunLengths(l)
For Base = 2 To Extension(Molecule) If NumberedBases(Base) = 1 Then RunLengths(Base) = 1 Else RunLengths(Base) = RunLengthsfBase - 1) + 1 End If 'Worksheets("Molecules").Cells(l + Molecule * 4, Base + 1). Value = RunLengthsfBase) Next Base
' — save only the terminal value of a run length For Base = 1 To Extension(Molecule) If RunLengthsfBase + 1) > RunLengthsfBase) Then RunLengths(Base) = 0 'Worksheets("Molecules").Cells(l + Molecule * 4, Base + l).Value = RunLengthsfBase) Next Base 'Worksheets("Molecules").Cells(l + Molecule * 4, 50 + 1). Value = RunLengths(Molecule) 'boundary condition
TwoHit = 0 ThreeHit = 0 For Base = 1 To Extension(Molecule) If RunLengthsfBase) = 2 Then Worksheets("Molecules").Cells(l + Molecule * 4, Base + l).Interior.ColorIndex = Magenta TwoHit = 1 End If
If RunLengthsfBase) > 2 Then Worksheets("Molecules").Cells(l + Molecule * 4, Base + l).Interior.ColorIndex = Cyan ThreeHit = l End If Next Base '--Now determine what fraction of molecules have either 2 bases or 3+ base hits and report results TwoHitAccumulator = TwoHitAccumulator + TwoHit ThreePlusHitAccumulator = ThreePlusHitAccumulator + ThreeHit Next Molecule
WorksheetsC'In Out").Range("E24").Value = TwoHitAccumulator / MoleculesMax WorksheetsC'In Out").Range("E25").Value = ThreePlusHitAccumulator / MoleculesMax
End Sub
Public Sub Main_Line() Initialize
' — Creates the new sfrands based on number of washes for varying degrees of completion per cycle If MoleculesMax > 0 And WashCyclesMax > 0 Then CreateTargetSfrands AnalyzeTargetSfrands For WashCycles = 1 To WashCyclesMax 'Do the desired number of wash cycles Worksheets("Molecules").Range("I3")Nalue = WashCycles Synthesize Next WashCycles DrawSynthesizedSfrands AnalyzeResults AnalyzeSynthesizedSfrands End If End Sub Example 3 [0109] Figure 2 illustrates yet another simulated analysis of a number of target polynucleotides u sing s hort-cycle sequencing. The s imulation w as run using the program described in Examples 2a and 2b but using a larger number of target polynucleotides. [0110] That is, in this simulation, the input values used were a cycle period of 0.8 half-lives, 60 repeats of the cycle, and 200 target polynucleotide strands. Figure 2 illustrates the results obtained. Homopolymers stretches which occurred in the same simulated complementary strand are highlighted in magenta wherever nucleotides of the same base type were incoφorated in a row, and in cyan wherever more than two nucleotides of the same base type were incoφorated in a row. [0111] The output values obtained were 48 incoφorations in the longest extended complementary strand, 20 in the shortest, and 32.00 as the average number of incoφorations for the 200 simulatedly extended complementary sfrands.
[0112] Further, the percentage of growing stands extended by two or more nucleotides in a homopolymer stretch was 78.5%; and the percentage of growing sfrands extended by three or more nucleotides in a homopolymer stretch was 4.0%. That is, using a cycle period of 0.8 half-lives resulted in 96.0% of the complementary strands being extended by two or less nucleotides in a homopolymer stretch per cycle of incoφoration. Moreover, 95.5% of the 200 target polynucleotides of the simulation were extended by at least 25 incoφorated nucleotides, while 100% were extended by at least 20 nucleotides. This illustrated that using a cycle period of 0.8 half-lives, and repeating the cycles 60 times, allows analysis of a 20 base sequence of 200 target polynucleotides. Example 4
[0113] This example demonstrates a method according to the invention in which a single nucleotide in a position in a nucleic acid sequence is identified. A template-bound primer is sequentially exposed first to a labeled nucleotide and then to an unlabeled nucleotide of the same type under conditions and in the presence of reagents that allow template-dependent primer extension. The template is analyzed in order to determine whether the first nucleotide is incoφorated in the primer at the first position or not. If not, then the sequential exposure to labeled and unlabeled nucleotides is repeated using another type of nucleotide until one such nucleotide is deteπnined to have incoφorated at the first position. Once an incoφorated nucleotide is determined, the identity of the nucleotide in the position in the nucleic acid sequence is identified as the complementary nucleotide. Example 5 [0114] In this example, a series of reactions are performed as described above in
Example 1. A nucleic acid primer is hybridized to a target nucleic acid at a primer binding site in the target. The primer comprises a donor fluorophore. The hybridized primer is exposed to a first nucleotide comprising an acceptor fluorophore comprising a blocking moiety that, when incoφorated into the primer, prevents further polymerization of the primer. The presence or absence of fluorescent emission from each of the donor and the acceptor is determined. A nucleotide that has been incoφorated into the primer via complementary base pairing with the target is identified by the presence of fluorescent emission from the acceptor, and a sequence placeholder is identified as the absence of fluorescent emission from the donor and the acceptor. A sequence of the target nucleic acid is complied based upon the sequence of the incoφorated nucleotides and the placeholders.

Claims

Claims We claim: 1. A method for sequencing a nucleic acid template, the method comprising the steps of: (a) exposing a nucleic acid template to a primer capable of hybridizing to said template and a polymerase capable of catalyzing nucleotide addition to said primer; (b) adding a labeled nucleotide for a predetermined time, said predetermined time being coordinated with an amount of polymerization inhibition such that on average only 0, 1, or 2 labeled nucleotides are added to said primer; (c) removing excess labeled nucleotide; (d) neutralizing label in any incoφorated nucleotide; (e) repeating steps a, b, c, and d at least once; and (f) determining a sequence of said template based upon the order of incoφoration of said labeled nucleotides.
2. A method for conducting a nucleic acid sequencing reaction, the method comprising the steps of: providing a nucleic acid template and a primer capable of hybridizing to a portion of said template, thereby to form a primed template; exposing said primed template to a nucleotide for a period of time that is statistically insufficient for incoφoration of more nucleotides than are resolvable by a detection system used to detect incoφoration of said nucleotide into said primer; detecting incoφoration of said nucleotide; neutralizing label in an incoφorated nucleotide; repeating said providing, exposing, detecting, and neutralizing steps at least once; and determining a sequence of said template based upon the order of nucleotides incoφorated into said primer.
3. A method for identifying a nucleotide incoφorated into a primer in template- dependent nucleic acid sequencing, the method comprising the steps of: conducting a plurality of base incoφoration cycles, wherein each cycle comprises exposing a template nucleic acid to a labeled nucleotide that is not a chain- terminating nucleotide, wherein said labeled nucleotide is incoφorated into a primer hybridized to said template if said nucleotide is capable of hybridizing to a template nucleotide immediately upstream of said primer, and wherein there is about a 99% probability that two or fewer of said nucleotides are incoφorated into the same primer strand per cycle; and identifying incoφorated nucleotides .
4. A method for template-dependent nucleic acid sequencing, the method comprising the steps of: (a) exposing a template nucleic acid to a labeled nucleotide under conditions that allow incoφoration of said nucleotide into a primer attached to said template; (b) removing unhybridized nucleotide from said template at a time after said exposing step that is sufficient for incoφoration of no more than about two of said nucleotides per template; (c) determining if a nucleotide is incoφorated into said primer; (d) identifying any incoφorated nucleotide; (e) repeating steps a, b, c, and d; and (f) compiling a sequence of said template based upon the sequence of nucleotides incoφorated into said primer.
5. A method for template-dependent nucleic acid sequencing, the method comprising the steps of: (a) exposing a template nucleic acid to a labeled nucleotide under conditions that allow incoφoration of said nucleotide into a primer attached to said template; (b) removing unhybridized nucleotide at a time after said exposing step that is statistically insufficient for incoφoration of a greater number of nucleotides than are individually optically resolvable during a predetermined detection period; (c) detecting incoφoration of individual labeled nucleotides during said detection period; (d) neutralizing label present in incoφorated nucleotides; (e) repeating steps a, b, c, and d at least once; and (f) compiling a sequence of said template based upon an order of incoφorated nucleotides.
6. A method for nucleic acid sequencing, the method comprising the steps of: (a) selecting a nucleic acid template to be sequenced; (b) exposing said template to a primer that is capable of hybridizing to a portion of said template to foπn a primed template; (c) selecting a desired number of nucleotides to be added to said primer; (d) determining a reduction in the rate at which a second nucleotide is added to said primer given that a first labeled nucleotide has already been added to said primer; (e) identifying a tolerable rate of eπoneous detection of an incoφorated nucleotide; (f) exposing said primed template to a labeled nucleotide (g) removing unincoφorated labeled nucleotide at a time after said exposing step that is determined based upon said desired number, said rate reduction, and said tolerable eπor, such that said time is statistically insufficient for incoφoration of more nucleotides than are resolvable by a detection system used to detect incoφoration of said nucleotide into said primer; (h) identifying incoφorated nucleotide; (i) neutralizing label present in said incoφorated nucleotide; fj) repeating steps f, g, and h at least once; and (k) determining a sequence of said template based upon an order of said incoφorated nucleotides.
7. A method for sequencing a template nucleic acid, the method comprising the steps of: (a) conducting a cycle of template-dependent nucleic acid primer extension in the presence of a polymerase and a labeled nucleotide; (b) inhibiting polymerase activity such that it is statistically unlikely that more than about 2 nucleotides are incoφorated into the same primer strand in said cycle; (c) washing unincoφorated labeled nucleotide away from said template; (d) detecting any incoφoration of said labeled nucleotide; (e) neutralizing label in any incoφorated labeled nucleotide; (f) removing said inhibition; (g) repeating steps a, b, c, d, e, and f; and (h) compiling a sequence of said template based upon the sequence of nucleotides incoφorated into said primer.
8. A method for sequencing a target nucleic acid, the method comprising the steps of: conducting a plurality of primer extension cycles, wherein each cycle comprises the steps of exposing a target nucleic acid to a primer capable of hybridizing to said target thereby to form a primed target, exposing said primed target to a labeled nucleotide in the presence of a nucleic acid polymerase, coordinating transient inhibition of said polymerase and time of exposure to said labeled nucleotide such that it is statistically likely that at least one of said labeled nucleotide is incoφorated in said primer, but statistically unlikely that more than two of said labeled nucleotide are incoφorated in said primer.
9. A method for identifying a nucleotide incoφorated into a primer in a template- dependent primer extension reaction, the method comprising the steps of: exposing a template nucleic acid to a primer capable of hybridizing to said template and a polymerase capable of catalyzing template-dependent nucleotide addition to said primer; adding a labeled nucleotide; optically detecting whether said labeled nucleotide is incoφorated into said primer, wherein said detecting occurs at a rate sufficient to detect 1 , but no more than 2, incoφorated nucleotides per detection cycle; and identifying an incoφorated nucleotide.
10. A method for determining the sequence of a template nucleic acid, the method comprising the steps of: (a) exposing a nucleic acid template to a primer capable of hybridizing to a portion of said template in order to form a template/primer complex reaction mixture; (b) adding a labeled nucleotide in the presence of a polymerase to said mixture under conditions that promote incoφoration of said nucleotide into said primer if said nucleotide is complementary to a nucleotide in said template that is downstream of said primer; (c) coordinating removal of said labeled nucleotide and inhibition of said polymerase so that no more than about 2 nucleotides are incoφorated into the same primer; (d) identifying labeled nucleotide that has been incoφorated into said primer; (e) repeating steps a, b, c, and d at least once; and (f) determining a sequence of said template based upon the order of said nucleotides incoφorated into said primer.
11. A method for identifying a nucleotide present in a template sequence, the method comprising the steps of: exposing a template nucleic acid to a primer capable of hybridizing to a portion of said template upstream of a region of said template to be sequenced; introducing a labeled nucleic acid and a polymerase to said template under conditions wherein said labeled nucleic acid will be incoφbrated in said primer if said labeled nucleic acid is capable of hybridizing with a base downstream of said primer; and controlling the rate of said incoφoration by limiting the time of exposure of said labeled nucleic acid to said template or by inhibiting said polymerase at a predefined time after exposure of said template to said labeled nucleotide; detecting incoφoration of said labeled nucleotide into said primer; and identifying said nucleotide in said template as the complement of labeled nucleotide incoφorated into said primer.
12. A method for sequencing a target nucleic acid, the method comprising the steps of: hybridizing a nucleic acid primer comprising a donor fluorophore to a target nucleic acid at a primer binding site in said target; exposing said hybridized primer to a first nucleotide comprising an acceptor fluorophore that, when incoφorated into said primer, prevents further polymerization of said primer; detecting the presence or absence of fluorescent emission from each of said donor and said acceptor; identifying a nucleotide that has been incoφorated into said primer via complementary base pairing with said target as the presence of fluorescent emission from said acceptor; identifying a sequence placeholder as the absence of fluorescent emission from said donor and said acceptor; and repeating said exposing, detecting, and each of said identifying steps, thereby to compile a sequence of said target nucleic acid based upon the sequence of said incoφorated nucleotides and said placeholders.
13. A method for identifying a placeholder in a nucleic acid sequence determined by synthesis, the method comprising the steps of: hybridizing a nucleic acid primer comprising a donor fluorophore to a target nucleic acid at a primer binding site in said target; exposing said hybridized primer to a first nucleotide comprising an acceptor fluorophore that, when incoφorated into said primer, prevents further polymerization of said primer; determining whether there is fluorescent emission from said donor and said acceptor; and identifying a placeholder in said nucleic acid sequence as the absence of emission in both said donor and said acceptor.
14. A method for sequencing a nucleic acid, the method comprising the steps of: exposing a template-bound nucleic acid primer to a nucleotide comprising a label that impedes progress of polymerase in the addition of a subsequent nucleotide; determining whether said first labeled nucleotide has been incoφorated into said primer; exposing said primer to an unlabeled first nucleotide if said first labeled nucleotide has been incoφorated into said primer; repeating said exposing and deteπnining steps with a second nucleotide if said first nucleotide did not incoφorate into said primer.
15. The method of claim 2, further comprising adding a first labeled nucleotide under conditions that optimize the incoφoration of one of said first nucleotide per primer sfrand; removing unincoφorated first labeled nucleotide; detecting any incoφorated first labeled nucleotide; neutralizing label in said first labeled nucleotide; and adding a second labeled nucleotide under conditions that optimize the incoφoration of one of said second nucleotides per primer strand.
16. The method of claim 1 wherein said method does not utilize a blocking moiety.
17. The method of claim 1 wherein said period of time is concluded by washing said nucleotides not incoφorated into said complementary sfrand.
18. The method of claim 1 wherein said period of time is c oncluded by washing said polymerization agent.
19. The method of any of claim 1 wherein said period is no more than 5 half-lives of said incoφoration reactions.
20. The method of claim 1 wherein said period is no more than 4 half-lives of said incoφoration reactions.
21. The method of claim 1 wherein said period is no more than 3 half-lives of said incoφoration reactions.
22. The method of claim 1 wherein said period is no more than 2 half-lives of said incoφoration reactions.
23. The method of claim 1 wherein said period is no more than 1 half-lives of said incoφoration reactions.
24. The method of claim 1 wherein said period is no more than 0.5 half-lives of said incoφoration reactions.
25. The method of claim 1 wherein said period permits less than 5% chance of incoφoration of more than two of said nucleotides into said complementary sfrand.
26. The method of claim 1 wherein said period is no more than 1 half-life of said incoφoration reactions and said wash cycles is repeated at least 40 times.
PCT/US2004/037613 2003-11-12 2004-11-12 Short cycle methods for sequencing polynucleotides WO2005047523A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002545619A CA2545619A1 (en) 2003-11-12 2004-11-12 Short cycle methods for sequencing polynucleotides
EP04810723A EP1692312A4 (en) 2003-11-12 2004-11-12 Short cycle methods for sequencing polynucleotides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US51986203P 2003-11-12 2003-11-12
US60/519,862 2003-11-12
US54627704P 2004-02-19 2004-02-19
US60/546,277 2004-02-19
US54761104P 2004-02-24 2004-02-24
US60/547,611 2004-02-24

Publications (2)

Publication Number Publication Date
WO2005047523A2 true WO2005047523A2 (en) 2005-05-26
WO2005047523A3 WO2005047523A3 (en) 2005-12-22

Family

ID=34595948

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/037613 WO2005047523A2 (en) 2003-11-12 2004-11-12 Short cycle methods for sequencing polynucleotides

Country Status (4)

Country Link
US (7) US7169560B2 (en)
EP (1) EP1692312A4 (en)
CA (1) CA2545619A1 (en)
WO (1) WO2005047523A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014397A2 (en) * 2005-07-28 2007-02-01 Helicos Biosciences Corporation Consecutive base single molecule sequencing
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7709197B2 (en) 2005-06-15 2010-05-04 Callida Genomics, Inc. Nucleic acid analysis by random mixtures of non-overlapping fragments
US7906285B2 (en) 2003-02-26 2011-03-15 Callida Genomics, Inc. Random array DNA analysis by hybridization
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9222132B2 (en) 2008-01-28 2015-12-29 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US9267172B2 (en) 2007-11-05 2016-02-23 Complete Genomics, Inc. Efficient base determination in sequencing reactions
EP3045542B1 (en) 2008-03-28 2016-11-16 Pacific Biosciences of California, Inc. Methods for nucleic acid sequencing
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
US9845500B2 (en) 2000-12-01 2017-12-19 Life Technologies Corporation Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
US11389779B2 (en) 2007-12-05 2022-07-19 Complete Genomics, Inc. Methods of preparing a library of nucleic acid fragments tagged with oligonucleotide bar code sequences

Families Citing this family (468)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281205A1 (en) * 1997-02-12 1998-08-13 Eugene Y. Chan Methods and products for analyzing polymers
DE69930310T3 (en) 1998-12-14 2009-12-17 Pacific Biosciences of California, Inc. (n. d. Ges. d. Staates Delaware), Menlo Park KIT AND METHOD FOR THE NUCLEIC ACID SEQUENCING OF INDIVIDUAL MOLECULES BY POLYMERASE SYNTHESIS
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US7668697B2 (en) * 2006-02-06 2010-02-23 Andrei Volkov Method for analyzing dynamic detectable events at the single molecule level
GB0307428D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20050221339A1 (en) * 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US20050239085A1 (en) * 2004-04-23 2005-10-27 Buzby Philip R Methods for nucleic acid sequence determination
US20070117104A1 (en) * 2005-11-22 2007-05-24 Buzby Philip R Nucleotide analogs
US7833709B2 (en) 2004-05-28 2010-11-16 Wafergen, Inc. Thermo-controllable chips for multiplex analyses
WO2005123957A2 (en) * 2004-06-10 2005-12-29 Ge Healthcare Bio-Sciences Corp. Method for nucleic acid analysis
US8536661B1 (en) 2004-06-25 2013-09-17 University Of Hawaii Biosensor chip sensor protection methods
WO2006022370A1 (en) * 2004-08-27 2006-03-02 National Institute For Materials Science Method of analyzing dna sequence using field-effect device, and base sequence analyzer
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2006094149A2 (en) * 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
US20090305248A1 (en) * 2005-12-15 2009-12-10 Lander Eric G Methods for increasing accuracy of nucleic acid sequencing
US20070154921A1 (en) * 2005-12-16 2007-07-05 Applera Corporation Method and System for Phase-Locked Sequencing
EP2363205A3 (en) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
US20070196832A1 (en) * 2006-02-22 2007-08-23 Efcavitch J William Methods for mutation detection
SG10201405158QA (en) 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
US20090075252A1 (en) * 2006-04-14 2009-03-19 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
EP2530168B1 (en) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Microfluidic Devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US8137626B2 (en) * 2006-05-19 2012-03-20 California Institute Of Technology Fluorescence detector, filter device and related methods
EP4108780A1 (en) 2006-06-14 2022-12-28 Verinata Health, Inc. Rare cell analysis using sample splitting and dna tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc Use of highly parallel snp genotyping for fetal diagnosis
EP2024512A4 (en) 2006-06-14 2009-12-09 Artemis Health Inc Methods for the diagnosis of fetal abnormalities
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
US8656949B2 (en) 2006-08-15 2014-02-25 University Of Maryland College Park Microfluidic devices and methods of fabrication
WO2008027558A2 (en) 2006-08-31 2008-03-06 Codon Devices, Inc. Iterative nucleic acid assembly using activation of vector-encoded traits
WO2008036614A1 (en) 2006-09-18 2008-03-27 California Institute Of Technology Apparatus for detecting target molecules and related methods
EP2071927A2 (en) 2006-09-28 2009-06-24 Illumina, Inc. Compositions and methods for nucleotide sequencing
US7910354B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20090111705A1 (en) 2006-11-09 2009-04-30 Complete Genomics, Inc. Selection of dna adaptor orientation by hybrid capture
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
CA2672315A1 (en) 2006-12-14 2008-06-26 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes using large scale fet arrays
US8262900B2 (en) * 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US11339430B2 (en) 2007-07-10 2022-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US9163053B2 (en) * 2007-05-18 2015-10-20 Fluidigm Corporation Nucleotide analogs
US7678894B2 (en) * 2007-05-18 2010-03-16 Helicos Biosciences Corporation Nucleotide analogs
US8431367B2 (en) 2007-09-14 2013-04-30 Predictive Biosciences Corporation Detection of nucleic acids and proteins
US8222040B2 (en) * 2007-08-28 2012-07-17 Lightspeed Genomics, Inc. Nucleic acid sequencing by selective excitation of microparticles
US8759077B2 (en) * 2007-08-28 2014-06-24 Lightspeed Genomics, Inc. Apparatus for selective excitation of microparticles
WO2009052214A2 (en) 2007-10-15 2009-04-23 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
US7811810B2 (en) 2007-10-25 2010-10-12 Industrial Technology Research Institute Bioassay system including optical detection apparatuses, and method for detecting biomolecules
US7767441B2 (en) * 2007-10-25 2010-08-03 Industrial Technology Research Institute Bioassay system including optical detection apparatuses, and method for detecting biomolecules
WO2009073629A2 (en) 2007-11-29 2009-06-11 Complete Genomics, Inc. Efficient shotgun sequencing methods
US20090156412A1 (en) * 2007-12-17 2009-06-18 Helicos Biosciences Corporation Surface-capture of target nucleic acids
US20090171640A1 (en) * 2007-12-28 2009-07-02 Microsoft Corporation Population sequencing using short read technologies
US20090181390A1 (en) * 2008-01-11 2009-07-16 Signosis, Inc. A California Corporation High throughput detection of micrornas and use for disease diagnosis
US7767400B2 (en) * 2008-02-03 2010-08-03 Helicos Biosciences Corporation Paired-end reads in sequencing by synthesis
US8252911B2 (en) * 2008-02-12 2012-08-28 Pacific Biosciences Of California, Inc. Compositions and methods for use in analytical reactions
US20090226906A1 (en) * 2008-03-05 2009-09-10 Helicos Biosciences Corporation Methods and compositions for reducing nucleotide impurities
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
US8470164B2 (en) 2008-06-25 2013-06-25 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
US8808986B2 (en) 2008-08-27 2014-08-19 Gen9, Inc. Methods and devices for high fidelity polynucleotide synthesis
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
KR20110138340A (en) * 2009-01-20 2011-12-27 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Single cell gene expression for diagnosis, prognosis and identification of drug targets
GB0904957D0 (en) 2009-03-23 2009-05-06 Univ Erasmus Medical Ct Tumour gene profile
EP3415235A1 (en) 2009-03-23 2018-12-19 Raindance Technologies Inc. Manipulation of microfluidic droplets
WO2010126614A2 (en) 2009-04-30 2010-11-04 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
US8776573B2 (en) 2009-05-29 2014-07-15 Life Technologies Corporation Methods and apparatus for measuring analytes
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
WO2010141390A2 (en) 2009-06-05 2010-12-09 Life Technologies Corporation Nucleotide transient binding for sequencing methods
US9416409B2 (en) 2009-07-31 2016-08-16 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
CN102625838B (en) * 2009-08-14 2016-01-20 阿霹震中科技公司 For generating sample that rRNA eliminates or for from the method for sample separation rRNA, composition and test kit
CA3047466A1 (en) 2009-09-08 2011-03-17 Laboratory Corporation Of America Holdings Compositions and methods for diagnosing autism spectrum disorders
US10174368B2 (en) 2009-09-10 2019-01-08 Centrillion Technology Holdings Corporation Methods and systems for sequencing long nucleic acids
WO2011032040A1 (en) 2009-09-10 2011-03-17 Centrillion Technology Holding Corporation Methods of targeted sequencing
KR20120100938A (en) 2009-09-23 2012-09-12 셀매틱스, 인크. Methods and devices for assessing infertility and/or egg quality
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US8236570B2 (en) 2009-11-03 2012-08-07 Infoscitex Methods for identifying nucleic acid ligands
US10207240B2 (en) 2009-11-03 2019-02-19 Gen9, Inc. Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
WO2011066185A1 (en) 2009-11-25 2011-06-03 Gen9, Inc. Microfluidic devices and methods for gene synthesis
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
US9217144B2 (en) 2010-01-07 2015-12-22 Gen9, Inc. Assembly of high fidelity polynucleotides
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP2534267B1 (en) 2010-02-12 2018-04-11 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
CA2790434A1 (en) 2010-02-18 2011-08-25 Anthony P. Shuber Compositions and methods for treating cancer
US9465228B2 (en) 2010-03-19 2016-10-11 Optical Biosystems, Inc. Illumination apparatus optimized for synthetic aperture optics imaging using minimum selective excitation patterns
US8502867B2 (en) 2010-03-19 2013-08-06 Lightspeed Genomics, Inc. Synthetic aperture optics imaging method using minimum selective excitation patterns
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
AU2011249913B2 (en) 2010-05-06 2014-09-11 Ibis Biosciences, Inc. Integrated sample preparation systems and stabilized enzyme mixtures
US9234240B2 (en) 2010-05-07 2016-01-12 The Board Of Trustees Of The Leland Stanford Junior University Measurement and comparison of immune diversity by high-throughput sequencing
US9670243B2 (en) * 2010-06-02 2017-06-06 Industrial Technology Research Institute Compositions and methods for sequencing nucleic acids
AU2011226767B1 (en) 2010-06-30 2011-11-10 Life Technologies Corporation Ion-sensing charge-accumulation circuits and methods
US8731847B2 (en) 2010-06-30 2014-05-20 Life Technologies Corporation Array configuration and readout scheme
JP5952813B2 (en) 2010-06-30 2016-07-13 ライフ テクノロジーズ コーポレーション Method and apparatus for testing ISFET arrays
EP2589065B1 (en) 2010-07-03 2015-08-19 Life Technologies Corporation Chemically sensitive sensor with lightly doped drains
CN103069006A (en) 2010-07-23 2013-04-24 艾索特里克斯遗传实验室有限责任公司 Identification of differentially represented fetal or maternal genomic regions and uses thereof
WO2012018387A2 (en) 2010-08-02 2012-02-09 Population Diagnotics, Inc. Compositions and methods for discovery of causative mutations in genetic disorders
WO2012036679A1 (en) 2010-09-15 2012-03-22 Life Technologies Corporation Methods and apparatus for measuring analytes
AU2011301935B2 (en) 2010-09-16 2015-06-11 Ibis Biosciences, Inc. Stabilization of ozone-labile fluorescent dyes by thiourea
US9938590B2 (en) 2010-09-16 2018-04-10 Gen-Probe Incorporated Capture probes immobilizable via L-nucleotide tail
EP2619564B1 (en) 2010-09-24 2016-03-16 Life Technologies Corporation Matched pair transistor circuits
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US9255293B2 (en) 2010-11-01 2016-02-09 Gen-Probe Incorporated Integrated capture and amplification of target nucleic acid for sequencing
US9074251B2 (en) * 2011-02-10 2015-07-07 Illumina, Inc. Linking sequence reads using paired code tags
EP3000883B8 (en) 2010-11-12 2018-02-28 Gen9, Inc. Methods and devices for nucleic acids synthesis
WO2012064975A1 (en) 2010-11-12 2012-05-18 Gen9, Inc. Protein arrays and methods of using and making the same
CN108744262A (en) 2010-11-23 2018-11-06 普莱萨格生命科学公司 Treatment and composition for for physical delivery
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
CN105755545B (en) 2010-12-27 2019-05-03 艾比斯生物科学公司 The preparation method and composition of nucleic acid samples
WO2012100194A1 (en) 2011-01-20 2012-07-26 Ibis Biosciences, Inc. Microfluidic transducer
CN103703143B (en) 2011-01-31 2016-12-14 爱普瑞斯生物公司 The method of the multiple epi-positions in identification of cell
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
KR20190006083A (en) 2011-03-09 2019-01-16 셀 시그널링 테크놀러지, 인크. Methods and reagents for creating monoclonal antibodies
US20120252682A1 (en) 2011-04-01 2012-10-04 Maples Corporate Services Limited Methods and systems for sequencing nucleic acids
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013022778A1 (en) 2011-08-05 2013-02-14 Ibis Biosciences, Inc. Nucleic acid sequencing by electrochemical detection
DK3594340T3 (en) 2011-08-26 2021-09-20 Gen9 Inc COMPOSITIONS AND METHODS FOR COLLECTING WITH HIGH ACCURACY OF NUCLEIC ACIDS
SG11201401222WA (en) 2011-10-03 2014-09-26 Celmatix Inc Methods and devices for assessing risk to a putative offspring of developing a condition
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2850785C (en) 2011-10-06 2022-12-13 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2851388C (en) 2011-10-10 2023-11-21 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
US9228233B2 (en) 2011-10-17 2016-01-05 Good Start Genetics, Inc. Analysis methods
EP2769007B1 (en) 2011-10-19 2016-12-07 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
WO2013063308A1 (en) 2011-10-25 2013-05-02 University Of Massachusetts An enzymatic method to enrich for capped rna, kits for performing same, and compositions derived therefrom
US11180807B2 (en) 2011-11-04 2021-11-23 Population Bio, Inc. Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
CA2854832C (en) 2011-11-07 2023-05-23 Ingenuity Systems, Inc. Methods and systems for identification of causal genomic variants
GB201120711D0 (en) 2011-12-01 2012-01-11 Univ Erasmus Medical Ct Method for classifying tumour cells
US9970984B2 (en) 2011-12-01 2018-05-15 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
AU2012352965B2 (en) * 2011-12-16 2014-08-21 Li-Cor, Inc. Luminescence imaging scanner
US9803188B2 (en) 2011-12-22 2017-10-31 Ibis Biosciences, Inc. Systems and methods for isolating nucleic acids
EP2794927B1 (en) 2011-12-22 2017-04-12 Ibis Biosciences, Inc. Amplification primers and methods
US10150993B2 (en) 2011-12-22 2018-12-11 Ibis Biosciences, Inc. Macromolecule positioning by electrical potential
EP3269820A1 (en) 2011-12-22 2018-01-17 Ibis Biosciences, Inc. Kit for the amplification of a sequence from a ribonucleic acid
US9334491B2 (en) 2011-12-22 2016-05-10 Ibis Biosciences, Inc. Systems and methods for isolating nucleic acids from cellular samples
WO2013102091A1 (en) 2011-12-28 2013-07-04 Ibis Biosciences, Inc. Nucleic acid ligation systems and methods
WO2013102081A2 (en) 2011-12-29 2013-07-04 Ibis Biosciences, Inc. Macromolecule delivery to nanowells
JP2015503923A (en) 2012-01-09 2015-02-05 オスロ ウニヴェルスィテーツスィーケフース ハーエフOslo Universitetssykehus Hf Methods and biomarkers for the analysis of colorectal cancer
WO2013106737A1 (en) 2012-01-13 2013-07-18 Data2Bio Genotyping by next-generation sequencing
US8747748B2 (en) 2012-01-19 2014-06-10 Life Technologies Corporation Chemical sensor with conductive cup-shaped sensor surface
US8821798B2 (en) 2012-01-19 2014-09-02 Life Technologies Corporation Titanium nitride as sensing layer for microwell structure
WO2013109981A1 (en) 2012-01-20 2013-07-25 Sequenom, Inc. Diagnostic processes that factor experimental conditions
WO2013112923A1 (en) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
WO2013116774A1 (en) 2012-02-01 2013-08-08 Gen-Probe Incorporated Asymmetric hairpin target capture oligomers
WO2013120018A1 (en) 2012-02-09 2013-08-15 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP3363901B1 (en) 2012-02-17 2020-12-30 Fred Hutchinson Cancer Research Center Compositions and methods for accurately identifying mutations
US9176031B2 (en) 2012-02-24 2015-11-03 Raindance Technologies, Inc. Labeling and sample preparation for sequencing
EP2820174B1 (en) 2012-02-27 2019-12-25 The University of North Carolina at Chapel Hill Methods and uses for molecular tags
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
EP2834370B1 (en) 2012-04-03 2019-01-02 The Regents Of The University Of Michigan Biomarker associated with irritable bowel syndrome and crohn's disease
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
EP3543350B1 (en) 2012-04-24 2021-11-10 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
US20150133310A1 (en) 2012-05-02 2015-05-14 Ibis Biosciences, Inc. Nucleic acid sequencing systems and methods
ES2683707T3 (en) 2012-05-02 2018-09-27 Ibis Biosciences, Inc. DNA sequencing
US9512477B2 (en) 2012-05-04 2016-12-06 Boreal Genomics Inc. Biomarker anaylsis using scodaphoresis
JP6445426B2 (en) 2012-05-10 2018-12-26 ザ ジェネラル ホスピタル コーポレイション Method for determining nucleotide sequence
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
AU2012380717B2 (en) 2012-05-24 2018-08-16 Fundacio Institucio Catalana De Recerca I Estudis Avancats Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
US8786331B2 (en) 2012-05-29 2014-07-22 Life Technologies Corporation System for reducing noise in a chemical sensor array
WO2013186306A1 (en) 2012-06-15 2013-12-19 Boehringer Ingelheim International Gmbh Method for identifying transcriptional regulatory elements
CA2877094A1 (en) 2012-06-18 2013-12-27 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
IL236303B (en) 2012-06-25 2022-07-01 Gen9 Inc Methods for nucleic acid assembly and high throughput sequencing
WO2014005076A2 (en) 2012-06-29 2014-01-03 The Regents Of The University Of Michigan Methods and biomarkers for detection of kidney disorders
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP2882868B1 (en) 2012-08-08 2019-07-31 H. Hoffnabb-La Roche Ag Increasing dynamic range for identifying multiple epitopes in cells
EP2895622A4 (en) 2012-09-11 2016-05-18 Theranos Inc Information management systems and methods using a biological signature
DK2895621T3 (en) 2012-09-14 2020-11-30 Population Bio Inc METHODS AND COMPOSITION FOR DIAGNOSIS, FORECAST AND TREATMENT OF NEUROLOGICAL CONDITIONS
CA2922005A1 (en) 2012-09-27 2014-04-03 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2701750T3 (en) 2012-10-16 2019-02-25 Abbott Molecular Inc Procedures for sequencing a nucleic acid
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9080968B2 (en) 2013-01-04 2015-07-14 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US9841398B2 (en) 2013-01-08 2017-12-12 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
CN105190656B (en) 2013-01-17 2018-01-16 佩索纳里斯公司 Method and system for genetic analysis
WO2014116729A2 (en) 2013-01-22 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Haplotying of hla loci with ultra-deep shotgun sequencing
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US8962366B2 (en) 2013-01-28 2015-02-24 Life Technologies Corporation Self-aligned well structures for low-noise chemical sensors
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
GB2547875B (en) 2013-02-01 2017-12-13 Univ California Methods for meta-genomics analysis of microbes
US9303263B2 (en) 2013-03-01 2016-04-05 Vivonics, Inc. Aptamers that bind CD271
US8963216B2 (en) 2013-03-13 2015-02-24 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8841217B1 (en) 2013-03-13 2014-09-23 Life Technologies Corporation Chemical sensor with protruded sensor surface
US9701999B2 (en) 2013-03-14 2017-07-11 Abbott Molecular, Inc. Multiplex methylation-specific amplification systems and methods
EP2971154A4 (en) 2013-03-14 2017-03-01 Ibis Biosciences, Inc. Nucleic acid control panels
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
EP2971159B1 (en) 2013-03-14 2019-05-08 Molecular Loop Biosolutions, LLC Methods for analyzing nucleic acids
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
CN105283758B (en) 2013-03-15 2018-06-05 生命科技公司 Chemical sensor with consistent sensor surface area
WO2014144092A1 (en) 2013-03-15 2014-09-18 Nugen Technologies, Inc. Sequential sequencing
CN105264366B (en) 2013-03-15 2019-04-16 生命科技公司 Chemical sensor with consistent sensor surface area
CN105358709B (en) 2013-03-15 2018-12-07 雅培分子公司 System and method for detecting genome copy numbers variation
DK3327123T3 (en) 2013-03-15 2019-11-25 Lineage Biosciences Inc METHODS FOR SEQUENCING THE IMMUN REPERTOIR
EP3533884A1 (en) 2013-03-15 2019-09-04 Ibis Biosciences, Inc. Dna sequences to assess contamination in dna sequencing
CA2906076A1 (en) 2013-03-15 2014-09-18 Abvitro, Inc. Single cell bar-coding for antibody discovery
US9116117B2 (en) 2013-03-15 2015-08-25 Life Technologies Corporation Chemical sensor with sidewall sensor surface
EP2981921B1 (en) 2013-04-03 2023-01-18 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9725724B2 (en) 2013-05-16 2017-08-08 Vivonics, Inc. Neutral nucleic acid ligands
IL309903A (en) 2013-05-24 2024-03-01 Sequenom Inc Methods and processes for non-invasive assessment of genetic variations
US8847799B1 (en) 2013-06-03 2014-09-30 Good Start Genetics, Inc. Methods and systems for storing sequence read data
US10458942B2 (en) 2013-06-10 2019-10-29 Life Technologies Corporation Chemical sensor array having multiple sensors per well
EP3540076A1 (en) 2013-06-21 2019-09-18 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
DK3030682T3 (en) 2013-08-05 2020-09-14 Twist Bioscience Corp DE NOVO SYNTHESIZED GENE LIBRARIES
EP3036359B1 (en) 2013-08-19 2019-10-23 Abbott Molecular Inc. Next-generation sequencing libraries
US9898575B2 (en) 2013-08-21 2018-02-20 Seven Bridges Genomics Inc. Methods and systems for aligning sequences
US9116866B2 (en) 2013-08-21 2015-08-25 Seven Bridges Genomics Inc. Methods and systems for detecting sequence variants
EP3039161B1 (en) 2013-08-30 2021-10-06 Personalis, Inc. Methods and systems for genomic analysis
EP3053073B1 (en) 2013-09-30 2019-07-03 Seven Bridges Genomics Inc. Methods and system for detecting sequence variants
WO2015051275A1 (en) 2013-10-03 2015-04-09 Personalis, Inc. Methods for analyzing genotypes
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
IL295860B2 (en) 2013-10-04 2024-01-01 Sequenom Inc Methods and processes for non-invasive assessment of genetic variations
JP6680680B2 (en) 2013-10-07 2020-04-15 セクエノム, インコーポレイテッド Methods and processes for non-invasive assessment of chromosomal alterations
CN105849279B (en) 2013-10-18 2020-02-18 七桥基因公司 Methods and systems for identifying disease-induced mutations
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
WO2015058120A1 (en) 2013-10-18 2015-04-23 Seven Bridges Genomics Inc. Methods and systems for aligning sequences in the presence of repeating elements
US10832797B2 (en) 2013-10-18 2020-11-10 Seven Bridges Genomics Inc. Method and system for quantifying sequence alignment
WO2015057565A1 (en) 2013-10-18 2015-04-23 Good Start Genetics, Inc. Methods for assessing a genomic region of a subject
EP3058332B1 (en) 2013-10-18 2019-08-28 Seven Bridges Genomics Inc. Methods and systems for genotyping genetic samples
US9092402B2 (en) 2013-10-21 2015-07-28 Seven Bridges Genomics Inc. Systems and methods for using paired-end data in directed acyclic structure
BR112016010095A2 (en) 2013-11-07 2017-09-12 Univ Leland Stanford Junior free cell nucleic acids for human microbiome analysis and components thereof.
EP2891722B1 (en) 2013-11-12 2018-10-10 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating endometriosis
EP3068883B1 (en) 2013-11-13 2020-04-29 Nugen Technologies, Inc. Compositions and methods for identification of a duplicate sequencing read
US9546398B2 (en) * 2013-11-14 2017-01-17 Agilent Technologies, Inc. Polymerase idling method for single molecule DNA sequencing
AU2014348306B2 (en) 2013-11-17 2020-11-12 Quantum-Si Incorporated Active-source-pixel, integrated device for rapid analysis of biological and chemical specimens
WO2015089243A1 (en) 2013-12-11 2015-06-18 The Regents For Of The University Of California Methods for labeling dna fragments to recontruct physical linkage and phase
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015095355A2 (en) 2013-12-17 2015-06-25 The Brigham And Women's Hospital, Inc. Detection of an antibody against a pathogen
DE202014010499U1 (en) 2013-12-17 2015-10-20 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
WO2015105963A1 (en) 2014-01-10 2015-07-16 Seven Bridges Genomics Inc. Systems and methods for use of known alleles in read mapping
WO2015107430A2 (en) 2014-01-16 2015-07-23 Oslo Universitetssykehus Hf Methods and biomarkers for detection and prognosis of cervical cancer
WO2015112974A1 (en) 2014-01-27 2015-07-30 The General Hospital Corporation Methods of preparing nucleic acids for sequencing
US9817944B2 (en) 2014-02-11 2017-11-14 Seven Bridges Genomics Inc. Systems and methods for analyzing sequence data
WO2015131107A1 (en) 2014-02-28 2015-09-03 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
WO2015175530A1 (en) 2014-05-12 2015-11-19 Gore Athurva Methods for detecting aneuploidy
US10760109B2 (en) 2014-06-06 2020-09-01 The Regents Of The University Of Michigan Compositions and methods for characterizing and diagnosing periodontal disease
WO2015200378A1 (en) 2014-06-23 2015-12-30 The General Hospital Corporation Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq)
CN114214314A (en) 2014-06-24 2022-03-22 生物辐射实验室股份有限公司 Digital PCR barcoding
DE202015009002U1 (en) 2014-07-15 2016-08-18 Kymab Limited Targeting of human PCSK9 for cholesterol treatment
EP3332790A1 (en) 2014-07-15 2018-06-13 Kymab Limited Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
WO2016008899A1 (en) 2014-07-15 2016-01-21 Kymab Limited Targeting human pcsk9 for cholesterol treatment
US10208350B2 (en) 2014-07-17 2019-02-19 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
MX2017001134A (en) 2014-07-24 2017-10-11 Abbott Molecular Inc Compositions and methods for the detection and analysis of mycobacterium tuberculosis.
US11783911B2 (en) 2014-07-30 2023-10-10 Sequenom, Inc Methods and processes for non-invasive assessment of genetic variations
EP4219710A3 (en) 2014-08-01 2023-08-16 Dovetail Genomics, LLC Tagging nucleic acids for sequence assembly
SG11201700891SA (en) 2014-08-06 2017-03-30 Nugen Technologies Inc Digital measurements from targeted sequencing
CN112903638A (en) 2014-08-08 2021-06-04 宽腾矽公司 Integrated device with external light source for detection, detection and analysis of molecules
EP3194933A1 (en) 2014-08-08 2017-07-26 Quantum-si Incorporated Optical system and assay chip for probing, detecting, and analyzing molecules
EP3194935B1 (en) 2014-08-08 2018-10-31 Quantum-si Incorporated Integrated device for temporal binning of received photons
WO2016023916A1 (en) 2014-08-12 2016-02-18 Kymab Limited Treatment of disease using ligand binding to targets of interest
GB2558326B (en) 2014-09-05 2021-01-20 Population Bio Inc Methods and compositions for inhibiting and treating neurological conditions
US9323569B2 (en) * 2014-09-10 2016-04-26 Amazon Technologies, Inc. Scalable log-based transaction management
US9519674B2 (en) * 2014-09-10 2016-12-13 Amazon Technologies, Inc. Stateless datastore-independent transactions
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
EP3950944A1 (en) 2014-09-15 2022-02-09 AbVitro LLC High-throughput nucleotide library sequencing
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
CA2964349C (en) 2014-10-14 2023-03-21 Seven Bridges Genomics Inc. Systems and methods for smart tools in sequence pipelines
EP4026913A1 (en) 2014-10-30 2022-07-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US10000799B2 (en) 2014-11-04 2018-06-19 Boreal Genomics, Inc. Methods of sequencing with linked fragments
GB201419731D0 (en) * 2014-11-05 2014-12-17 Illumina Cambridge Ltd Sequencing from multiple primers to increase data rate and density
WO2016071701A1 (en) 2014-11-07 2016-05-12 Kymab Limited Treatment of disease using ligand binding to targets of interest
JP6767978B2 (en) 2014-12-03 2020-10-14 アイソプレキシス コーポレイション Analysis and screening of cell secretion profiles
US10077472B2 (en) 2014-12-18 2018-09-18 Life Technologies Corporation High data rate integrated circuit with power management
EP4095261A1 (en) 2015-01-06 2022-11-30 Molecular Loop Biosciences, Inc. Screening for structural variants
US9984201B2 (en) 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
WO2016126987A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
US10669304B2 (en) 2015-02-04 2020-06-02 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016134034A1 (en) 2015-02-17 2016-08-25 Dovetail Genomics Llc Nucleic acid sequence assembly
US10208339B2 (en) 2015-02-19 2019-02-19 Takara Bio Usa, Inc. Systems and methods for whole genome amplification
EP3822361A1 (en) 2015-02-20 2021-05-19 Takara Bio USA, Inc. Method for rapid accurate dispensing, visualization and analysis of single cells
US10192026B2 (en) 2015-03-05 2019-01-29 Seven Bridges Genomics Inc. Systems and methods for genomic pattern analysis
US11807896B2 (en) 2015-03-26 2023-11-07 Dovetail Genomics, Llc Physical linkage preservation in DNA storage
JP2018518155A (en) 2015-04-15 2018-07-12 ザ ジェネラル ホスピタル コーポレイション LNA-based mutant enrichment next generation sequencing assay
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US10275567B2 (en) 2015-05-22 2019-04-30 Seven Bridges Genomics Inc. Systems and methods for haplotyping
US10392613B2 (en) 2015-07-14 2019-08-27 Abbott Molecular Inc. Purification of nucleic acids using copper-titanium oxides
US10526664B2 (en) 2015-07-14 2020-01-07 Abbott Molecular Inc. Compositions and methods for identifying drug resistant tuberculosis
US10793895B2 (en) 2015-08-24 2020-10-06 Seven Bridges Genomics Inc. Systems and methods for epigenetic analysis
US10724110B2 (en) 2015-09-01 2020-07-28 Seven Bridges Genomics Inc. Systems and methods for analyzing viral nucleic acids
US10584380B2 (en) 2015-09-01 2020-03-10 Seven Bridges Genomics Inc. Systems and methods for mitochondrial analysis
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
AU2016319110B2 (en) 2015-09-11 2022-01-27 The General Hospital Corporation Full interrogation of nuclease DSBs and sequencing (FIND-seq)
WO2017049231A1 (en) 2015-09-18 2017-03-23 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
EP3353325B1 (en) 2015-09-24 2024-03-20 AbVitro LLC Single amplicon activated exclusion pcr
CA2999888A1 (en) 2015-09-24 2017-03-30 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
US10928392B2 (en) 2015-09-25 2021-02-23 Abvitro Llc High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences
JP2018529353A (en) 2015-09-30 2018-10-11 ザ ジェネラル ホスピタル コーポレイション Comprehensive in vitro reporting of cleavage events by sequencing (CIRCLE-seq)
US11347704B2 (en) 2015-10-16 2022-05-31 Seven Bridges Genomics Inc. Biological graph or sequence serialization
CN108368542B (en) 2015-10-19 2022-04-08 多弗泰尔基因组学有限责任公司 Methods for genome assembly, haplotype phasing, and target-independent nucleic acid detection
CA3006867A1 (en) 2015-12-01 2017-06-08 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
US20170199960A1 (en) 2016-01-07 2017-07-13 Seven Bridges Genomics Inc. Systems and methods for adaptive local alignment for graph genomes
CN108431223A (en) 2016-01-08 2018-08-21 生物辐射实验室股份有限公司 Multiple pearls under per drop resolution
US10364468B2 (en) 2016-01-13 2019-07-30 Seven Bridges Genomics Inc. Systems and methods for analyzing circulating tumor DNA
EP4012416A1 (en) 2016-01-22 2022-06-15 Purdue Research Foundation Use of a charged mass labeling system for the detection of target analytes
US10460829B2 (en) 2016-01-26 2019-10-29 Seven Bridges Genomics Inc. Systems and methods for encoding genetic variation for a population
WO2017139260A1 (en) 2016-02-08 2017-08-17 RGENE, Inc. Multiple ligase compositions, systems, and methods
US10519498B2 (en) 2016-02-11 2019-12-31 Qiagen Sciences, Llc Additives to improve sequencing by synthesis performance
EP3420108A4 (en) 2016-02-23 2019-11-06 Dovetail Genomics LLC Generation of phased read-sets for genome assembly and haplotype phasing
US10262102B2 (en) 2016-02-24 2019-04-16 Seven Bridges Genomics Inc. Systems and methods for genotyping with graph reference
EP3430154B1 (en) 2016-03-14 2020-11-11 Rgene, Inc. Hyper-thermostable lysine-mutant ssdna/rna ligases
KR102326769B1 (en) 2016-03-25 2021-11-17 카리우스, 인코포레이티드 Synthetic nucleic acid spike-ins
EP3436607B1 (en) 2016-03-28 2023-06-14 Ncan Genomics, Inc. Linked duplex target capture
US10961573B2 (en) 2016-03-28 2021-03-30 Boreal Genomics, Inc. Linked duplex target capture
US11355328B2 (en) 2016-04-13 2022-06-07 Purdue Research Foundation Systems and methods for isolating a target ion in an ion trap using a dual frequency waveform
IL262946B2 (en) 2016-05-13 2023-03-01 Dovetail Genomics Llc Recovering long-range linkage information from preserved samples
ES2929367T3 (en) 2016-05-18 2022-11-28 Hoffmann La Roche Quantitative ultrafast PCR amplification using an electrowet based device
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
EP3464642A4 (en) 2016-05-31 2020-02-19 The Regents of the University of California Methods for evaluating, monitoring, and modulating aging process
US11624064B2 (en) 2016-06-13 2023-04-11 Grail, Llc Enrichment of mutated cell free nucleic acids for cancer detection
US11396678B2 (en) 2016-07-06 2022-07-26 The Regent Of The University Of California Breast and ovarian cancer methylation markers and uses thereof
US10093986B2 (en) 2016-07-06 2018-10-09 Youhealth Biotech, Limited Leukemia methylation markers and uses thereof
WO2018009707A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Solid tumor methylation markers and uses thereof
US11091795B2 (en) 2016-07-11 2021-08-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for diagnosing and treating arrhythmias
WO2018013558A1 (en) 2016-07-12 2018-01-18 Life Technologies Corporation Compositions and methods for detecting nucleic acid regions
CA3020629A1 (en) 2016-07-21 2018-01-25 Takara Bio Usa, Inc. Multi-z imaging and dispensing with multi-well devices
WO2018022890A1 (en) 2016-07-27 2018-02-01 Sequenom, Inc. Genetic copy number alteration classifications
EP3500672A4 (en) 2016-08-22 2020-05-20 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
WO2018042251A1 (en) 2016-08-29 2018-03-08 Oslo Universitetssykehus Hf Chip-seq assays
US11250931B2 (en) 2016-09-01 2022-02-15 Seven Bridges Genomics Inc. Systems and methods for detecting recombination
CA3037190A1 (en) 2016-09-15 2018-03-22 ArcherDX, Inc. Methods of nucleic acid sample preparation for analysis of cell-free dna
AU2017328950B2 (en) 2016-09-15 2023-09-14 Archerdx, Llc Methods of nucleic acid sample preparation
US10417457B2 (en) 2016-09-21 2019-09-17 Twist Bioscience Corporation Nucleic acid based data storage
WO2018057928A1 (en) 2016-09-23 2018-03-29 Grail, Inc. Methods of preparing and analyzing cell-free nucleic acid sequencing libraries
JP6929354B2 (en) 2016-09-24 2021-09-01 アブビトロ, エルエルシー Affinity-oligonucleotide conjugates and their use
US10190155B2 (en) 2016-10-14 2019-01-29 Nugen Technologies, Inc. Molecular tag attachment and transfer
US11725232B2 (en) 2016-10-31 2023-08-15 The Hong Kong University Of Science And Technology Compositions, methods and kits for detection of genetic variants for alzheimer's disease
JP7161991B2 (en) 2016-11-02 2022-10-27 アーチャーディーエックス, エルエルシー Methods of Nucleic Acid Sample Preparation for Immune Repertoire Sequencing
CA3040930A1 (en) 2016-11-07 2018-05-11 Grail, Inc. Methods of identifying somatic mutational signatures for early cancer detection
EP4036578A1 (en) 2016-11-11 2022-08-03 Isoplexis Corporation Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells
WO2018098372A1 (en) 2016-11-22 2018-05-31 IsoPlexis Corporation Systems, devices and methods for cell capture and methods of manufacture thereof
US11268137B2 (en) 2016-12-09 2022-03-08 Boreal Genomics, Inc. Linked ligation
US20180163201A1 (en) 2016-12-12 2018-06-14 Grail, Inc. Methods for tagging and amplifying rna template molecules for preparing sequencing libraries
EP3554514A4 (en) 2016-12-16 2020-08-05 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
EP3555290B1 (en) 2016-12-19 2022-11-02 Bio-Rad Laboratories, Inc. Droplet tagging contiguity preserved tagmented dna
US10982351B2 (en) 2016-12-23 2021-04-20 Grail, Inc. Methods for high efficiency library preparation using double-stranded adapters
EP3574424A1 (en) 2017-01-24 2019-12-04 Sequenom, Inc. Methods and processes for assessment of genetic variations
DK3354746T3 (en) 2017-01-30 2019-09-02 Gmi Gregor Mendel Inst Fuer Molekulare Pflanzenbiologie Gmbh NEW SPIKE-IN NUCLEOTIDES FOR NORMALIZING SEQUENCE DATA
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
EP3586255A4 (en) 2017-02-22 2021-03-31 Twist Bioscience Corporation Nucleic acid based data storage
BR112019018272A2 (en) 2017-03-02 2020-07-28 Youhealth Oncotech, Limited methylation markers to diagnose hepatocellular carcinoma and cancer
WO2018170169A1 (en) 2017-03-15 2018-09-20 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
WO2018183918A1 (en) 2017-03-30 2018-10-04 Grail, Inc. Enhanced ligation in sequencing library preparation
US11118222B2 (en) 2017-03-31 2021-09-14 Grail, Inc. Higher target capture efficiency using probe extension
WO2018183942A1 (en) 2017-03-31 2018-10-04 Grail, Inc. Improved library preparation and use thereof for sequencing-based error correction and/or variant identification
CA3059370C (en) 2017-04-12 2022-05-10 Karius, Inc. Methods for concurrent analysis of dna and rna in mixed samples
WO2018195091A1 (en) 2017-04-18 2018-10-25 Dovetail Genomics, Llc Nucleic acid characteristics as guides for sequence assembly
WO2018209165A1 (en) 2017-05-12 2018-11-15 Laboratory Corporation Of America Holdings Systems and methods for biomarker identificaton
JP7169993B2 (en) 2017-05-12 2022-11-11 ラボラトリー コーポレイション オブ アメリカ ホールディングス Compositions and methods for detecting non-celiac-gluten sensitivity
WO2018213803A1 (en) 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
WO2018218222A1 (en) 2017-05-26 2018-11-29 Goldfless Stephen Jacob High-throughput polynucleotide library sequencing and transcriptome analysis
WO2018227091A1 (en) 2017-06-08 2018-12-13 The Brigham And Women's Hospital, Inc. Methods and compositions for identifying epitopes
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
AU2018284227A1 (en) 2017-06-12 2020-01-30 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
CN110770356A (en) 2017-06-20 2020-02-07 生物辐射实验室股份有限公司 MDA using bead oligonucleotides
CA3068273A1 (en) 2017-06-21 2018-12-27 Bluedot Llc Systems and methods for identification of nucleic acids in a sample
WO2019002265A1 (en) 2017-06-26 2019-01-03 Universität Für Bodenkultur Wien Novel biomarkers for detecting senescent cells
EP3545106B1 (en) 2017-08-01 2022-01-19 Helitec Limited Methods of enriching and determining target nucleotide sequences
EP3679370A1 (en) 2017-09-07 2020-07-15 Juno Therapeutics, Inc. Methods of identifying cellular attributes related to outcomes associated with cell therapy
KR20200047706A (en) 2017-09-11 2020-05-07 트위스트 바이오사이언스 코포레이션 GPCR binding protein and method for synthesis thereof
WO2019055819A1 (en) 2017-09-14 2019-03-21 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
WO2019055829A1 (en) 2017-09-15 2019-03-21 Nazarian Javad Methods for detecting cancer biomarkers
KR20200057024A (en) 2017-09-20 2020-05-25 가던트 헬쓰, 인크. Methods and systems for differentiating somatic and germline variants
WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. Methods and systems for sample extraction
US11851650B2 (en) 2017-09-28 2023-12-26 Grail, Llc Enrichment of short nucleic acid fragments in sequencing library preparation
JP7260553B2 (en) 2017-10-06 2023-04-18 ザ・ユニバーシティ・オブ・シカゴ Screening of T lymphocytes against cancer-specific antigens
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
SG11202003574TA (en) 2017-10-20 2020-05-28 Twist Bioscience Corp Heated nanowells for polynucleotide synthesis
EP4180534A1 (en) 2017-11-02 2023-05-17 Bio-Rad Laboratories, Inc. Transposase-based genomic analysis
JP7038209B2 (en) 2017-11-13 2022-03-17 エフ.ホフマン-ラ ロシュ アーゲー Equipment for sample analysis using epitaco electrophoresis
US11414656B2 (en) 2017-12-15 2022-08-16 Grail, Inc. Methods for enriching for duplex reads in sequencing and error correction
WO2019126249A1 (en) 2017-12-20 2019-06-27 Laboratory Corporation Of America Holdings Compositions and methods to detect head and neck cancer
WO2019126803A1 (en) 2017-12-22 2019-06-27 Grail, Inc. Error removal using improved library preparation methods
CA3088911A1 (en) 2018-01-04 2019-07-11 Twist Bioscience Corporation Dna-based digital information storage
US11366303B2 (en) 2018-01-30 2022-06-21 Rebus Biosystems, Inc. Method for detecting particles using structured illumination
EP4324962A2 (en) 2018-01-31 2024-02-21 Bio-Rad Laboratories, Inc. Methods and compositions for deconvoluting partition barcodes
WO2019152543A1 (en) 2018-01-31 2019-08-08 Dovetail Genomics, Llc Sample prep for dna linkage recovery
US11512002B2 (en) 2018-04-18 2022-11-29 University Of Virginia Patent Foundation Silica materials and methods of making thereof
WO2019213619A1 (en) 2018-05-04 2019-11-07 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
WO2019217899A2 (en) 2018-05-11 2019-11-14 Laboratory Corporation Of America Holdings Compositions and methods to detect kidney fibrosis
WO2019222706A1 (en) 2018-05-18 2019-11-21 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US20190385700A1 (en) 2018-06-04 2019-12-19 Guardant Health, Inc. METHODS AND SYSTEMS FOR DETERMINING The CELLULAR ORIGIN OF CELL-FREE NUCLEIC ACIDS
AU2019310041A1 (en) 2018-07-23 2021-02-04 Guardant Health, Inc. Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
SI3625368T1 (en) 2018-08-08 2023-04-28 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
EP3841202B1 (en) 2018-08-20 2023-10-04 Bio-Rad Laboratories, Inc. Nucleotide sequence generation by barcode bead-colocalization in partitions
AU2019331907A1 (en) 2018-08-30 2021-04-08 Guardant Health, Inc. Methods and systems for detecting contamination between samples
CA3109539A1 (en) 2018-08-31 2020-03-05 Guardant Health, Inc. Microsatellite instability detection in cell-free dna
WO2020096691A2 (en) 2018-09-04 2020-05-14 Guardant Health, Inc. Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
DK3814533T3 (en) 2018-09-20 2021-11-15 Tamirna Gmbh Micro-RNA signatures to predict liver dysfunction
WO2020074742A1 (en) 2018-10-12 2020-04-16 F. Hoffmann-La Roche Ag Detection methods for epitachophoresis workflow automation
EP3874060A1 (en) 2018-10-31 2021-09-08 Guardant Health, Inc. Methods, compositions and systems for calibrating epigenetic partitioning assays
US10876148B2 (en) 2018-11-14 2020-12-29 Element Biosciences, Inc. De novo surface preparation and uses thereof
US10768173B1 (en) 2019-09-06 2020-09-08 Element Biosciences, Inc. Multivalent binding composition for nucleic acid analysis
US10704094B1 (en) 2018-11-14 2020-07-07 Element Biosciences, Inc. Multipart reagents having increased avidity for polymerase binding
US11680261B2 (en) 2018-11-15 2023-06-20 Grail, Inc. Needle-based devices and methods for in vivo diagnostics of disease conditions
CA3121805A1 (en) 2018-12-07 2020-06-11 Octant, Inc. Systems for protein-protein interaction screening
JP2022512328A (en) 2018-12-07 2022-02-03 エレメント バイオサイエンシーズ,インク. Flow cell device and its use
CN113286883A (en) 2018-12-18 2021-08-20 格里尔公司 Methods for detecting disease using RNA analysis
CN113454218A (en) 2018-12-20 2021-09-28 夸登特健康公司 Methods, compositions, and systems for improved recovery of nucleic acid molecules
WO2020141464A1 (en) 2019-01-03 2020-07-09 Boreal Genomics, Inc. Linked target capture
US20220081714A1 (en) 2019-01-04 2022-03-17 Northwestern University Storing temporal data into dna
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
US11492727B2 (en) 2019-02-26 2022-11-08 Twist Bioscience Corporation Variant nucleic acid libraries for GLP1 receptor
WO2020176680A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
WO2020176659A1 (en) 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
US20220325268A1 (en) 2019-05-14 2022-10-13 Roche Sequencing Solutions, Inc Devices and methods for sample analysis
CA3140902A1 (en) 2019-05-28 2020-12-03 Octant, Inc. Transcriptional relay system
EP3976822A1 (en) 2019-05-31 2022-04-06 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
CN114729342A (en) 2019-06-21 2022-07-08 特韦斯特生物科学公司 Barcode-based nucleic acid sequence assembly
JP7194311B2 (en) 2019-07-10 2022-12-21 ウルティマ ジェノミクス, インコーポレイテッド RNA sequencing method
US11287422B2 (en) 2019-09-23 2022-03-29 Element Biosciences, Inc. Multivalent binding composition for nucleic acid analysis
JP2022552194A (en) 2019-10-10 2022-12-15 1859,インク. Methods and systems for microfluidic screening
DK3812472T3 (en) 2019-10-21 2023-02-20 Univ Freiburg Albert Ludwigs TRULY UNBIASED IN VITRO ASSAYS FOR PROFILING THE OFF-TARGET ACTIVITY OF ONE OR MORE TARGET-SPECIFIC PROGRAMMABLE NUCLEASES IN CELLS (ABNOBA-SEQ)
CN114746560A (en) 2019-11-26 2022-07-12 夸登特健康公司 Methods, compositions, and systems for improved binding of methylated polynucleotides
WO2021152586A1 (en) 2020-01-30 2021-08-05 Yeda Research And Development Co. Ltd. Methods of analyzing microbiome, immunoglobulin profile and physiological state
WO2021214766A1 (en) 2020-04-21 2021-10-28 Yeda Research And Development Co. Ltd. Methods of diagnosing viral infections and vaccines thereto
WO2021222828A1 (en) 2020-04-30 2021-11-04 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
WO2021224677A1 (en) 2020-05-05 2021-11-11 Akershus Universitetssykehus Hf Compositions and methods for characterizing bowel cancer
JP2023526252A (en) 2020-05-14 2023-06-21 ガーダント ヘルス, インコーポレイテッド Detection of homologous recombination repair defects
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4189111A1 (en) 2020-07-30 2023-06-07 Guardant Health, Inc. Methods for isolating cell-free dna
EP4205126A1 (en) 2020-08-25 2023-07-05 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
US20220154285A1 (en) 2020-09-30 2022-05-19 Guardant Health, Inc. Analysis of methylated dna comprising methylation-sensitive or methylation-dependent restrictions
EP4267757A1 (en) 2020-12-23 2023-11-01 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
KR20230156364A (en) 2021-03-05 2023-11-14 가던트 헬쓰, 인크. Methods and related aspects for analyzing molecular reactions
US20220344004A1 (en) 2021-03-09 2022-10-27 Guardant Health, Inc. Detecting the presence of a tumor based on off-target polynucleotide sequencing data
EP4308723A1 (en) 2021-03-15 2024-01-24 F. Hoffmann-La Roche AG Targeted next-generation sequencing via anchored primer extension
WO2022204321A1 (en) 2021-03-24 2022-09-29 Ambry Genetics Corporation Conservative concurrent evaluation of dna modifications
WO2022208171A1 (en) 2021-03-31 2022-10-06 UCL Business Ltd. Methods for analyte detection
WO2023004344A1 (en) 2021-07-20 2023-01-26 Regeneron Pharmaceuticals, Inc. Butyrophilin-like 2 for treating inflammatory disorders
WO2023035003A1 (en) 2021-09-03 2023-03-09 Elegen Corp. Multi-way bead-sorting devices, systems, and methods of use thereof using pressure sources
EP4253550A1 (en) 2022-04-01 2023-10-04 GenCC GmbH 6 Co. KG Method for the manufacture of a viral system, a vector system or any transport system for cancer-specific crispr complexes
US20230360725A1 (en) 2022-05-09 2023-11-09 Guardant Health, Inc. Detecting degradation based on strand bias
WO2023218408A1 (en) 2022-05-11 2023-11-16 Freya Biosciences Aps Methods of identifying strains associated with the human female genitourinary tract

Family Cites Families (483)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
JPS5941169B2 (en) 1975-12-25 1984-10-05 シチズン時計株式会社 Elastomer
US4153855A (en) 1977-12-16 1979-05-08 The United States Of America As Represented By The Secretary Of The Army Method of making a plate having a pattern of microchannels
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4344064A (en) 1979-12-06 1982-08-10 Western Electric Co., Inc. Article carrying a distinctive mark
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US5260433A (en) 1982-06-23 1993-11-09 Enzo Diagnostics, Inc. Saccharide specific binding system labeled nucleotides
US4707237A (en) 1982-09-09 1987-11-17 Ciba Corning Diagnostics Corp. System for identification of cells by electrophoresis
US5198540A (en) 1982-10-28 1993-03-30 Hubert Koster Process for the preparation of oligonucleotides in solution
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
USRE34069E (en) 1983-08-18 1992-09-15 Biosyntech Gmbh Process for the preparation of oligonucleotides
DE3329892A1 (en) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg METHOD FOR PRODUCING OLIGONUCLEOTIDES
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US4581624A (en) 1984-03-01 1986-04-08 Allied Corporation Microminiature semiconductor valve
US5360523A (en) 1984-03-29 1994-11-01 Li-Cor, Inc. DNA sequencing
US4729947A (en) 1984-03-29 1988-03-08 The Board Of Regents Of The University Of Nebraska DNA sequencing
US5258506A (en) 1984-10-16 1993-11-02 Chiron Corporation Photolabile reagents for incorporation into oligonucleotide chains
US6060237A (en) 1985-02-26 2000-05-09 Biostar, Inc. Devices and methods for optical detection of nucleic acid hybridization
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4865968A (en) 1985-04-01 1989-09-12 The Salk Institute For Biological Studies DNA sequencing
US4739044A (en) 1985-06-13 1988-04-19 Amgen Method for derivitization of polynucleotides
US4863849A (en) 1985-07-18 1989-09-05 New York Medical College Automatable process for sequencing nucleotide
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US5242797A (en) 1986-03-21 1993-09-07 Myron J. Block Nucleic acid assay method
US4811218A (en) 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
CA1340806C (en) 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US5242796A (en) 1986-07-02 1993-09-07 E. I. Du Pont De Nemours And Company Method, system and reagents for DNA sequencing
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4994372A (en) 1987-01-14 1991-02-19 President And Fellows Of Harvard College DNA sequencing
US5001060A (en) 1987-02-06 1991-03-19 Lubrizol Enterprises, Inc. Plant anaerobic regulatory element
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US4994368A (en) 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US4942124A (en) 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
US4793705A (en) 1987-10-07 1988-12-27 The United States Of America As Represented By The United States Department Of Energy Single molecule tracking
US4962037A (en) 1987-10-07 1990-10-09 United States Of America Method for rapid base sequencing in DNA and RNA
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
US4971903A (en) 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
US4962020A (en) 1988-07-12 1990-10-09 President And Fellows Of Harvard College DNA sequencing
CH679555A5 (en) 1989-04-11 1992-03-13 Westonbridge Int Ltd
GB8910880D0 (en) 1989-05-11 1989-06-28 Amersham Int Plc Sequencing method
US4979824A (en) 1989-05-26 1990-12-25 Board Of Trustees Of The Leland Stanford Junior University High sensitivity fluorescent single particle and single molecule detection apparatus and method
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5112736A (en) 1989-06-14 1992-05-12 University Of Utah Dna sequencing using fluorescence background electroblotting membrane
DE69011631T2 (en) 1989-06-14 1995-03-23 Westonbridge Int Ltd MICRO PUMP.
US5108892A (en) 1989-08-03 1992-04-28 Promega Corporation Method of using a taq dna polymerase without 5'-3'-exonuclease activity
US5096554A (en) 1989-08-07 1992-03-17 Applied Biosystems, Inc. Nucleic acid fractionation by counter-migration capillary electrophoresis
FR2650840B1 (en) 1989-08-11 1991-11-29 Bertin & Cie RAPID DETECTION AND / OR IDENTIFICATION OF A SINGLE BASED ON A NUCLEIC ACID SEQUENCE, AND ITS APPLICATIONS
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
AU649407B2 (en) 1989-09-21 1994-05-26 Infigen, Inc. Enhanced gene expression in response to lactation signals
WO1991006678A1 (en) 1989-10-26 1991-05-16 Sri International Dna sequencing
CA2028261C (en) 1989-10-28 1995-01-17 Won Suck Yang Non-invasive method and apparatus for measuring blood glucose concentration
US5171132A (en) 1989-12-27 1992-12-15 Seiko Epson Corporation Two-valve thin plate micropump
US5091652A (en) 1990-01-12 1992-02-25 The Regents Of The University Of California Laser excited confocal microscope fluorescence scanner and method
WO1991011533A1 (en) 1990-01-26 1991-08-08 E.I. Du Pont De Nemours And Company Method for isolating primer extension products from template-directed dna polymerase reactions
DE4006152A1 (en) 1990-02-27 1991-08-29 Fraunhofer Ges Forschung MICROMINIATURIZED PUMP
US5096388A (en) 1990-03-22 1992-03-17 The Charles Stark Draper Laboratory, Inc. Microfabricated pump
SE470347B (en) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Microstructure for fluid flow systems and process for manufacturing such a system
EP0465229B1 (en) 1990-07-02 1994-12-28 Seiko Epson Corporation Micropump and process for manufacturing a micropump
EP0834576B1 (en) 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detection of nucleic acid sequences
ES2155822T3 (en) 1990-12-06 2001-06-01 Affymetrix Inc COMPOUNDS AND ITS USE IN A BINARY SYNTHESIS STRATEGY.
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5529679A (en) 1992-02-28 1996-06-25 Hitachi, Ltd. DNA detector and DNA detection method
US5888819A (en) 1991-03-05 1999-03-30 Molecular Tool, Inc. Method for determining nucleotide identity through primer extension
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5518900A (en) 1993-01-15 1996-05-21 Molecular Tool, Inc. Method for generating single-stranded DNA molecules
US5762876A (en) 1991-03-05 1998-06-09 Molecular Tool, Inc. Automatic genotype determination
US5167784A (en) 1991-09-04 1992-12-01 Xerox Corporation Sequencing large nucleic acid fragments
WO1993005183A1 (en) 1991-09-09 1993-03-18 Baylor College Of Medicine Method and device for rapid dna or rna sequencing determination by a base addition sequencing scheme
DE4143343C2 (en) 1991-09-11 1994-09-22 Fraunhofer Ges Forschung Microminiaturized, electrostatically operated micromembrane pump
US5265327A (en) 1991-09-13 1993-11-30 Faris Sadeg M Microchannel plate technology
AU669489B2 (en) 1991-09-18 1996-06-13 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
US5502773A (en) 1991-09-20 1996-03-26 Vanderbilt University Method and apparatus for automated processing of DNA sequence data
US5405747A (en) 1991-09-25 1995-04-11 The Regents Of The University Of California Office Of Technology Transfer Method for rapid base sequencing in DNA and RNA with two base labeling
US5756285A (en) 1991-09-27 1998-05-26 Amersham Life Science, Inc. DNA cycle sequencing
US5674679A (en) 1991-09-27 1997-10-07 Amersham Life Science, Inc. DNA cycle sequencing
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6051380A (en) 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
JP3509859B2 (en) 1991-11-07 2004-03-22 ナノトロニクス,インコーポレイテッド Hybridization of chromophore and fluorophore conjugated polynucleotides to create donor-donor energy transfer systems
CA2125144A1 (en) 1991-12-23 1993-07-08 Chiron Diagnostics Corporation Htlv-1 probes for use in solution phase sandwich hybridization assays
US6555349B1 (en) 1993-01-22 2003-04-29 Cornell Research Foundation, Inc. Methods for amplifying and sequencing nucleic acid molecules using a three component polymerase
US5209834A (en) 1992-03-09 1993-05-11 The United States Of America As Represented By The United States Department Of Energy Ordered transport and identification of particles
GB9208733D0 (en) * 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
DE4220077A1 (en) 1992-06-19 1993-12-23 Bosch Gmbh Robert Micro-pump for delivery of gases - uses working chamber warmed by heating element and controlled by silicon wafer valves.
JPH0622798A (en) 1992-07-07 1994-02-01 Hitachi Ltd Method for determining base sequence
US5284568A (en) 1992-07-17 1994-02-08 E. I. Du Pont De Nemours And Company Disposable cartridge for ion selective electrode sensors
US5306403A (en) 1992-08-24 1994-04-26 Martin Marietta Energy Systems, Inc. Raman-based system for DNA sequencing-mapping and other separations
US5403709A (en) 1992-10-06 1995-04-04 Hybridon, Inc. Method for sequencing synthetic oligonucleotides containing non-phosphodiester internucleotide linkages
US6436635B1 (en) 1992-11-06 2002-08-20 Boston University Solid phase sequencing of double-stranded nucleic acids
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
AU671820B2 (en) 1993-02-10 1996-09-12 Promega Corporation Non-radioactive DNA sequencing
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
EP0705271B1 (en) 1993-06-25 2002-11-13 Affymetrix, Inc. (a Delaware Corporation) Hybridization and sequencing of nucleic acids
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5547859A (en) 1993-08-02 1996-08-20 Goodman; Myron F. Chain-terminating nucleotides for DNA sequencing methods
DE4326466A1 (en) 1993-08-06 1995-02-09 Boehringer Mannheim Gmbh Infrared dye-labeled nucleotides and their use in nucleic acid detection
US6376178B1 (en) 1993-09-03 2002-04-23 Duke University Method of nucleic acid sequencing
US5659171A (en) 1993-09-22 1997-08-19 Northrop Grumman Corporation Micro-miniature diaphragm pump for the low pressure pumping of gases
US6401267B1 (en) 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
US6156501A (en) 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6309601B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Scanning optical detection system
WO1995012608A1 (en) 1993-11-02 1995-05-11 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5610287A (en) 1993-12-06 1997-03-11 Molecular Tool, Inc. Method for immobilizing nucleic acid molecules
CH689836A5 (en) 1994-01-14 1999-12-15 Westonbridge Int Ltd Micropump.
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US5654419A (en) 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
EP0754240B1 (en) 1994-02-07 2003-08-20 Beckman Coulter, Inc. Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
JP3448090B2 (en) 1994-02-16 2003-09-16 浜松ホトニクス株式会社 Energy transfer detection method and apparatus
AU1854895A (en) 1994-03-08 1995-09-25 Amersham International Plc Modifying nucleotide analogues
US5552278A (en) 1994-04-04 1996-09-03 Spectragen, Inc. DNA sequencing by stepwise ligation and cleavage
US20020168642A1 (en) 1994-06-06 2002-11-14 Andrzej Drukier Sequencing duplex DNA by mass spectroscopy
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US6071394A (en) 1996-09-06 2000-06-06 Nanogen, Inc. Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
US6379897B1 (en) 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US5834189A (en) 1994-07-08 1998-11-10 Visible Genetics Inc. Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types
US5853979A (en) 1995-06-30 1998-12-29 Visible Genetics Inc. Method and system for DNA sequence determination and mutation detection with reference to a standard
US6001229A (en) 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
US5808045A (en) 1994-09-02 1998-09-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US5872244A (en) 1994-09-02 1999-02-16 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US6214987B1 (en) * 1994-09-02 2001-04-10 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides
US5763594A (en) 1994-09-02 1998-06-09 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
DE4433894A1 (en) 1994-09-22 1996-03-28 Fraunhofer Ges Forschung Method and device for controlling a micropump
US6015668A (en) 1994-09-30 2000-01-18 Life Technologies, Inc. Cloned DNA polymerases from thermotoga and mutants thereof
US5912155A (en) 1994-09-30 1999-06-15 Life Technologies, Inc. Cloned DNA polymerases from Thermotoga neapolitana
DE69531430T2 (en) 1994-10-07 2004-07-01 Bayer Corp. relief valve
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US6654505B2 (en) 1994-10-13 2003-11-25 Lynx Therapeutics, Inc. System and apparatus for sequential processing of analytes
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5707506A (en) 1994-10-28 1998-01-13 Battelle Memorial Institute Channel plate for DNA sequencing
US5514256A (en) 1994-10-28 1996-05-07 Battelle Memorial Institute Apparatus for improved DNA sequencing
FR2726286B1 (en) 1994-10-28 1997-01-17 Genset Sa SOLID PHASE NUCLEIC ACID AMPLIFICATION PROCESS AND REAGENT KIT USEFUL FOR CARRYING OUT SAID PROCESS
US5846396A (en) 1994-11-10 1998-12-08 Sarnoff Corporation Liquid distribution system
US5603351A (en) 1995-06-07 1997-02-18 David Sarnoff Research Center, Inc. Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
US5556790A (en) 1994-12-05 1996-09-17 Pettit; John W. Method for Automated DNA sequencing
US5710628A (en) 1994-12-12 1998-01-20 Visible Genetics Inc. Automated electrophoresis and fluorescence detection apparatus and method
US5786142A (en) 1995-05-30 1998-07-28 Visible Genetics Inc. Electrophoresis and fluorescence detection method
SE9500342D0 (en) 1995-01-31 1995-01-31 Marek Kwiatkowski Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation
WO1996027025A1 (en) 1995-02-27 1996-09-06 Ely Michael Rabani Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5876187A (en) 1995-03-09 1999-03-02 University Of Washington Micropumps with fixed valves
US5795782A (en) 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US6362002B1 (en) 1995-03-17 2002-03-26 President And Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US5994058A (en) 1995-03-20 1999-11-30 Genome International Corporation Method for contiguous genome sequencing
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US5675155A (en) 1995-04-26 1997-10-07 Beckman Instruments, Inc. Multicapillary fluorescent detection system
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
CA2222744C (en) 1995-05-31 2008-03-25 Amersham Life Science, Inc. Thermostable dna polymerases
US6077664A (en) 1995-06-07 2000-06-20 Promega Corporation Thermophilic DNA polymerases from Thermotoga neapolitana
US5861287A (en) 1995-06-23 1999-01-19 Baylor College Of Medicine Alternative dye-labeled primers for automated DNA sequencing
CN1106937C (en) 1995-06-26 2003-04-30 美国3M公司 Multilayer polymer film with additional coatings or layers
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5981186A (en) 1995-06-30 1999-11-09 Visible Genetics, Inc. Method and apparatus for DNA-sequencing using reduced number of sequencing mixtures
US5916747A (en) 1995-06-30 1999-06-29 Visible Genetics Inc. Method and apparatus for alignment of signals for use in DNA based-calling
US5807679A (en) 1995-07-07 1998-09-15 Myriad Genetics, Inc. Island hopping--a method to sequence rapidly very large fragments of DNA
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
DE19527155C2 (en) 1995-07-25 1998-12-10 Deutsches Krebsforsch Method of sequencing by oligomer hybridization
US5948614A (en) 1995-09-08 1999-09-07 Life Technologies, Inc. Cloned DNA polymerases from thermotoga maritima and mutants thereof
US5733729A (en) 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US6130098A (en) 1995-09-15 2000-10-10 The Regents Of The University Of Michigan Moving microdroplets
US5843655A (en) 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US6132580A (en) 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US6165765A (en) 1995-10-18 2000-12-26 Shanghai Institute Of Biochemistry, Chinese Academy Of Sciences DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
SE9504099D0 (en) 1995-11-16 1995-11-16 Pharmacia Biotech Ab A method of sequencing
US5776767A (en) 1995-12-12 1998-07-07 Visible Genetics Inc. Virtual DNA sequencer
US5705018A (en) 1995-12-13 1998-01-06 Hartley; Frank T. Micromachined peristaltic pump
JP4073038B2 (en) 1995-12-15 2008-04-09 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Thermostable DNA polymerase from Thermoanaerobacter thermohydrosulfurica and its mutant enzyme from which exonuclease activity has been removed
US6147205A (en) 1995-12-15 2000-11-14 Affymetrix, Inc. Photocleavable protecting groups and methods for their use
WO1997022719A1 (en) 1995-12-18 1997-06-26 Washington University Method for nucleic acid analysis using fluorescence resonance energy transfer
KR100207410B1 (en) 1995-12-19 1999-07-15 전주범 Fabrication method for lightpath modulation device
US5789168A (en) 1996-05-01 1998-08-04 Visible Genetics Inc. Method for amplification and sequencing of nucleic acid polymers
US5830657A (en) 1996-05-01 1998-11-03 Visible Genetics Inc. Method for single-tube sequencing of nucleic acid polymers
US5795722A (en) 1997-03-18 1998-08-18 Visible Genetics Inc. Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
US20010018514A1 (en) 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US6312893B1 (en) 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
TW406461B (en) 1996-03-01 2000-09-21 Cooper Ind Inc Enhanced polymer ic weathershed and surge arrester and method of making same
AU2217597A (en) 1996-03-18 1997-10-22 Sequenom, Inc. Dna sequencing by mass spectrometry
US6361937B1 (en) 1996-03-19 2002-03-26 Affymetrix, Incorporated Computer-aided nucleic acid sequencing
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
SE9601318D0 (en) 1996-04-04 1996-04-04 Pharmacia Biosensor Ab Method for nucleic acid analysis
EP0910664A1 (en) 1996-04-15 1999-04-28 University Of Southern California Synthesis of fluorophore-labeled dna
US5867266A (en) 1996-04-17 1999-02-02 Cornell Research Foundation, Inc. Multiple optical channels for chemical analysis
US6432634B1 (en) 1996-04-18 2002-08-13 Visible Genetics Inc. Method, apparatus and kits for sequencing of nucleic acids using multiple dyes
DK0898596T3 (en) 1996-04-19 2001-12-17 Amersham Pharm Biotech Uk Ltd Square type dyes and their use in a sequencing method
JP3418292B2 (en) 1996-04-24 2003-06-16 株式会社日立製作所 Gene analyzer
EP0896632B1 (en) 1996-05-01 2001-12-12 Visible Genetics Inc. Method for detection and identification of microorganisms
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
JP2000512744A (en) 1996-05-16 2000-09-26 アフィメトリックス,インコーポレイテッド System and method for detecting label material
US5846727A (en) 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
JP2000512498A (en) 1996-06-14 2000-09-26 サルノフ コーポレーション Polynucleotide sequencing method
US5771124A (en) 1996-07-02 1998-06-23 Siliscape Compact display system with two stage magnification and immersed beam splitter
WO1998002575A1 (en) 1996-07-16 1998-01-22 Periannan Senapathy Method for contiguous genome sequencing
AU4042597A (en) 1996-07-19 1998-02-10 Hybridon, Inc. Method for sequencing nucleic acids using matrix-assisted laser desorption ionization time-of-flight mass spectrometry
US5922608A (en) 1996-07-31 1999-07-13 Beckman Instruments, Inc. Macromolecule sequencing packet and method of use
US6136212A (en) 1996-08-12 2000-10-24 The Regents Of The University Of Michigan Polymer-based micromachining for microfluidic devices
EP0927268A1 (en) 1996-08-27 1999-07-07 Visible Genetics Inc. Apparatus and method for performing sequencing of nucleic acid polymers
US5832165A (en) 1996-08-28 1998-11-03 University Of Utah Research Foundation Composite waveguide for solid phase binding assays
US6221654B1 (en) 1996-09-25 2001-04-24 California Institute Of Technology Method and apparatus for analysis and sorting of polynucleotides based on size
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
US6020457A (en) 1996-09-30 2000-02-01 Dendritech Inc. Disulfide-containing dendritic polymers
EP0838850A3 (en) 1996-10-24 1999-05-06 Hamamatsu Photonics K.K. Method for placing flourescent single molecules on surface of substrate and method for visualizing structural defect of surface of substrate
US5858671A (en) 1996-11-01 1999-01-12 The University Of Iowa Research Foundation Iterative and regenerative DNA sequencing method
US6258533B1 (en) 1996-11-01 2001-07-10 The University Of Iowa Research Foundation Iterative and regenerative DNA sequencing method
US6002471A (en) 1996-11-04 1999-12-14 California Institute Of Technology High resolution scanning raman microscope
AU746737B2 (en) 1996-11-06 2002-05-02 Sequenom, Inc. Compositions and methods for immobilizing nucleic acids to solid supports
EP1164203B1 (en) 1996-11-06 2007-10-10 Sequenom, Inc. DNA Diagnostics based on mass spectrometry
DE69727489T2 (en) 1996-11-06 2004-11-25 Sequenom, Inc., San Diego METHOD OF MASS SPECTROMETRY
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6024925A (en) 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
US6140053A (en) 1996-11-06 2000-10-31 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
US6225062B1 (en) 1996-11-12 2001-05-01 Visible Genetics Inc. Method and kit for direct isothermal sequencing of nucleic acids
US5971355A (en) 1996-11-27 1999-10-26 Xerox Corporation Microdevice valve structures to fluid control
US5958703A (en) 1996-12-03 1999-09-28 Glaxo Group Limited Use of modified tethers in screening compound libraries
US6017702A (en) 1996-12-05 2000-01-25 The Perkin-Elmer Corporation Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate
US5876934A (en) 1996-12-18 1999-03-02 Pharmacia Biotech Inc. DNA sequencing method
DE19653439A1 (en) 1996-12-20 1998-07-02 Svante Dr Paeaebo Methods for the direct, exponential amplification and sequencing of DNA molecules and their application
DE19653494A1 (en) 1996-12-20 1998-06-25 Svante Dr Paeaebo Process for decoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application
US6828094B2 (en) 1996-12-20 2004-12-07 Roche Diagnostics Gmbh Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6046005A (en) 1997-01-15 2000-04-04 Incyte Pharmaceuticals, Inc. Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group
US6309824B1 (en) 1997-01-16 2001-10-30 Hyseq, Inc. Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes
US6136543A (en) 1997-01-31 2000-10-24 Hitachi, Ltd. Method for determining nucleic acids base sequence and apparatus therefor
US6403311B1 (en) 1997-02-12 2002-06-11 Us Genomics Methods of analyzing polymers using ordered label strategies
CA2281205A1 (en) 1997-02-12 1998-08-13 Eugene Y. Chan Methods and products for analyzing polymers
US6117973A (en) 1997-02-24 2000-09-12 Georgia Tech Research Corp. PNA monomers with electron donor or acceptor
US5837860A (en) 1997-03-05 1998-11-17 Molecular Tool, Inc. Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds
US6117634A (en) 1997-03-05 2000-09-12 The Reagents Of The University Of Michigan Nucleic acid sequencing and mapping
WO1998040223A1 (en) 1997-03-11 1998-09-17 Polaroid Corporation Substrate with non-visible indicium
WO1998040520A1 (en) 1997-03-14 1998-09-17 Hybridon, Inc. Method for sequencing of modified nucleic acids using electrospray ionization-fourier transform mass spectrometry
US7144699B2 (en) 1997-03-20 2006-12-05 Affymetrix, Inc. Iterative resequencing
ATE269908T1 (en) 1997-04-01 2004-07-15 Manteia S A METHOD FOR SEQUENCING NUCLEIC ACIDS
US6391622B1 (en) 1997-04-04 2002-05-21 Caliper Technologies Corp. Closed-loop biochemical analyzers
EP0972082A4 (en) 1997-04-04 2007-04-25 Caliper Life Sciences Inc Closed-loop biochemical analyzers
US6235471B1 (en) 1997-04-04 2001-05-22 Caliper Technologies Corp. Closed-loop biochemical analyzers
EP0985142A4 (en) 1997-05-23 2006-09-13 Lynx Therapeutics Inc System and apparaus for sequential processing of analytes
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
US5945284A (en) 1997-05-27 1999-08-31 The Perkin-Elmer Corporation Length determination of nucleic acid repeat sequences by discontinuous primer extension
SE9702008D0 (en) 1997-05-28 1997-05-28 Pharmacia Biotech Ab A method and a system for nucleic acid seouence analysis
US5919626A (en) 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
AU8224998A (en) 1997-07-04 1999-01-25 Nycomed Amersham Plc Peroxidase-catalysed fluorescence
WO1999005221A1 (en) 1997-07-28 1999-02-04 Nycomed Amersham Plc Cyanine dyes
PT1017848E (en) 1997-07-28 2003-02-28 Medical Biosystems Ltd ANALYSIS OF NUCLEIC ACID SEQUENCES
US6245506B1 (en) 1997-07-30 2001-06-12 Bbi Bioseq, Inc. Integrated sequencing device
GB9716231D0 (en) 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues
US5882904A (en) 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants
BR9811158A (en) 1997-08-12 2000-07-25 Eastman Chem Co Alkyd modified by acrylic, water-based latex, preparation process, and coating composition
US5994085A (en) 1997-08-26 1999-11-30 Cantor; Thomas L. Methods and devices for detecting non-complexed prostate specific antigen
US6087099A (en) 1997-09-08 2000-07-11 Myriad Genetics, Inc. Method for sequencing both strands of a double stranded DNA in a single sequencing reaction
US6346379B1 (en) 1997-09-11 2002-02-12 F. Hoffman-La Roche Ag Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes
WO1999013110A1 (en) 1997-09-11 1999-03-18 Seq, Ltd. Method to make fluorescent nucleotide photoproducts for dna sequencing and analysis
AU9476298A (en) 1997-09-11 1999-03-29 Seq, Ltd. Method for dna sequencing analysis
TW352471B (en) 1997-09-20 1999-02-11 United Microelectronics Corp Method for preventing B-P-Si glass from subsiding
US5836750A (en) 1997-10-09 1998-11-17 Honeywell Inc. Electrostatically actuated mesopump having a plurality of elementary cells
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6511803B1 (en) 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US5958694A (en) 1997-10-16 1999-09-28 Caliper Technologies Corp. Apparatus and methods for sequencing nucleic acids in microfluidic systems
US6049380A (en) 1997-11-12 2000-04-11 Regents Of The University Of California Single molecule identification using selected fluorescence characteristics
US6322968B1 (en) 1997-11-21 2001-11-27 Orchid Biosciences, Inc. De novo or “universal” sequencing array
US6268131B1 (en) 1997-12-15 2001-07-31 Sequenom, Inc. Mass spectrometric methods for sequencing nucleic acids
US6407858B1 (en) 1998-05-14 2002-06-18 Genetic Microsystems, Inc Focusing of microscopes and reading of microarrays
US6262838B1 (en) 1998-03-20 2001-07-17 Genetic Microsystems Inc Focusing in microscope systems
US6269846B1 (en) 1998-01-13 2001-08-07 Genetic Microsystems, Inc. Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays
JP4317953B2 (en) 1998-01-22 2009-08-19 独立行政法人理化学研究所 DNA sequence determination method
WO1999037810A1 (en) 1998-01-23 1999-07-29 Amersham Pharmacia Biotech, Inc. A method, reagent solution and kits for dna sequencing
US6280954B1 (en) 1998-02-02 2001-08-28 Amersham Pharmacia Biotech Ab Arrayed primer extension technique for nucleic acid analysis
JP4306960B2 (en) 1998-02-04 2009-08-05 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Dideoxy dye terminator
US6150147A (en) 1998-02-06 2000-11-21 Affymetrix, Inc. Biological array fabrication methods with reduction of static charge
IL123256A0 (en) 1998-02-10 1998-09-24 Yeda Res & Dev Methods for dna amplification and sequencing
WO1999044045A1 (en) 1998-02-27 1999-09-02 Massachusetts Institute Of Technology Single molecule detection with surface-enhanced raman scattering and applications in dna or rna sequencing
CA2324248A1 (en) 1998-03-18 1999-09-23 Amersham Pharmacia Biotech Inc. Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus
GB9805918D0 (en) 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6719868B1 (en) 1998-03-23 2004-04-13 President And Fellows Of Harvard College Methods for fabricating microfluidic structures
AU3199699A (en) 1998-03-23 1999-10-18 Invitrogen Corporation Modified nucleotides and methods useful for nucleic acid sequencing
DE29806082U1 (en) 1998-04-02 1998-06-18 Ideal Electronics Inc Cooling device for a central processing unit
CA2328881A1 (en) 1998-04-16 1999-10-21 Northeastern University Expert system for analysis of dna sequencing electropherograms
US5945325A (en) 1998-04-20 1999-08-31 California Institute Of Technology Thermally stable para-nitrobenzyl esterases
EP1082458A1 (en) 1998-05-01 2001-03-14 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and dna molecules
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6130046A (en) 1998-05-04 2000-10-10 Affymetrix, Inc. Techniques for synthesis integrity evaluation utilizing cycle fidelity probes
US6261848B1 (en) 1998-05-08 2001-07-17 The Johns Hopkins University Miniature immuno-optical rapid analyte sensor platform
ATE530891T1 (en) 1998-05-22 2011-11-15 California Inst Of Techn MINIATURIZED CELL SORTER
WO1999065076A1 (en) 1998-06-05 1999-12-16 Hitachi, Ltd. Semiconductor device and method for manufacturing the same
JPH11352409A (en) 1998-06-05 1999-12-24 Olympus Optical Co Ltd Fluorescence detector
WO1999064840A1 (en) 1998-06-09 1999-12-16 Caliper Technologies Corp. Fluorescent polarization detection in microfluidic systems
US6287821B1 (en) 1998-06-11 2001-09-11 Orchid Biosciences, Inc. Nucleotide analogues with 3'-pro-fluorescent fluorophores in nucleic acid sequence analysis
US6872521B1 (en) 1998-06-16 2005-03-29 Beckman Coulter, Inc. Polymerase signaling assay
EP1086209B1 (en) 1998-06-17 2007-08-22 Amersham Biosciences Corp. Fy7 polymerase
GB9813216D0 (en) 1998-06-18 1998-08-19 Pyrosequencing Ab Reaction monitoring systems
US6404907B1 (en) 1998-06-26 2002-06-11 Visible Genetics Inc. Method for sequencing nucleic acids with reduced errors
US6235473B1 (en) 1998-07-02 2001-05-22 Orchid Biosciences, Inc. Gene pen devices for array printing
US7399844B2 (en) 1998-07-09 2008-07-15 Agilent Technologies, Inc. Method and reagents for analyzing the nucleotide sequence of nucleic acids
WO2000006770A1 (en) 1998-07-30 2000-02-10 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US20030022207A1 (en) * 1998-10-16 2003-01-30 Solexa, Ltd. Arrayed polynucleotides and their use in genome analysis
US20040106110A1 (en) 1998-07-30 2004-06-03 Solexa, Ltd. Preparation of polynucleotide arrays
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
GB0002310D0 (en) 2000-02-01 2000-03-22 Solexa Ltd Polynucleotide sequencing
US6447724B1 (en) 1998-08-11 2002-09-10 Caliper Technologies Corp. DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
WO2000009753A1 (en) 1998-08-11 2000-02-24 Caliper Technologies Corp. Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes
US6716394B2 (en) 1998-08-11 2004-04-06 Caliper Technologies Corp. DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
US6210896B1 (en) 1998-08-13 2001-04-03 Us Genomics Molecular motors
US6263286B1 (en) 1998-08-13 2001-07-17 U.S. Genomics, Inc. Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer
US6245507B1 (en) 1998-08-18 2001-06-12 Orchid Biosciences, Inc. In-line complete hyperspectral fluorescent imaging of nucleic acid molecules
US6306643B1 (en) 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
AU9505798A (en) 1998-09-24 2000-04-10 Biotraces, Inc. Sequencing duplex dna by mass spectroscopy
AU6504099A (en) 1998-09-29 2000-04-17 Diversa Corporation Nucleic acids and proteins from Cenarchaeum symbiosum
DE19844931C1 (en) * 1998-09-30 2000-06-15 Stefan Seeger Procedures for DNA or RNA sequencing
US6458945B1 (en) 1998-10-01 2002-10-01 Variagenics, Inc. Method for analyzing polynucleotides
US6566059B1 (en) 1998-10-01 2003-05-20 Variagenics, Inc. Method for analyzing polynucleotides
US6221592B1 (en) 1998-10-20 2001-04-24 Wisconsin Alumi Research Foundation Computer-based methods and systems for sequencing of individual nucleic acid molecules
US6607888B2 (en) 1998-10-20 2003-08-19 Wisconsin Alumni Research Foundation Method for analyzing nucleic acid reactions
DE19849348A1 (en) 1998-10-26 2000-04-27 Univ Ludwigs Albert Identification and/or sequencing of an unknown DNA or RNA sequence adjacent to a known DNA or RNA region comprises linker-mediated PCR following amplification by linear PCR
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
RU2143343C1 (en) 1998-11-03 1999-12-27 Самсунг Электроникс Ко., Лтд. Microinjector and microinjector manufacture method
US6309701B1 (en) 1998-11-10 2001-10-30 Bio-Pixels Ltd. Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
US6387982B1 (en) 1998-11-23 2002-05-14 Dentsply Detrey G.M.B.H. Self etching adhesive primer composition and polymerizable surfactants
US6245518B1 (en) 1998-12-11 2001-06-12 Hyseq, Inc. Polynucleotide arrays and methods of making and using the same
DE69930310T3 (en) 1998-12-14 2009-12-17 Pacific Biosciences of California, Inc. (n. d. Ges. d. Staates Delaware), Menlo Park KIT AND METHOD FOR THE NUCLEIC ACID SEQUENCING OF INDIVIDUAL MOLECULES BY POLYMERASE SYNTHESIS
EP1141402A4 (en) 1998-12-18 2004-10-06 Univ California Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation
US6340750B1 (en) 1998-12-18 2002-01-22 The Texas A&M University System Through bond energy transfer in fluorescent dyes for labelling biological molecules
GB9828785D0 (en) 1998-12-30 1999-02-17 Amersham Pharm Biotech Ab Sequencing systems
DE60042775D1 (en) 1999-01-06 2009-10-01 Callida Genomics Inc IMPROVED SEQUENCING BY HYBRIDIZATION THROUGH THE USE OF PROBABLE MIXTURES
US6361671B1 (en) 1999-01-11 2002-03-26 The Regents Of The University Of California Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels
WO2000042223A1 (en) 1999-01-15 2000-07-20 Myriad Genetics, Inc. Method for controlling the distribution of dna sequencing termination products
GB9901475D0 (en) 1999-01-22 1999-03-17 Pyrosequencing Ab A method of DNA sequencing
US6270644B1 (en) 1999-01-27 2001-08-07 Affymetrix, Inc. Capillary array electrophoresis scanner
EP1163052B1 (en) 1999-02-23 2010-06-02 Caliper Life Sciences, Inc. Manipulation of microparticles in microfluidic systems
AU3508600A (en) 1999-02-26 2000-09-14 Orchid Biosciences, Inc. Microstructures for use in biological assays and reactions
US6558945B1 (en) 1999-03-08 2003-05-06 Aclara Biosciences, Inc. Method and device for rapid color detection
EP1159453B1 (en) 1999-03-10 2008-05-28 ASM Scientific, Inc. A method for direct nucleic acid sequencing
EP1192274A2 (en) 1999-03-25 2002-04-03 Hyseq, Inc. Solution-based methods and materials for sequence analysis by hybridization
EP1165839A2 (en) 1999-03-26 2002-01-02 Whitehead Institute For Biomedical Research Universal arrays
US6403317B1 (en) 1999-03-26 2002-06-11 Affymetrix, Inc. Electronic detection of hybridization on nucleic acid arrays
AU3567900A (en) 1999-03-30 2000-10-16 Solexa Ltd. Polynucleotide sequencing
US6261775B1 (en) 1999-04-09 2001-07-17 The Regents Of The University Of California Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma
US6573047B1 (en) 1999-04-13 2003-06-03 Dna Sciences, Inc. Detection of nucleotide sequence variation through fluorescence resonance energy transfer label generation
US6368562B1 (en) 1999-04-16 2002-04-09 Orchid Biosciences, Inc. Liquid transportation system for microfluidic device
US20030108867A1 (en) 1999-04-20 2003-06-12 Chee Mark S Nucleic acid sequencing using microsphere arrays
US6521428B1 (en) 1999-04-21 2003-02-18 Genome Technologies, Llc Shot-gun sequencing and amplification without cloning
US20020142329A1 (en) 1999-04-30 2002-10-03 Aclara Biosciences, Inc. Compositions and methods employing cleavable electrophoretic tag reagents
US6673550B2 (en) 1999-04-30 2004-01-06 Aclara Biosciences, Inc. Electrophoretic tag reagents comprising fluorescent compounds
US6395559B1 (en) 1999-05-04 2002-05-28 Orchid Biosciences, Inc. Multiple fluid sample processor with single well addressability
US7655443B1 (en) 1999-05-07 2010-02-02 Siemens Healthcare Diagnostics, Inc. Nucleic acid sequencing with simultaneous quantitation
US6423273B1 (en) 1999-05-19 2002-07-23 Orchid Biosciences, Inc. Method of forming seals for a microfluidic device
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6472141B2 (en) 1999-05-21 2002-10-29 Caliper Technologies Corp. Kinase assays using polycations
US6515120B1 (en) 1999-05-25 2003-02-04 Praelux Incorporated Method for sequencing and characterizing polymeric biomolecules using aptamers and a method for producing aptamers
US6485690B1 (en) 1999-05-27 2002-11-26 Orchid Biosciences, Inc. Multiple fluid sample processor and system
US6225109B1 (en) 1999-05-27 2001-05-01 Orchid Biosciences, Inc. Genetic analysis device
US6309886B1 (en) 1999-06-04 2001-10-30 The Regents Of The University Of California High throughput analysis of samples in flowing liquid
WO2000079007A1 (en) 1999-06-19 2000-12-28 Hyseq Inc. Improved methods of sequence assembly in sequencing by hybridization
CA2721172C (en) 1999-06-28 2012-04-10 California Institute Of Technology Microfabricated elastomeric valve and pump systems
US6818395B1 (en) * 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US6444106B1 (en) 1999-07-09 2002-09-03 Orchid Biosciences, Inc. Method of moving fluid in a microfluidic device
US6444173B1 (en) 1999-07-09 2002-09-03 Orchid Biosciences, Inc. Method of moving and detecting fluid in a microfluidic device
US6448090B1 (en) 1999-07-09 2002-09-10 Orchid Biosciences, Inc. Fluid delivery system for a microfluidic device using alternating pressure waveforms
US6268219B1 (en) 1999-07-09 2001-07-31 Orchid Biosciences, Inc. Method and apparatus for distributing fluid in a microfluidic device
US6395232B1 (en) 1999-07-09 2002-05-28 Orchid Biosciences, Inc. Fluid delivery system for a microfluidic device using a pressure pulse
WO2001004357A2 (en) 1999-07-13 2001-01-18 Whitehead Institute For Biomedical Research Generic sbe-fret protocol
US20020045182A1 (en) 1999-07-16 2002-04-18 Lynx Therapeutics, Inc. Multiplexed differential displacement for nucleic acid determinations
US6927065B2 (en) 1999-08-13 2005-08-09 U.S. Genomics, Inc. Methods and apparatus for characterization of single polymers
AU7086800A (en) 1999-08-30 2001-03-26 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The High speed parallel molecular nucleic acid sequencing
US6528258B1 (en) 1999-09-03 2003-03-04 Lifebeam Technologies, Inc. Nucleic acid sequencing using an optically labeled pore
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6107061A (en) 1999-09-18 2000-08-22 The Perkin-Elmer Corporation Modified primer extension reactions for polynucleotide sequence detection
WO2001023610A2 (en) 1999-09-29 2001-04-05 Solexa Ltd. Polynucleotide sequencing
GB9923324D0 (en) 1999-10-01 1999-12-08 Pyrosequencing Ab Separation apparatus and method
US6309836B1 (en) 1999-10-05 2001-10-30 Marek Kwiatkowski Compounds for protecting hydroxyls and methods for their use
US6908736B1 (en) 1999-10-06 2005-06-21 Medical Biosystems, Ltd. DNA sequencing method
GB9923644D0 (en) 1999-10-06 1999-12-08 Medical Biosystems Ltd DNA sequencing
US6077674A (en) 1999-10-27 2000-06-20 Agilent Technologies Inc. Method of producing oligonucleotide arrays with features of high purity
EP1096024A1 (en) 1999-10-28 2001-05-02 Remacle, José Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays
WO2001032930A1 (en) 1999-11-04 2001-05-10 California Institute Of Technology Methods and apparatuses for analyzing polynucleotide sequences
WO2001038546A1 (en) 1999-11-23 2001-05-31 Amersham Biosciences Corp Improving dideoxynucleotide-triphosphate utilization by the hyper-thermophilic dna polymerase from the archaeon pyrococcus furiosus
CN1336960A (en) 1999-11-26 2002-02-20 株式会社百尼尔 DNA sequencing method which employs various DNA polymerases and kit used for the same
US6383749B2 (en) * 1999-12-02 2002-05-07 Clontech Laboratories, Inc. Methods of labeling nucleic acids for use in array based hybridization assays
US6384487B1 (en) 1999-12-06 2002-05-07 Micron Technology, Inc. Bow resistant plastic semiconductor package and method of fabrication
GB9929381D0 (en) 1999-12-10 2000-02-09 Pyrosequencing Ab A method of assessing the amount of nucleic acid in a sample
WO2001048184A2 (en) 1999-12-23 2001-07-05 Axaron Bioscience Ag Method for carrying out the parallel sequencing of a nucleic acid mixture on a surface
GB0002389D0 (en) 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
EP1198596A1 (en) 2000-02-15 2002-04-24 Lynx Therapeutics, Inc. Data analysis and display system for ligation-based dna sequencing
US6632645B1 (en) 2000-03-02 2003-10-14 Promega Corporation Thermophilic DNA polymerases from Thermoactinomyces vulgaris
JP3442338B2 (en) 2000-03-17 2003-09-02 株式会社日立製作所 DNA analyzer, DNA base sequencer, DNA base sequence determination method, and reaction module
WO2001075154A2 (en) 2000-04-03 2001-10-11 Axaron Bioscience Ag Novel method for the parallel sequencing of a nucleic acid mixture on a surface
US6436641B1 (en) 2000-04-17 2002-08-20 Visible Genetics Inc. Method and apparatus for DNA sequencing
AU2001270504A1 (en) 2000-05-04 2001-11-12 Syngenta Participations Ag Novel assay for nucleic acid analysis
US6342326B1 (en) 2000-05-10 2002-01-29 Beckman Coulter, Inc. Synthesis and use of acyl fluorides of cyanine dyes
AU2001262284A1 (en) 2000-05-12 2001-11-20 Gnothis Holding Sa Method for detecting polynucleotides using fluorescence correlation spectroscopy
GB0013276D0 (en) 2000-06-01 2000-07-26 Amersham Pharm Biotech Uk Ltd Nucleotide analogues
US20020168678A1 (en) 2000-06-07 2002-11-14 Li-Cor, Inc. Flowcell system for nucleic acid sequencing
US6869764B2 (en) 2000-06-07 2005-03-22 L--Cor, Inc. Nucleic acid sequencing using charge-switch nucleotides
ATE423221T1 (en) 2000-06-13 2009-03-15 Univ Boston USE OF MASS-MATCHED NUCLEOTIDES IN THE ANALYSIS OF OLIGONUCLEOTIDE MIXTURES AND IN HIGH-MULTIPLEX NUCLEIC ACID SEQUENCING
US6829753B2 (en) 2000-06-27 2004-12-07 Fluidigm Corporation Microfluidic design automation method and system
DE10031842A1 (en) 2000-06-30 2002-01-31 Gnothis Holding Sa Ecublens Multiplex sequencing method
GB0016258D0 (en) 2000-07-03 2000-08-23 Amersham Pharm Biotech Uk Ltd Base analogues
GB0016473D0 (en) 2000-07-05 2000-08-23 Amersham Pharm Biotech Uk Ltd Sequencing method
GB0016472D0 (en) 2000-07-05 2000-08-23 Amersham Pharm Biotech Uk Ltd Sequencing method and apparatus
CN101525660A (en) * 2000-07-07 2009-09-09 维西根生物技术公司 An instant sequencing methodology
US20030017461A1 (en) 2000-07-11 2003-01-23 Aclara Biosciences, Inc. Tag cleavage for detection of nucleic acids
US6397150B1 (en) 2000-07-27 2002-05-28 Visible Genetics Inc. Method and apparatus for sequencing of DNA using an internal calibrant
JP2004512533A (en) 2000-08-22 2004-04-22 アフィメトリックス インコーポレイテッド Systems, methods and computer software products for controlling biological microarray scanners
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
GB0022069D0 (en) 2000-09-08 2000-10-25 Pyrosequencing Ab Method
US6627748B1 (en) 2000-09-11 2003-09-30 The Trustees Of Columbia University In The City Of New York Combinatorial fluorescence energy transfer tags and their applications for multiplex genetic analyses
JP3638516B2 (en) 2000-09-28 2005-04-13 株式会社日立製作所 Nucleic acid detection method and nucleic acid detection kit
US6835537B1 (en) 2000-09-29 2004-12-28 Myriad Genetics, Inc. Method for equalizing band intensities on sequencing gels
US7258774B2 (en) 2000-10-03 2007-08-21 California Institute Of Technology Microfluidic devices and methods of use
AU2001296645A1 (en) 2000-10-06 2002-04-15 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
WO2002029113A2 (en) * 2000-10-06 2002-04-11 Novozymes Biotech, Inc. Methods for monitoring multiple gene expression
AU1189702A (en) 2000-10-13 2002-04-22 Fluidigm Corp Microfluidic device based sample injection system for analytical devices
US6448407B1 (en) 2000-11-01 2002-09-10 Pe Corporation (Ny) Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
US20020115092A1 (en) 2000-11-08 2002-08-22 The Scripps Research Institute Energy transfer labels with mechanically linked fluorophores
US6770472B2 (en) 2000-11-17 2004-08-03 The Board Of Trustees Of The Leland Stanford Junior University Direct DNA sequencing with a transcription protein and a nanometer scale electrometer
AU2002217784A1 (en) 2000-11-28 2002-06-11 Promega Corporation Purification of dna sequencing reactions using silica magnetic particles
WO2002055997A2 (en) 2001-01-12 2002-07-18 Karolinska Innovations Ab Substrate for fluorescence analysis
US20020197618A1 (en) 2001-01-20 2002-12-26 Sampson Jeffrey R. Synthesis and amplification of unstructured nucleic acids for rapid sequencing
US20020102595A1 (en) 2001-01-29 2002-08-01 Davis Lloyd Mervyn Methods for detection of incorporation of a nucleotide onto a nucleic acid primer
AU2002231934A1 (en) 2001-01-30 2002-08-12 Solexa Ltd. Arrayed polynucleotides and their use in genome analysis
US7026163B1 (en) 2001-02-23 2006-04-11 Mayo Foundation For Medical Education And Research Sulfotransferase sequence variants
CA2440615A1 (en) 2001-03-12 2002-09-19 Affymetrix, Inc. Nucleic acid labeling compounds
CA2440754A1 (en) 2001-03-12 2002-09-19 Stephen Quake Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
US20040038206A1 (en) * 2001-03-14 2004-02-26 Jia Zhang Method for high throughput assay of genetic analysis
DE10115309A1 (en) 2001-03-28 2002-10-02 Gnothis Holding Sa Ecublens Microscope arrangement for fluorescence spectroscopy, in particular fluorescence correlation spectroscopy
US20030027140A1 (en) 2001-03-30 2003-02-06 Jingyue Ju High-fidelity DNA sequencing using solid phase capturable dideoxynucleotides and mass spectrometry
DE10120798B4 (en) 2001-04-27 2005-12-29 Genovoxx Gmbh Method for determining gene expression
DE10120797B4 (en) 2001-04-27 2005-12-22 Genovoxx Gmbh Method for analyzing nucleic acid chains
CN1384203A (en) 2001-04-30 2002-12-11 香港科技创业股份有限公司 Low temperature circulating DNA extending reaction method with high extension specificity
US20020172948A1 (en) 2001-05-04 2002-11-21 Perlin Mark W. Method and system for nucleic acid sequencing
US20030211486A1 (en) 2001-05-25 2003-11-13 Frudakis Tony N. Compositions and methods for detecting polymorphisms associated with pigmentation
US20050260570A1 (en) 2001-05-29 2005-11-24 Mao Jen-I Sequencing by proxy
US7118907B2 (en) 2001-06-06 2006-10-10 Li-Cor, Inc. Single molecule detection systems and methods
US6689478B2 (en) * 2001-06-21 2004-02-10 Corning Incorporated Polyanion/polycation multilayer film for DNA immobilization
US6613523B2 (en) 2001-06-29 2003-09-02 Agilent Technologies, Inc. Method of DNA sequencing using cleavable tags
GB0119719D0 (en) 2001-08-13 2001-10-03 Solexa Ltd DNA sequence analysis
US7172865B2 (en) * 2001-08-13 2007-02-06 Saint Louis University Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
US6995841B2 (en) 2001-08-28 2006-02-07 Rice University Pulsed-multiline excitation for color-blind fluorescence detection
WO2003020968A2 (en) * 2001-08-29 2003-03-13 Genovoxx Gmbh Method for analyzing nucleic acid sequences and gene expression
US7223541B2 (en) 2001-08-29 2007-05-29 Ge Healthcare Bio-Sciences Corp. Terminal-phosphate-labeled nucleotides and methods of use
US20030104386A1 (en) 2001-08-31 2003-06-05 The Regents Of The University Of California Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing
DE60223276T2 (en) * 2001-08-31 2008-08-14 Datascope Investment Corp. Method for blocking nonspecific hybridizations of nucleic acid sequences
US6852492B2 (en) 2001-09-24 2005-02-08 Intel Corporation Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
US6975943B2 (en) 2001-09-24 2005-12-13 Seqwright, Inc. Clone-array pooled shotgun strategy for nucleic acid sequencing
US6982165B2 (en) 2001-09-24 2006-01-03 Intel Corporation Nucleic acid sequencing by raman monitoring of molecular deconstruction
DE10246005A1 (en) 2001-10-04 2003-04-30 Genovoxx Gmbh Automated nucleic acid sequencer, useful e.g. for analyzing gene expression, based on parallel incorporation of fluorescently labeled terminating nucleotides
US7406385B2 (en) * 2001-10-25 2008-07-29 Applera Corporation System and method for consensus-calling with per-base quality values for sample assemblies
US20040054162A1 (en) 2001-10-30 2004-03-18 Hanna Michelle M. Molecular detection systems utilizing reiterative oligonucleotide synthesis
WO2003044678A1 (en) 2001-11-22 2003-05-30 Hitachi, Ltd. Data processing system using base sequence-related data
JP4163622B2 (en) 2001-11-22 2008-10-08 株式会社日立製作所 Information processing method, information processing apparatus, information processing program, and recording medium on which information processing program is recorded
GB0128526D0 (en) 2001-11-29 2002-01-23 Amersham Pharm Biotech Uk Ltd Nucleotide analogues
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
GB0200938D0 (en) 2002-01-16 2002-03-06 Solexa Ltd Prism design for scanning applications
US7211382B2 (en) 2002-04-09 2007-05-01 Orchid Cellmark Inc. Primer extension using modified nucleotides
EP1497304B1 (en) * 2002-04-12 2014-06-25 Catalyst Assets LLC Dual-labeled nucleotides
US7108976B2 (en) 2002-06-17 2006-09-19 Affymetrix, Inc. Complexity management of genomic DNA by locus specific amplification
DE10256898B4 (en) 2002-11-29 2006-01-12 Senslab-Gesellschaft Zur Entwicklung Und Herstellung Bioelektrochemischer Sensoren Mbh Electrochemical detection of nucleic acids
US6855503B2 (en) * 2002-12-20 2005-02-15 Amersham Biosciences Corp Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing
US8676383B2 (en) 2002-12-23 2014-03-18 Applied Biosystems, Llc Device for carrying out chemical or biological reactions
US6977153B2 (en) 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
WO2004074503A2 (en) 2003-02-21 2004-09-02 Hoser Mark J Nucleic acid sequencing methods, kits and reagents
AU2004214891B2 (en) 2003-02-26 2010-01-07 Complete Genomics, Inc. Random array DNA analysis by hybridization
US20050170367A1 (en) * 2003-06-10 2005-08-04 Quake Stephen R. Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids
US7169560B2 (en) * 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
GB0400584D0 (en) * 2004-01-12 2004-02-11 Solexa Ltd Nucleic acid chacterisation
EP2248911A1 (en) 2004-02-19 2010-11-10 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20050239085A1 (en) 2004-04-23 2005-10-27 Buzby Philip R Methods for nucleic acid sequence determination
US7492462B2 (en) * 2006-01-17 2009-02-17 Honeywell International, Inc. Optochemical sensor
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP1692312A4 *

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10208341B2 (en) 1998-05-01 2019-02-19 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9957561B2 (en) 1998-05-01 2018-05-01 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9458500B2 (en) 1998-05-01 2016-10-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10214774B2 (en) 1998-05-01 2019-02-26 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9725764B2 (en) 1998-05-01 2017-08-08 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9212393B2 (en) 1998-05-01 2015-12-15 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9845500B2 (en) 2000-12-01 2017-12-19 Life Technologies Corporation Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
US7910304B2 (en) 2003-02-26 2011-03-22 Callida Genomics, Inc. Random array DNA analysis by hybridization
US7906285B2 (en) 2003-02-26 2011-03-15 Callida Genomics, Inc. Random array DNA analysis by hybridization
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9657344B2 (en) 2003-11-12 2017-05-23 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
US9944984B2 (en) 2005-06-15 2018-04-17 Complete Genomics, Inc. High density DNA array
US10351909B2 (en) 2005-06-15 2019-07-16 Complete Genomics, Inc. DNA sequencing from high density DNA arrays using asynchronous reactions
US11414702B2 (en) 2005-06-15 2022-08-16 Complete Genomics, Inc. Nucleic acid analysis by random mixtures of non-overlapping fragments
US9637784B2 (en) 2005-06-15 2017-05-02 Complete Genomics, Inc. Methods for DNA sequencing and analysis using multiple tiers of aliquots
US9637785B2 (en) 2005-06-15 2017-05-02 Complete Genomics, Inc. Tagged fragment library configured for genome or cDNA sequence analysis
US9650673B2 (en) 2005-06-15 2017-05-16 Complete Genomics, Inc. Single molecule arrays for genetic and chemical analysis
US10125392B2 (en) 2005-06-15 2018-11-13 Complete Genomics, Inc. Preparing a DNA fragment library for sequencing using tagged primers
US7709197B2 (en) 2005-06-15 2010-05-04 Callida Genomics, Inc. Nucleic acid analysis by random mixtures of non-overlapping fragments
WO2007014397A2 (en) * 2005-07-28 2007-02-01 Helicos Biosciences Corporation Consecutive base single molecule sequencing
WO2007014397A3 (en) * 2005-07-28 2007-09-13 Helicos Biosciences Corp Consecutive base single molecule sequencing
US9868978B2 (en) 2005-08-26 2018-01-16 Fluidigm Corporation Single molecule sequencing of captured nucleic acids
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US9267172B2 (en) 2007-11-05 2016-02-23 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US11389779B2 (en) 2007-12-05 2022-07-19 Complete Genomics, Inc. Methods of preparing a library of nucleic acid fragments tagged with oligonucleotide bar code sequences
US10662473B2 (en) 2008-01-28 2020-05-26 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US9222132B2 (en) 2008-01-28 2015-12-29 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US9523125B2 (en) 2008-01-28 2016-12-20 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US11098356B2 (en) 2008-01-28 2021-08-24 Complete Genomics, Inc. Methods and compositions for nucleic acid sequencing
US11214832B2 (en) 2008-01-28 2022-01-04 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
EP3045542B1 (en) 2008-03-28 2016-11-16 Pacific Biosciences of California, Inc. Methods for nucleic acid sequencing
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data

Also Published As

Publication number Publication date
US9012144B2 (en) 2015-04-21
US20110245086A1 (en) 2011-10-06
US9657344B2 (en) 2017-05-23
US20150292008A1 (en) 2015-10-15
US7491498B2 (en) 2009-02-17
US7897345B2 (en) 2011-03-01
US20050100932A1 (en) 2005-05-12
US20070122828A1 (en) 2007-05-31
US7169560B2 (en) 2007-01-30
US20090191565A1 (en) 2009-07-30
US20110151449A1 (en) 2011-06-23
EP1692312A2 (en) 2006-08-23
US20110152114A1 (en) 2011-06-23
EP1692312A4 (en) 2007-10-17
WO2005047523A3 (en) 2005-12-22
CA2545619A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
US7169560B2 (en) Short cycle methods for sequencing polynucleotides
US11643684B2 (en) Conformational probes and methods for sequencing nucleic acids
US20080287306A1 (en) Methods and devices for sequencing nucleic acids
US6087095A (en) DNA sequencing method
JP2006517798A (en) Methods and means for nucleic acid sequences
GB2398301A (en) A DNA molecule consisting of a stem portion and first and second loop portions
JP2004537257A (en) Methods and probes for detecting and / or quantifying nucleic acid sequences
US20070031875A1 (en) Signal pattern compositions and methods
AU2006219698A1 (en) Method for improving the characterisation of a polynucleotide sequence
US20100190151A1 (en) Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids
US20100190168A1 (en) Competitor molecules useful for lowering nonspecific adsorption of dye labeled nucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2545619

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004810723

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004810723

Country of ref document: EP